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Background: There is a widely held assumption that research engagement improves health-care
performance at various levels, but little direct empirical evidence.
Objectives: To conduct a theoretically and empirically grounded synthesis to map and explore plausible
mechanisms through which research engagement might improve health services performance. A review of
the effects on patients of their health-care practitioner's or institution's participation in clinical trials was
published after submission of the proposal for this review. It identiﬁed only 13 relevant papers and, overall,
suggested that the evidence that research engagement improves health-care performance was less strong
than some thought. We aimed to meet the need for a wider review.
Methods: An hourglass review was developed, consisting of three stages: (1) a planning and mapping
stage; (2) a focused review concentrating on the core question of whether or not research engagement
improves health care; and (3) a wider (but less systematic) review of papers identiﬁed during the two
earlier stages. Studies were included in the focused review if the concept of ‘engagement in research’ was
an input and some measure of ‘performance’ an output. The search strategy covered the period 1990 to
March 2012. MEDLINE, EMBASE, PsycINFO, Cumulative Index to Nursing and Allied Health Literature
(CINAHL), Web of Science and other relevant databases were searched. A total of 10,239 papers were
identiﬁed through the database searches, and 159 from other sources. A further relevance and quality
check on 473 papers was undertaken, and identiﬁed 33 papers for inclusion in the review. A standard
meta-analysis was not possible on the heterogeneous mix of papers in the focused review. Therefore an
explanatory matrix was developed to help characterise the circumstances in which research engagement
might improve health-care performance and the mechanisms that might be at work, identifying two main
dimensions along which to categorise the studies: the degree of intentionality and the scope of the impact.
Results: Of the 33 papers in the focused review, 28 were positive (of which six were positive/mixed) in
relation to the question of whether or not research engagement improves health-care performance. Five
papers were negative (of which two were negative/mixed). Seven out of 28 positive papers reported some
improvement in health outcomes. For the rest, the improved care took the form of improved processes of
care. Nine positive papers were at a clinician level and 19 at an institutional level. The wider review
demonstrated, for example, how collaborative and action research can encourage some progress along the
pathway from research engagement towards improved health-care performance. There is also evidence
that organisations in which the research function is fully integrated into the organisational structure
out-perform other organisations that pay less formal heed to research and its outputs. The focused and
wider reviews identiﬁed the diversity in the mechanisms through which research engagement might
improve health care: there are many circumstances and mechanisms at work, more than one mechanism is
often operative, and the evidence available for each one is limited.v
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ABSTRACT
viLimitations: To address the complexities of this evidence synthesis of research we needed to spend
signiﬁcant time mapping the literature, and narrowed the research question to make it feasible. We
excluded many potentially relevant papers (though we partially addressed this by conducting a wider
additional synthesis). Studies assessing the impact made on clinician behaviour by small, locally conducted
pieces of research could be difﬁcult to interpret without full knowledge of the context.
Conclusions: Drawing on the focused and wider reviews, it is suggested that when clinicians and
health-care organisations engage in research there is the likelihood of a positive impact on health-care
performance. Organisations that have deliberately integrated the research function into organisational
structures demonstrate how research engagement can, among other factors, contribute to improved
health-care performance. Further explorations are required of research networks and schemes to promote
the engagement of clinicians and managers in research. Detailed observational research focusing on
research engagement within organisations would build up an understanding of mechanisms.
Study registration: PROSPERO: CRD42012001990.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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This review responds to a 2010 call, by the National Institute for Health Research (NIHR) Service Delivery
and Organisation (SDO) programme, for a theoretically and empirically grounded synthesis to map and
explore plausible mechanisms through which research engagement might improve health services
performance at clinician, team, service or organisational levels. There is a widely held assumption that
research engagement improves health-care performance at various levels, but little direct empirical
evidence had been collated prior to this review to support this assumption.Objectives
In scoping the review, much depended on how key phrases such as ‘research engagement’, ‘engagement
in research’, ‘performance’, and ‘mechanisms’ were interpreted. Driving the invitation to tender (ITT) was a
concern to improve understanding of the impact of engagement in health research. With this in mind,
‘engagement in research’ was taken to mean a deliberate set of intellectual and practical activities
undertaken by health-care staff (including conducting research and playing an active role in the whole
research cycle) and organisations (including playing an active role in research networks, partnerships or
collaborations and ensuring the research function is fully integrated into organisational structures).
‘Performance’ reﬂected the consequences of clinical activity, and was therefore primarily taken to mean
improvements in the processes and outcomes of care, rather than other measures of performance such as
efﬁciency. ‘Mechanisms’ were seen in relatively simple terms as levers that instigate and sustain activity,
for example, research collaborations between researchers and health-care staff who are potential users of
the ﬁndings.
One important inﬂuence was an earlier review of the effects on patients of their health-care practitioner's
or institution's participation in clinical trials, published after the proposal for this review had been
submitted. This identiﬁed 13 relevant papers, and, overall, suggested that the evidence that research
engagement improves health-care performance was less strong than some thought. This evidence
synthesis updates that earlier review, drawing on more recently published literature and including other
types of research engagement than just participation in clinical trials.
This evidence synthesis also explores what the literature can tell us about the mechanisms involved in
promoting research engagement. To facilitate detailed analysis, a matrix was developed to characterise the
circumstances in which research engagement might improve health-care performance and the mechanisms
that might be at work, identifying two main dimensions along which to categorise the studies. These were
the degree of intentionality and the scope of the impact.
Least intentionality is when the improvement in health-care performance resulting from engagement in
research is a by-product of research that is conducted with the primary aim of testing a speciﬁc therapy or
approach. Research networks are broadly in the middle of this spectrum, and greatest intentionality is
when there is an explicit intention to produce improvements in health-care performance as a direct
consequence of research engagement by health-care staff through interventions such as collaborations,
participatory research, and/or organisational approaches. Broader impact refers to those who have
engaged in research becoming more willing and/or able to provide evidence-based care that is not related
to the speciﬁc ﬁndings of the research on which they are engaged. Speciﬁc impact refers to those who
have engaged in research becoming more willing and/or able to provide evidence-based care that is
related to the speciﬁc ﬁndings of the research on which they are engaged.xi
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SCIENTIFIC SUMMARY
xiiMethodsThe hourglass review
Responding to the challenges presented by the review question, an innovative approach was developed.
This approach, named an hourglass review, consisted of three stages. The ﬁrst stage involved a broad
mapping exercise exploring a large number of bodies of literature that might contain empirical evidence
relating to the question and any mechanisms and theoretical perspectives that might be relevant. The
second stage was a focused (or formal) review that concentrated on the core question of whether or not
research engagement improves health care. The ﬁnal stage involved a wider (but less systematic) review of
papers identiﬁed during the two earlier stages that were relevant to the review question. This stage
included many papers that did not meet the inclusion criteria for the focused review.
The hourglass shape refers to the scope of the analysis at each stage, and to the number of papers
considered in detail; in terms of the volume of titles and abstracts processed, the throughput of the review
was greatest in the second stage.Stage 1: Planning and mapping
For this exercise the team drew on existing knowledge, initial scans of the literature, team meetings and
brainstorming sessions, and consultation with the advisory group. This helped inform the search terms for
the next stage. Many theoretical perspectives were also identiﬁed, and the selection of ones to inform the
matrix development was strongly inﬂuenced by the decision after the initial broad exploration that the
review should focus on the term ‘engagement in research’ and not additionally include the wider term
‘engagement with research’. This meant that theories were selected, such as collaborative research
theories, which related to research processes but not just research utilisation.Stage 2: Focused reviewSearch strategy
This was developed by members of the review team and an information scientist. It involved a
comprehensive search of as many of the relevant databases as time allowed and sought to identify
empirical research studies covering a whole range of research approaches – quantitative and qualitative
(i.e. not limited to clinical trials). The search sought to identify studies where the concept of ‘engagement
in research’ was an input and some measure of ‘performance’ was an output, and the initial broad
interpretation of these terms tightened as the review progressed. The search strategy covered the period
1990 to March 2012. MEDLINE, EMBASE, PsycINFO, Cumulative Index to Nursing and Allied Health
Literature (CINAHL), Web of Science, Applied Social Sciences Index and Abstracts (ASSIA), British Nursing
Index, Health Management Information Consortium (HMIC) and System for Information on Grey Literature
in Europe (SIGLE) databases were searched. The database searches were supplemented by hand-searching
ﬁve journals that specialise in this area, by papers suggested by the advisory group, and by snowballing. To
address the likely bias towards the publication of studies with positive results, a search of the grey
literature was conducted and key authors in the ﬁeld were contacted to identify unpublished literature.
The database searches identiﬁed 10,239 papers, and 159 were identiﬁed from other sources. The focused
review involved an initial examination of the title of each paper (and the abstract when the title provided
too little detail) to exclude documents that were clearly not relevant. As a second step, two or more
reviewers studied the titles and full abstracts in greater depth to assess the eligibility of each paper. A
further relevance and quality check on 473 papers was undertaken to determine whether or not they were
suitable to proceed to the data extraction stage. Determining the inclusion criteria at this third step was
complicated because the relationship between research engagement and improved health care had to be
demonstrated in some way, and preferably in a way that allowed some measure of control in the study.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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An abbreviated version of the ﬁnal inclusion criteria is presented below:
(a) includes empirical data
(b) explicitly includes engagement in research in any way including
– agenda setting
– conducting research
– action research
– research networks where the research involvement is noted(c) includes assessment of health-care processes/outcomes (for example, use of clinical guidelines).Analysis
A heterogeneous mix of material was identiﬁed and a standard meta-analysis was not possible. A detailed
data extraction sheet was completed for each paper and key aspects of the included studies were collated
in a table. Using the matrix, each paper that reached the ﬁnal data extraction step was also analysed in
relation to:
l Importance of the paper to the review. This was based on quality (especially how well controlled the study
was), size of the study, and relevance to the review question – a necessary feature because a number of
papers contained information of relevance to the review, but not as the main focus of the paper.
l Whether the ﬁndings of the paper were positive or negative in relation to the review question (i.e.
positive if they showed research engagement did improve health care, and negative if not). Within
each group some were also classiﬁed as mixed.
l The degree of intentionality of the link between research engagement and health-care performance
(by-product, research network, or intervention).
l The scope of the impact made by research engagement (broader impact/speciﬁc impact).
l The level of engagement discussed (clinician or organisational).Stage 3: Wider review
The informal wider review was intended, in particular, to facilitate an exploration of the mechanisms. The
additional papers included at this stage were the most relevant for the analysis of all 440 papers excluded
from the ﬁnal step of the focused review, with the addition of relevant papers identiﬁed during the
mapping stage and the ongoing snowballing exercises. Relevance was determined in relation to theories
and mechanisms.ResultsResults on the main question from the focused review
Thirty-three papers were included in the focused review. Twenty-eight papers were positive (of which six
were positive/mixed) in relation to the question of whether or not research engagement improves health-
care performance. Five were negative (of which two were negative/mixed). Seven of the 28 positive papers
reported some improvement in health outcomes; the rest reported improved care in the form of improved
(usually more evidence-based) processes of care.
Twenty-one of these 33 papers came into the ‘by-product’ category of least intentionality, and this
included all 12 of the 13 papers from the earlier review included in this evidence synthesis. The more
recent and wider search therefore produced an additional nine papers in this category. By including papers
in the other categories of mid and greatest intentionality (research networks and deliberate interventions
such as collaborations) the total number of papers was increased by a further 12, with eight being in
network category. All eight were classiﬁed as being positive, or positive/mixed, as were three of the four
intervention studies.xiii
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xivThe earlier review examined two levels of health-care performance: practitioners and institutions. In this
review 11 papers were at the clinician level and 22 studies were at higher levels, collectively described as
the institutional level. Of the 28 positive papers, 19 were institutional and nine clinician level. Of the ﬁve
negative papers, three were institutional and two clinician level.
Thus, the focused review collated more evidence than had previously been brought together on the
question of whether or not research engagement improves health-care performance, and it was generally
positive, but not easy to interpret.Results from the focused and wider reviews on the analysis of mechanisms
and the role of organisations
The mechanisms identiﬁed in the focused review papers provided a starting point for an analysis of issues
associated with engagement in research, including enhanced clinician attitudes towards research, trust in
speciﬁc ﬁndings, and improved protocols and infrastructure. This analysis was supplemented by the wider
review which provided further empirical and descriptive studies, theoretical analyses and previous reviews
that were relevant. For example, in the network category the wider range of papers included negative
ones, and studies from outside the USA, and allowed a fuller analysis of the mechanisms associated with
such networks. In the highest category of intention only four papers were included in the focused review,
but others from the wider review demonstrated how collaborative or action research can encourage
progress along the pathway from research engagement towards improved health-care performance by
involving potential users in some aspects of the whole research process.
Health-care organisations and systems provide the context within which research engagement operates at
other levels. The studies in the wider review provided cumulative evidence that organisations in which the
research function is fully integrated into the organisational structure can out-perform other organisations
that pay less formal heed to research and its outputs. However, at this organisational level, as at other
levels, engagement in research is only one of many inﬂuences on performance. Disaggregating how these
mechanisms operate in complex systems is not straightforward.Conclusions
l Drawing on the focused review (especially using the by-product and network categories from the
matrix) the review suggests that when clinicians and health-care organisations engage in research there
is the likelihood of a positive impact on health-care performance. However, this is more likely to be
demonstrated through improved health-care processes than through improved patient outcomes.
l There is considerable diversity in the mechanisms through which research engagement might improve
health care: there are many circumstances and mechanisms at work, more than one mechanism is
often operative, and their effectiveness depends on the context in which they operate. The evidence
available for each one is limited. This limits the immediate implications for practice.
l Generally, at lower levels of intentionality (where improved health-care performance is a by-product of
a research study) a series of one-off studies were identiﬁed in which a diversity of detailed mechanisms
was considered. At higher levels of intentionality (e.g. networks and collaborations) mechanisms were
more established and research processes themselves became an increasingly important means through
which research engagement can improve health-care performance.
l The number of research networks is growing, and these new structures continue to develop and
evolve. The contribution of collaborative approaches to research is also developing.
l At an organisational level, the mechanisms through which research engagement promotes
performance improvement are often only one facet within a wider, multipronged change strategy.
Organisations that have deliberately integrated the research function into organisational structures
demonstrate how research engagement can, among other factors, contribute to improvement in
health-care performance.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8Recommendations for research
1. Further explorations of how particular mechanisms promote research engagement. Evaluations of
research networks and of schemes to promote the engagement of clinicians and managers in research
would be particularly valuable.
2. Detailed observational research focusing on research engagement within organisations, to build
understanding of mechanisms, and to explore potentially negative impacts of research engagement
alongside beneﬁts.
3. Organisation-wide interventions designed to promote research engagement also require further
research. There are signiﬁcant methodological challenges in conducting evaluations of these complex
interventions and a need for methodological development to improve evaluations of how different
mechanisms operate in complex systems.
4. Scoping exercise to identify possibilities of using large databases of research production and
hospital performance.
5. There is a role for social theory in developing and understanding the role of research engagement in
promoting health-care improvement.Study registration
This study is registered as PROSPERO CRD42012001990.Funding
The National Institute for Health Research Health Services and Delivery Research programme.xv
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DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8Chapter 1 BackgroundThe research questionThis evidence synthesis responds to a call by the National Institute for Health Research (NIHR) Service
Delivery and Organisation (SDO) programme in 2010 that requested a synthesis ‘which maps and explores
the likely or plausible mechanisms through which research engagement might bear on wider performance
at clinician, team, service or organisational levels’.1 The invitation to tender (ITT) called for a review of the
relevant research literature to see what empirical support exists for any theoretical mechanisms, and
stated that ‘A theoretically and empirically grounded assessment of the relationships, if any, between
research engagement and performance should explore issues of causation’.1 These statements led us
originally to formulate the research question we intended to address in this review as follows: Engagement
in research: does it improve performance at a clinician, team, service and organisational level in
health-care organisations?
We found there was a widely held assumption that research engagement improved health-care
performance at the various levels, as, for example, expressed in the 2010 White Paper, Equity and
excellence: liberating the NHS2 and in a 2010 brieﬁng from the NHS Confederation.3 The brieﬁng reported
possible explanations, expert comments and some evidence to support this view, including reference to
the web site of the Association of UK University Hospitals (AUKUH) which had issued a press release
showing that university hospitals on average did better than non-AUKUH hospitals in the quality of service
scores produced by the Care Quality Commission.4 However, this AUKUH analysis was very brief and did
not take into account other possible factors. In practice, in our early explorations at the time of the ITT in
mid-2010, we could identify very little direct empirical evidence to support this assumption. Nevertheless,
we identiﬁed diverse bodies of knowledge that we thought might help to address the question.
Given these circumstances, we knew that this review would not be straightforward and that we would
have to think constructively about both its scope and our methodological approach as we explored the
ﬁeld, making revisions to our proposed approach where needed. These changes are discussed in more
detail in Chapter 3. Below we set out the interpretation we put on key terms, the scope of the study we
eventually conducted, and provide a brief guide to the contents of the remainder of this report.Interpretation of key termsWe started the overall evidence synthesis by making the initial scoping, planning and mapping stage as
wide as possible in an attempt to maximise our chances of capturing any coherent bodies of empirical
evidence relating to the question or to any mechanisms that might be relevant. This wide scope also
included our initial interpretations of the terms ‘research engagement’, ‘engagement in research’,
‘performance’ and ‘mechanisms’ that had been used in the ITT.‘Research engagement’ and ‘engagement in research’
In line with discussions about reforms to health research systems which illustrated the Government's
desire to involve the health-care system in research,5 we initially interpreted the term ‘research
engagement’ broadly. We also recognised the need to look for both positive and negative impacts of
research engagement.
Driving this ITT was a concern to improve understanding of the impact on health-care performance of
engagement in research. With this in mind, we took ‘engagement in research’ to mean a deliberate set of1
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2intellectual and practical activities undertaken by health-care staff and organisations. These include
the following:
(a) Health-care staff (as individual clinicians and as teams):
¢ being involved in actively undertaking research studies
¢ playing an active role within the whole research cycle, including research design
and commissioning
¢ undertaking research training for a research degree
¢ playing an active role in research networks, partnerships or collaborations.
(b) Health-care services and organisations:
¢ supporting health-care staff in the activities outlined in (a) above
¢ playing an active role in research networks, partnerships or collaborations, either internally (within
the particular service or organisation) or externally (with other organisations and researchers).The ITT explicitly and prominently highlighted the literature on engagement in medical leadership as being
a different but related domain to that of research engagement, implying, we assumed, that it might
potentially make an important contribution to the requested evidence synthesis. Our interpretation of
‘engagement in research’ as an active process undertaken by health-care staff ties in with the literature on
medical/workforce engagement and impact on performance.6–9 For example, Bakker8 deﬁnes work
engagement as a ‘positive, fulﬁlling, work-related state of mind that is characterised by vigour, dedication,
and absorption’ (p. 51).
In a recent paper relating medical engagement to organisational performance, Spurgeon et al.9 talk about
‘the active and positive contribution of doctors within their normal working roles to maintaining and
enhancing the performance of the organisation which itself recognises this commitment in supporting and
encouraging high quality care’ (p. 115) (our italics). Thus, health-care services and organisations also have
an active role to play. The relation between workforce engagement and performance is dependent on a
symbiosis between organisations and those who work within them.10,11 This organisational support and
encouragement is a two-way process involving organisations working to engage employees and the latter
having a degree of choice as to their response.12,13
Although such insights were helpful, the literature on medical/workplace engagement did not, as we
initially hoped, prove a fruitful source of empirical ﬁndings on our own narrower question. There were two
main reasons. First, ‘engagement’ is a complex term that means different things to different people. It is
variously interpreted in the literature and there is no universal deﬁnition:13 this can impede the
identiﬁcation and interpretation of empirical ﬁndings. Thus, while many authorities advocate physician
engagement as the key to organisational performance,14 a common theme in papers discussing this issue
is that there is limited empirical evidence about the positive impact of enhanced medical engagement on
organisational performance,7,9,15 although it has been demonstrated that lack of engagement presents
signiﬁcant problems in the organisational pursuit of change and improvement.7 Spurgeon et al.9
summarise the current position, describing ‘engagement’ as a multifaceted construct whose complexity
has probably contributed to the lack of clarity in understanding the links between levels of
engagement and performance. This study did ﬁnd a correlation between medical engagement and
service improvement.
Second, the literature on medical/workplace engagement takes little heed of research activity as a factor
in improving performance, and the ability to ‘engage in research’ (however deﬁned) is not seen as one
of the core competencies in medical professionalism. Thus, it is claimed that there ‘is increasing
acknowledgement by the medical profession that doctors need to be competent managers and leaders
at all stages of their careers’ (p. 3) (our italics) but engagement in research as a possible part of thoseNIHR Journals Library www.journalslibrary.nihr.ac.uk
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skills required to enable doctors to function efﬁciently and effectively within complex systems and quote
Tooke's16 view that ‘the doctor's role as diagnostician and the handler of clinical uncertainty and ambiguity
requires a profound educational base in science and evidence-based practice (EBP) as well as research
awareness’ (p. 17). Tooke's16 insight is conﬁrmed by others. In a broad ranging discussion of the changing
nature of medical professionalism in the context of practice innovation, Mechanic17 talks about ‘practicing
in an evidence-based way that acknowledges and takes account of current medical research and
understanding’ (p. 329). However, there is no discussion in these key papers (or to our knowledge in the
medical engagement literature more generally) of what this research awareness is or should be, of how it
is to be achieved and maintained, or how it might (in the context of medical engagement more generally)
be a factor that contributes to improved performance.
In this context we note that the terms ‘engagement in research’ and ‘engagement with research’ are
sometimes used interchangeably in the literature. Given this, it seemed relevant at the start of our review
to explore how far a broader deﬁnition of research engagement could also include engagement with
research, taking this term to mean a less substantial involvement at individual and team level related more
to receiving and transmitting the ﬁndings of research. It could therefore include aspects of activities such
as continuing medical education (CME) and knowledge mobilisation, which often focus on encouraging
research utilisation alone, and not on research utilisation as an integral phase in the whole research cycle.
This is an important distinction between ‘engagement with research’ and ‘engagement in research’, and
since our brief was to explore the whole pathway from research engagement to performance we ﬁnally
decided to concentrate our resources primarily on the interpretation of research engagement as
‘engagement in research’ in the sense given above.‘Performance’
In health care, the case for the universal measurement of clinical and organisational performance is well
established,18 but the speciﬁc nature of performance measurement is a contested topic and there is no
neat prescription for the design of performance measurement systems in the NHS, or more generally.19 A
wide range of measures has been used: ‘there exists, for any organisation, a range of possible measures.
This is true especially of health care, with measures of clinical process, health outcomes, access, efﬁciency,
productivity and employee variables all offering some potential’ (p. 107).20
Complicating the picture further, Mannion et al.21 suggest that different channels of communication may
convey different performance information.
A variety of systems to assess aspects of NHS performance have been used in recent years – including the
star rating system for NHS trusts, clinical governance reviews, National Service Framework reviews, national
and local audits, performance monitoring by strategic health authorities, and Quality Accounts.21,22
Reﬂecting the origins of performance measurement in industry, much of the literature on health-care
performance initially focused on health-care organisations and on their use of measures of activity and
cost.23 Over time health-care organisations' need to demonstrate clinical quality as well as efﬁciency24,25 led
to the development of measures of clinical output and outcome and a move to a balanced scorecard
approach.23 Within the context of the 2008 Darzi review,26 and subsequent Government White Papers,2 in
the NHS in England this emphasis on the measurement of the quality of care delivered has continued. The
development of clinical audit has also focused attention on the measurement of clinical performance
against measures of clinical process and health outcome. In some clinical ﬁelds in the NHS in England,
clinical audit is now mandatory and the participation of health-care organisations in these clinical audits is
monitored through the Quality Accounts that NHS health-care providers are required to produce annually.
Despite all these changes there has, until the relatively late arrival in 2010 of the Quality Accounts, been a
marked absence of indicators relating to research activity or engagement in research in NHS trusts. If
Pettigrew et al.27 are right in their contention that performance measurement systems are an important
determinant of organisational performance in their own right [‘you get what you measure’ (p. 8)], then© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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4this earlier failure to develop research indicators suggests that although medical research has generally
been seen as a good thing, it took a shift to a quality agenda for research activity and research
engagement in trusts to be seen as potential drivers of improved organisational performance.
Given all this, we decided that exploring improvements in health-care performance at all levels across all
possible measures in a focused review would have been a very large and perhaps impossible task.
Reﬂecting the quality agenda, we therefore decided to concentrate our focused review on papers that
discussed improvements in clinical processes and outcomes.‘Mechanisms’
In a broad sense ‘mechanisms’ have been deﬁned as ‘underlying entities, processes, or [social] structures
which operate in particular contexts to generate outcomes of interest’ (p. 368).28 However, in this review
we took a simpler interpretation related to our notion of engagement in research as a set of activities, and
deﬁned ‘mechanisms’ as levers that instigate or sustain a relationship between those activities and
improved health-care performance.Scope of the reviewIn an attempt to identify the nature of whatever evidence might already have been collated, we initially
explored and mapped a wide range of bodies of knowledge. These are listed in Chapter 3. However, it
became clear that no single, readily identiﬁable area of knowledge would comprehensively address the
review question. The lack of direct evidence about research engagement in these bodies of knowledge
indicated that, in any overall assessment of how health-care performance might be improved, many other
factors are analysed ahead of research engagement. It also suggested that our search for evidence about
the impact of research engagement would be complex. Furthermore, within the many bodies of research
that explore the diffusion of innovations and were reviewed by Greenhalgh et al.,29,30 not only does
research engagement appear to play a limited direct role in the explanations discussed, but also there is a
great variability of circumstances in which innovations can be adopted. We assumed that there was likely
to be a similar variability in the mechanisms through which research engagement might improve
health-care performance, and in the circumstances in which those mechanisms would succeed.
In the next chapter, we highlight ﬁndings from a number of existing reviews of varying degrees of
relevance to our evidence synthesis. Of these, one review impacted directly on the structure and scope of
our evidence synthesis. This was a systematic review by Clarke and Loudon published in 201131 (i.e. after
proposals for our project had been submitted). It focused on the narrower topic of the effect on patients
of their health-care practitioner's or institution's participation in clinical trials. It concluded that there might
be a ‘trial effect’ of better outcomes, greater adherence to guidelines and more use of evidence but,
crucially, went on to state ‘the consequences for patient health are uncertain and the most robust
conclusion may be that there is no apparent evidence that patients treated by practitioners or in
institutions that take part in trials do worse than those treated elsewhere’ (p. 1).
Given this uncertainty about whether or not research engagement improves performance, we decided ﬁrst
to address this question in a focused review before moving on to questions about the mechanisms
through which such changes might come about. It was also apparent that it would be impossible to
conduct comprehensive systematic database searches in all the bodies of knowledge we had covered in
our original scoping and mapping exercise. Therefore, although we wanted a broader coverage than
Clarke and Loudon,31 we decided to concentrate on the central question of whether or not research
engagement (tightly deﬁned to cover engagement in research rather than the broader engagement with
research) led to measurable improvement in actual health-care processes and outcomes. The second half
of this deﬁnition (‘measurable improvement in health-care processes and outcomes’) was also tightly
deﬁned. It excluded studies that considered whether or not research engagement led merely to steps
along the path to improved performance (such as increased research utilisation, changes in attitudesNIHR Journals Library www.journalslibrary.nihr.ac.uk
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quality of care.
After the initial mapping phase we also decided the scope of our review was already too wide to include
the slightly separate but equally important topic of whether or not engaging the public and patients as
partners in research improved health-care performance.32 We recognise the importance of this issue, and
also that there are ways in which patients can engage with research and then press their clinicians to
provide what might be seen as research-informed treatments. Nevertheless, the steer in the original brief
was to focus on health-care professionals and organisations. We also noted that the topic of patient
involvement in health research was being covered by a separate review by Evans et al., also
commissioned by the NIHR SDO programme: Public involvement in research: assessing impact through a
realist evaluation.
Considerable beneﬁts from health research have been demonstrated using various approaches, including
the Payback Framework.33–36 We assumed, however, that we should interpret our research question to
focus on whether or not any identiﬁed improvements in the performance of clinicians or health-care
organisations had resulted in some way from the processes of their being engaged in research, whether or
not that improvement occurred concurrently with the conduct of research or subsequently. In our search
for papers it proved challenging to establish the precise inclusion criteria to enable us to focus on this
interpretation, and we return to this issue at several points in this report. Nevertheless, our analysis of the
papers from the focused review provided an answer to the question of whether research engagement
improves performance.
Finally, in order to address the question of the mechanisms that might cause research engagement to lead
to improved health care, we recognised that it would be important to draw on a wider range of papers
than just those that met the inclusion criteria for the focused review. We therefore decided to supplement
the focused review with a wider but more informal review of a more extensive range of papers. In the
searches for the focused review we identiﬁed many papers, but ﬁnally included in that review only those
that met our inclusion criteria (i.e. included empirical data and covered in a single paper the whole
pathway from research engagement to improved health-care performance; see Chapter 3, Methods for
more details). The starting point for the wider review was all the papers that reached the full-paper review
step of the focused review, plus some additional papers that we had identiﬁed in the mapping exercises.
Using criteria, again set out in Chapter 3, we identiﬁed a broad range of papers, and in particular included
those that provided important descriptive or theoretical accounts, and/or provided evidence about progress
along some of the steps between research engagement and anticipated improvement in health-care
performance, and/or supported (or challenged) the ﬁndings from the focused review about whether or not
engagement in research improves health-care performance. We drew on the papers from the wider review
to supplement those from the focused review to enable us to conduct a fuller analysis of causation in the
links between research engagement and performance by exploring evidence about potential mechanisms
and about the theories underpinning their development and adoption.A road map of the reportWe have attempted to write this report as a coherent whole, but inevitably in addressing the complexity of
the subject matter we have followed various theoretical and empirical pathways. Therefore, in Box 1 we
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BOX 1 A road map of the report
Chapter 1 sets out the background to the review including our interpretation of the research question and of
various key terms (research engagement, performance, and mechanisms), and the scope of the review
Chapter 2 describes the existing theories, reviews and analyses on which our review draws and uses them to
develop a matrix to help us analyse the variety of mechanisms through which research engagement might
improve health-care performance. Inevitably the relationship between the theories and the subsequent
methods and data collection was iterative and so the matrix reported here is the ﬁnal version after revisions
during the review
Chapter 3 describes the methods used in what we have christened an ‘hourglass’ review that consists of
three main stages: Stage 1: Planning and mapping; Stage 2: The focused review; and Stage 3: Wider review
and report
Chapter 4 presents the ﬁndings from the focused review on the question of whether or not research
engagement improves health-care performance
Chapter 5 analyses the relationships between research engagement and performance by drawing on
empirical and theoretical evidence, including evidence on potential mechanisms, from both the focused
review and the wider review
Chapter 6 draws on both the focused review and, especially, the wider review to analyse how organisational
support for research engagement from health-care organisations can improve performance
Chapter 7 presents our discussion and conclusions, including implications for practice and recommendations
for research
BACKGROUND
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developing an analytic matrixKey theoretical positions that informed the reviewAs noted, the ITT for this review requested a ‘theoretically and empirically grounded assessment’.
Therefore, our initial planning and mapping exercise explored several major theoretical approaches that
could, potentially, contribute to informing the conduct of the review and to building a framework within
which to analyse the mechanisms through which engagement in research can improve performance. Here
we are describing existing theories and reviews that count as part of the background to the project. The
process by which we selected those existing theories and reviews, described below, and drew on them to
help build the matrix, inevitably involved iteration and was informed by the Stage 1 planning and mapping
exercise. Initially in the mapping stage we were as inclusive as possible. However, what drove the selection
of these speciﬁc included theories was the decision (described in Chapter 1) to concentrate on research
engagement as ‘engagement in research’ and not go for a wider version that would also have included
‘engagement with research’.Research engagement as a way of increasing ability and willingness to use
research: the theory of absorptive capacity, and theories about the
characteristics of research adopters
Absorptive capacity
The concept of ‘absorptive capacity’ as described by Cohen and Levinthal in the context of industrial
research37,38 (see also Rosenberg39) suggests that conducting research and development (R&D) within a ﬁrm
helps that ﬁrm to develop and maintain its broader capabilities to assimilate and exploit externally available
information from research. Further, they claim that ‘absorptive capacity may be created as a
byproduct of a ﬁrm's R&D investment’ (p. 129).38 Subsequent authors also used the concept in the analysis
of industrial development, noting, for example, that ‘Japanese ﬁrms, which were importing many
technologies from Europe and North America, were exceptionally good at the improvement of both
processes and products but they were only able to do this because of their own strengths in R&D’ (p. 120).40
The original theory could apply at different levels, including individual and organisational levels. Various
authors developed the concept further in relation to organisations. In particular, Zahra and George41
broadened understanding of this concept beyond the original view that an organisation's engagement in
research is the key issue. In 2006 Lane et al.42 reviewed the use of the concept of absorptive capacity in
the many subsequent articles claiming to be drawing on it. Lane et al.42 suggest that much of the later
writing has followed the approach of Zahra and George.41 This has also occurred in the health ﬁeld where,
for example, a study exploring the capacities of health-care organisations to absorb research deﬁned
absorptive capacity in terms of environmental scanning, collection of satisfaction data, and the level of
workforce professionalism.43 The result is that the simpler interpretation of absorptive capacity being a
by-product of research is sometimes overlooked.
Nevertheless, and returning to the original by-product concept, it can still be argued that when clinicians
and managers in a health-care system are seen as stakeholders in the research system then their
engagement in research can be a way of boosting their ability and willingness to use research from
wherever it might originate. For example, drawing on parallels from the literature on industrial research,
Buxton and Hanney44–47 include this increased capacity to use research as one of the beneﬁts identiﬁed in
their multidimensional categorisation of beneﬁts from health research, and this approach is replicated in© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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8other health research impact assessment frameworks that build on the Payback Framework,48,49 and when
the development of health research systems in low- and middle-income countries is being considered.50
Part of the theoretical underpinning behind the idea that research engagement contributes to building
absorptive capacity is the notion that, in practice at least, knowledge is not a pure public good but instead
requires a level of understanding of research before it can be absorbed.51 Such understanding can be built
up by undertaking research.Characteristics of research adopters
Rogers52 identiﬁes 26 ways in which those who are early adopters of innovations differ from those who
are later adopters of research, but being engaged in research is not included. Greenhalgh et al.,30 adapting
earlier work,53 list the personal characteristics of those who adopt innovations. Personal values are included
in the list, and Greenhalgh et al. cite the work of one study54 that suggests actors adopting medical
innovations include those motivated by values, for example ‘“academic” doctors feel the need to align
with evidence from research trials’ (p. 111).30
The above discussion relates to the absorption and/or adoption of research ﬁndings by a wider group of
people than those who originally undertook the research. It is, however, relevant to consider if aspects of
these theories also relate to those who produce speciﬁc research ﬁndings, and might then be in a position
to adopt them in their regular practice. Both Rogers52 and Greenhalgh et al.30 draw on the work of Ryan
and Gross55 to set out a model of the stages in the process of adoption, and the ﬁrst stage is knowledge
(i.e. awareness of the innovation). However, although participating in research evaluating a speciﬁc
innovation is a highly effective way of accessing knowledge about it, and this increased knowledge can be
seen as a by-product of that participation, this point is not speciﬁcally made in the model (and clearly not
everyone whom it is hoped will adopt an innovation could be involved in a trial).The co-ordination of research engagement to enhance its effectiveness:
a role of research networks
Research networks are increasingly important in several countries, including the USA and the UK. In the
USA, practice-based research networks (PBRNs) have been in existence for several decades. They not only
provide a means for community practitioners to become involved in research, but can also facilitate the
‘downstream’ dissemination and implementation of research results into community-based clinical
practice by:NIHR. . . enhancing providers’ acceptance of research results and strengthening their commitment to
acting on research findings. This level of participation also often encourages practice organizational
changes that facilitate the research and allows participants access to more or earlier information
compared with others who did not participate in the research.
p. 444156As they mature, it becomes clear that research networks can have more than one goal. Some have evolved
from structures whose primary purpose is to involve clinicians and health-care organisations in clinical trials
to become structures that also aim to spread information about research and research ﬁndings. In
addition, research networks can encourage members to identify research needs in order to make the
research undertaken more relevant,11 and to this extent they use the collaborative approach
described below.
In the UK, clinical research networks are a central pillar in the development of the English NIHR.57 The
objectives of the Clinical Research Network Coordinating Centre58 are more restrictive than those
described above for the research networks in the USA and focus on aspects such as increasing the
efﬁciency of clinical research processes and increasing the number of NHS trusts that are involved in clinical
research. This might suggest that any improvements in health care that result from the researchJournals Library www.journalslibrary.nihr.ac.uk
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as possible outcomes. The Cancer Research Network led the way because it was hypothesised that:© Que
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Park, S. . . if more patients could have access to late phase clinical trials, not only would their outcomes
improve as they gained access to novel therapies, but the inculcation of a research culture across all
hospitals delivering cancer care would also lead to a general improvement in the standard of care.
p. vii2959This claim does suggest some theorising about how these networks are a mechanism through which such
impacts might arise. It is also compatible with statements about the PBRNs in the USA. As such it is of
interest not only to know what research networks can achieve, but also how they do so.
There are some overlaps between the thinking in the ‘stages of innovation’ model promoted by Rogers,52
and the basic role of research networks. The ﬁrst step of the ‘stages of innovation’ model is that those
adopting an innovation have to have knowledge about it, and then be persuaded to believe they should
use it. We suggest that the knowledge and trust about an innovation that comes from being involved in
research helps explain the adoption process. Rogers52 also argues that trialability and observability are
important characteristics of innovations that are adopted. Although this might appear to be the same as
having knowledge about an innovation, Rogers52 was here talking about characteristics of the innovation
rather than the adopter. However, we believe this concept could be adapted to help explain how an
increase in the number of clinicians undertaking research (perhaps through research networks) might
increase adoption of evidence-based approaches. Thus, and to use and perhaps reinterpret terms used by
Rogers52 when describing the characteristics of innovations, research networks can promote ‘trialability’
(here deﬁned as giving clinical staff and health-care organisations the opportunity to gain experience of an
innovation on a limited basis in the context of a clinical trial) and ‘observability’ (here deﬁned as giving
clinical staff and health-care organisations the opportunity to observe the impact of innovations in other
parts of the network).Research engagement as a way of ensuring the research produced has more
likelihood of being used to improve the health-care system: theories of
collaboration and of action research
Under this heading we examine several partially overlapping theories that focus on ways of engaging
potential users from the health-care system in aspects of research processes with the aim of improving the
relevance of research to users, and increasing the likelihood of research being used.Collaborative research
In 2003 Denis and Lomas60 traced the development of a collaborative approach to research in which
researchers and potential users work together to identify research agendas, commission research, and so
on. They identiﬁed the 1983 study by Kogan and Henkel61 of the R&D system of the health department in
England as a key early contribution. According to Kogan and Henkel61 a critical feature of the collaborative
approach, as applied to research on policy-making, is that researchers and policy-makers should join forces
‘to identify research needs against policy relevance and feasibility’ (p. 143). They developed their theories
about the collaborative approach not only from their own extensive 7-year formative evaluation of
developments in the health department's R&D division, but also from models of social research impact
developed by Carol Weiss,62 including an interactive model which they claimed reinforced the notions that
the boundaries between science and society are permeable.
Work to analyse and operationalise this collaborative approach has been undertaken in the Canadian
Health Services Research Foundation (CHSRF), led by Jonathan Lomas.63,64 His concept of ‘linkage and
exchange’ between users and researchers has been particularly inﬂuential. The belief that collaborative
research is more likely to be relevant to potential users is a key concept. Collaborative approaches to
research somewhat mirror the concept of ‘Mode 2’ research (i.e. research that is context-driven,en's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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10problem-focused and interdisciplinary).65,66 The applicability of ‘Mode 2’ concepts to health research was
analysed by Ferlie and Wood.67
One early and successful example of developing and promoting collaborations between researchers and
health-care staff to maximise engagement in research, and encourage wider use of the ﬁndings of
research, was the post-war childhood leukaemia trials in the UK (and the USA). However, as Moscucci
et al.68 demonstrate, this success was very dependent on the context in which this collaboration developed
at the time. But, in addition to being applied in one-off situations, there are now efforts to go further than
the institutional developments described by Kogan and Henkel61 and build long-term collaborative
approaches that, it is hypothesised, will lead to research that is more likely to meet needs of a health-care
system, and hence be used and improve performance. (Some of these are described in Chapter 6.)
Greenhalgh et al.30 also build aspects of the collaborative approach into their model for considering the
determinants of diffusion of innovations in the organisation and delivery of health services. Again drawing
on the work of Rogers,69 they suggest that successful adoption of an innovation is more likely if developers
or their agents are linked with potential users at the development stage in order to capture and
incorporate the user perspective.
The collaborative approach is generally more interventionist than the absorptive capacity concept, but
sometimes they can be brought together. In current initiatives and writings about the health research
system there is often overlapping emphasis: ﬁrst, on collaborative working with users of research so as to
produce applied research that is more likely to be adopted by potential users because of its relevance to
them; and second, on engaging users in the wider research enterprise in a variety of ways and through
various networks to encourage the uptake of research ﬁndings more generally. This second approach can
be interpreted as an attempt to build absorptive capacity. In 2008 Collaborations for Leadership in Applied
Health Research and Care (CLAHRCs) were introduced by the English NIHR to boost the effectiveness and
translation of health research, and the following deﬁnition of CLAHRCs70 highlights their complex remit:NIHRThe collaborations have three key interlinked functions: conducting high quality applied health
research; implementing the findings from this and other research in clinical practice; and increasing
the capacity of local NHS organisations to engage with and apply research.
p. 10870Initiatives such as the CLAHRCs also illustrate how collaboration can work at various levels, with one aim
of collaboration at an organisational level being to help foster collaboration at other levels within the
participating bodies. (We discuss this further in Chapter 6.)Action research
The notion that research users should be closely involved in research activity in order to produce research
that meets their needs also overlaps with theories underpinning action research, or participatory action
research (PAR). The action research model was ﬁrst conceptualised by Lewin71 and has been described and
developed in much subsequent writing. It consists of a spiral of cycles of action and research, with four
phases: planning, acting, observing and reﬂecting. The aim is to enable investigators to link theory with
practice using a participatory and consensual approach towards investigating problems and developing
plans to deal with them.
A realist review published in 2012 by Jagosh et al.72 looks at the beneﬁts of participatory research and
examines the coconstruction of research through partnerships between researchers and people affected by
and/or responsible for action on the issues under study. Building on the work of Lasker et al.,73 they
adopted the theory of ‘partnership synergy’ to hypothesise that equitable partnerships with stakeholders'
participation throughout the project succeed largely through synergy.Journals Library www.journalslibrary.nihr.ac.uk
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performance of the health-care organisation
Given the wide scope of our original brief and the diversity of the ﬁelds of study involved, our decision to
focus on engagement in research rather than also include engagement with research was necessary to
give our review sufﬁcient focus. However, there are limitations to this approach. One of these is that it
cuts across some of the major theoretical approaches that underpin efforts to improve organisational
performance in health care, such as promoting learning organisations, adopting an organisational
approach to quality improvement (QI), and knowledge mobilisation. However, we found that in all
these ﬁelds, research-related discussion tends to be largely about research utilisation, EBP and
translation gaps: research engagement as a term is rarely used, and further reﬁnements of that term
not considered.
These issues are illustrated in a recent review of knowledge mobilisation and research utilisation by Crilly
et al.74 They note that there is a well-established literature on the utilisation of clinical evidence in health
care, but that there has been less consideration of the utilisation of management evidence and research by
health-care organisations. Their review aimed to redress this imbalance and paid particular attention to the
management literature, identifying 10 large domains or thematic categories in that literature. Their
subsequent search of the health and social science literature identiﬁed two further domains: the
evidence-based movement and ‘super structures’ – deﬁned as ‘the infrastructure of institutions and
funding that commission health-care research’ (p. 45). However, it was only in relation to this last domain
that this large review found any literature in which research and engagement were considered together as
a means to promote change. In a discussion of the various ‘structures’ developed by the English health
R&D system to boost the translation of research, Crilly et al.74 quoted the Department of Health's High
Level Group on Clinical Effectiveness recommendation about increasing the effectiveness of clinical care
through promoting the development of new models to encourage relevant research, engagement and
population focus and embed a critical culture that is more receptive to change.75
Crilly et al.74 also made a further and more general point. They noted that although learning processes and
their relationship with organisational design emerged as an important theme in their review, the whole
question of organisational form had received little attention in health-care literature, despite major
reorganisations designed to promote bench to bedside research translation and organisational learning.
We were therefore especially interested in our own review to identify health-care organisations that have
given particular attention to engagement in research in their overall approach to improved performance,
and explore the theoretical underpinnings of those approaches.
We found several examples, many of them from the USA. Thus, the Veterans Health Administration (VHA)
in the USA included various aspects of research engagement as part of a comprehensive re-engineering
exercise designed to improve the quality of health care provided.76 According to a former Undersecretary
for Health at the United States Department of Veterans Affairs (VA), the fact that VA investigators are
nested in a fully integrated health-care delivery system with a stable patient population that has an
exceptionally high prevalence of chronic conditions provides them ‘with unparalleled opportunities to
translate research questions into studies and research ﬁndings into clinical action’ (p. I–9).77 One high
proﬁle way in which this integration has been achieved is through the Quality Enhancement Research
Initiative (QUERI) programme, which was launched in 1998 to accelerate the implementation of new
research ﬁndings into clinical care by creating a bridge between those performing research and those
responsible for health systems operations. In a recent evaluation of QUERI, Graham and Tetroe78 highlight
how this comprehensive approach has successfully incorporated some of the theoretical approaches
described above, referring to a ‘paradigm shift to an action-oriented approach that meaningfully engages
clinicians, managers, patients/clients, and researchers in research-driven initiatives to improve quality’ (p. 1).
This shift, they claim, is towards coproduction of knowledge or ‘Mode 2’ knowledge production.© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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12In QUERI, and in other complex initiatives such as the CLAHRCs in the UK (the ‘community wide academic
health centres’ referred to above), various theoretical approaches overlap, and detailed evaluations of such
initiatives provide useful pointers to the different mechanisms through which research engagement might
lead to improved health care. (We return to these issues in Chapter 6.)Previous reviews and analysesThe ﬁndings from a range of previous reviews are relevant to our evidence synthesis to varying degrees
and shaped our thinking about its scope. As we discuss these previous reviews below, we attempt to
assess their relevance to our own review, but even the most relevant were not included in our focused
review because of the danger of double counting.Practitioner or institution participation in clinical trials
The systematic review by Clarke and Loudon published in 201131 has already been mentioned and is
important for several reasons. First, its ﬁndings can be interpreted as highlighting the need for a further
focused review to update, and if possible expand, the search in an attempt to identify if there is sufﬁcient
evidence to come to a somewhat ﬁrmer conclusion about whether or not research engagement is likely to
improve health-care performance. Second, it addresses the boundary between studies on practitioner or
institutional participation and those exploring whether or not patients who are involved in trials achieve
better health outcomes.Patient involvement in trials
Previous reviews, noticeably by Vist et al.,79 indicate that, on average, ‘the outcomes of patients
participating and not participating in RCTs were similar, suggesting that participation in RCTs, independent
of the effects of the clinical interventions being compared, is likely to be comparable’ (p. 2). However, an
earlier review by Stiller80 concluded that: ‘referral to a specialist centre or to a hospital treating many
patients with the disease, or inclusion in a clinical trial, is often linked with a higher survival rate for the
cancers which have been studied’; and he went on to suggest that there was ‘no evidence that centralised
referral or treatment according to protocols leads to lower survival rates’ (p. 360).
These reviews are of particular importance to our evidence synthesis because they provide a complex, but
partial, mirror image to the evidence about whether or not research engagement by clinicians and
organisations leads to improved health care. Their unit of analysis is patients, whereas the reviews by
Clarke and Loudon,31 and by ourselves, examine the care provided by clinicians and by institutions.
However, there are potential overlaps, for example, Vist et al.79 claim that the differences in care that were
identiﬁed in some studies ‘might be due to differences in adherence to a protocol by participating
clinicians’ (p. 4). This is another reason why we had to be very careful in devising the inclusion criteria for
our study.Health outcomes in teaching hospitals
There is a growing literature on whether or not the patients treated in a teaching hospital have better
health-care outcomes than those treated in non-teaching hospitals. If this was shown to be the case, then
it could potentially be important evidence about whether or not research engagement leads to improved
performance. Although most research-intensive hospitals are likely to be teaching hospitals, teaching
hospitals are not necessarily research-intensive. This makes it difﬁcult to interpret the ﬁndings.
Furthermore, the largest systematic review we found81 – of 132 PubMed studies – identiﬁed a great deal
of variability in the results between the studies but that overall no link could be conﬁrmed. Also, although
some papers did ﬁnd a positive relationship, many warned about the difﬁculty of coming to any clear
conclusions about this correlation given the large number of confounding factors.82,83NIHR Journals Library www.journalslibrary.nihr.ac.uk
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The idea of medical academics being motivated to engage in research to improve the health care of their
own patients is a powerful one. This most often takes the form of clinicians leading or participating in
traditional clinical trials. In some instances, however, clinicians set out to conduct research not to test the
general efﬁcacy of one therapy compared with an alternative approach, but rather to identify the best
treatment for an individual patient through multiple crossover studies conducted in single individuals. A
review of such N-of-1 trials84 concluded that they ‘are a useful tool for enhancing therapeutic precision in
a range of conditions and should be conducted more often’ (p. 761). Despite this conclusion, such trials
are resource-intensive and unlikely to occur in more than a small minority of cases.Collaborative approaches
The reviews of Clarke and Loudon31 and of Vist et al.79 focus on trials of new therapies, and do not
include papers describing speciﬁc interventions such as collaborative approaches. Among the reviews that
have explored these approaches, Lavis et al.85 concluded that, taking study design, study quality and
consistency of ﬁndings into consideration, the most rigorous statement they could make about factors that
encourage the use of research by health managers and policymakers was that ‘interactions between
researchers and health care policy-makers increased the prospects for research use by policy-makers’
(p. 39). This ﬁnding came, however, from a relatively small number of papers, and it is not clear how far
the interactions were collaborative prior to and during the research activity and would, therefore, meet our
inclusion criteria for engagement in research. Focusing speciﬁcally on health policy-making, Innvær et al.86
reviewed the literature on factors that led to research utilisation and showed that personal contact
between researchers and policy-makers was the factor most often identiﬁed. Again, it is not clear how far
this represents policy-maker engagement in agenda setting and the processes of research, or how far it is
restricted to dissemination activities and is therefore engagement with, but not in, research.Action research and participatory action research
Through action research health-care professionals (often nurses or therapists) work with researchers to
explore locally identiﬁed problems. Given the nature of the process, it is not easy to maintain the
distinction between these forms of research and direct implementation/improvement initiatives. Several
reviews have examined action research but have found that the impacts on patient care and health
outcomes are often not covered. For example, Soh et al.87 reviewed action research studies in intensive
care settings but of the 21 studies included only one described improved health-care outcomes.88
Munn-Giddings et al.89 reviewed studies of action research in nursing published between 2000 and 2005.
Munn-Giddings et al.89 identiﬁed 62 studies, but ‘Only 13% could be deﬁned as having their focus on a
direct impact on patient care’ (p. 474).Assessing research impact
A systematic review of previous attempts to assess research impact found comparatively few
comprehensive categorisations of the impacts of health research that attempted to include any analysis of
whether or not research engagement led to improved health care as a by-product.33 The studies that had
considered this were mostly limited to a few of the studies that used the Payback Framework in which
research engagement leading to beneﬁts as a by-product is one of the explicit categories of impact.Assessing research utilisation
Some reviews cover the step in the pathway from research engagement to research utilisation. These are
often more about engagement with research than engagement in research. For example, there are
extensive reviews of knowledge transfer and exchange,90,91 diffusion of innovations,29,30 and research
utilisation and knowledge mobilisation.74 All of them cover aspects of researchers interacting with potential
research users, which can in some cases, but not all, overlap with the collaborative approach. Mitton
et al.90 start their review by stating that: ‘Knowledge transfer and exchange (KTE) is an interactive process
involving the interchange of knowledge between research users and researcher producers’ (p. 729).
Some reviews of research utilisation include consideration of whether or not engagement in research is
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14a review of studies of research utilisation by nurses found that only 13 out of 55 papers examined research
participation as a possible factor.92 Although these studies described various forms of research involvement
and a total of 13 individual characteristics were identiﬁed, each one of these characteristics (including the
one most related to our concept of engagement in research) was assessed in fewer than four studies. This,
the authors claimed, prevented them ‘from drawing conclusions on the relationships between individual
characteristics typical of involvement in research activities and nurses' use of research ﬁndings in practice’
(p. 12).Additional analyses published in 2011
The ﬁnal body of work we cover in the ‘background’ is a supplement to the Annals of Oncology that was
published in late 2011 during the course of our own review. This supplement built on the work of a 2009
workshop addressing the question of ‘The impact of the process of clinical research on health service
outcomes’.93 In the introduction, Selby93 notes that the Vist et al. review79 (cited above) examined a
‘substantial literature’ evaluating the beneﬁts for individual patients of trial participation, but that there
was a lack of convincing evidence. Of more relevance to our own review is the conclusion of the
workshop that there is an even less extensive literature on the impact of research activity on the quality of
health-care outcomes within research-active institutions and health-care systems in general and that there
‘is a pressing need for more research in this area’ (p. vii3).
The focus of the papers in this Annals of Oncology supplement varied. In setting out the key question the
workshop thought should be addressed in future research, Pater et al.94 claim that their question:NIHR. . . has been deliberately phrased to indicate our concern with benefits that occur
contemporaneously with the research activity. We do not directly address the question of whether
institutions that participate in a particular research project are more likely to implement the results
once they become known.
p. vii5894Other papers in the supplement did, however, take a broader perspective and began to analyse some of
the factors that might cause research engagement to lead to health-care improvement.95 (We draw further
on this set of papers in later chapters.)Learning from previous studies and developing a matrix for
analysing the potential mechanismsThese various theoretical perspectives and systematic reviews provided an important starting point for our
own review. Taken overall they highlighted ﬁve key points:
l There appeared to be no ﬁrm answer to the question of whether or not research engagement does
improve health-care performance.
l Research engagement is often subsumed within larger, more complex interventions.
l Studies often focus on steps along the pathway from research engagement to health-care outcomes
and not the whole pathway.
l There are many studies that might contribute to a synthesis of possible mechanisms by which research
engagement might improve health care, but also a large number of disparate activities described.
l There would be value in developing a matrix to help organise the data analysis, categorise studies and
unpick which mechanisms operate in the very different circumstances described by the various papers.
From the above accounts we identiﬁed two main dimensions along which to categorise studies that assess
whether or not research engagement leads to improved performance. We have called these two
dimensions the degree of intentionality and the scope of the impact (Table 1).Journals Library www.journalslibrary.nihr.ac.uk
TABLE 1 Initial matrix characterising how research engagement can improve health-care performance
Broader impact (e.g. as a result of their
research engagement, health-care staff are
more willing/able to use research produced
by others to improve health care)
Speciﬁc impact (e.g. the ﬁndings from
studies are used more rapidly and/or
extensively by those involved in the
research engagement that led to them)
Least
intentionality –
by-product
Research engagement involves participating in
research studies, and the absorptive capacity
concept could be important in helping explain the
ability to adopt research conducted elsewhere
Research engagement involves participating in
research studies, and the mechanisms would be
associated with knowledge, etc., about the
speciﬁc research and its conduct
Some
intentionality –
research
networks
Research engagement involves network
membership which can include regular
participation in research studies and, in addition,
network communication about the conduct and
ﬁndings from research studies in the ﬁeld covered
by the network
Research engagement involves network
membership which can include regular
participation in research studies and network
communication about the conduct of those
speciﬁc trials
Greatest
intentionality –
interventions
Research engagement here might include
programmes to give clinicians/managers/policy-
makers some experience of identifying research
needs and participating in research. As a result
they might then be more willing/able to use
research from wherever it comes
Research engagement here can involve
collaborative research, QI research initiatives,
participatory and action research, and aspects
of organisational initiatives. As a result the
speciﬁc research produced is more relevant to
the needs of those involved and they are more
likely to use it
DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8The ﬁrst dimension involves the degree of intentionality in the link between research engagement and
health-care performance. Inevitably there are overlaps, but three main categories could be identiﬁed and
viewed as forming a spectrum:
l The end of this spectrum involving least intentionality includes the improved health-care performance
resulting from engagement in research that can be categorised (to adapt Cohen and Levinthal's
term37,38) as a by-product of a trial or other research which has been conducted to test a speciﬁc
therapy or approach. This does not of course mean the improvement happens by accident, but rather
that the production of these by-product beneﬁts was not the primary aim of the research study in
which the clinicians were engaged.
l Research networks can broadly be seen as somewhere near the middle of this spectrum. They exist
primarily to promote the conduct of research on speciﬁc therapies in a particular ﬁeld, but often have
additional wider remits of informing network members about the conduct of, and ﬁndings from,
research in a ﬁeld more generally, and addressing the identiﬁed research needs of network members.
l The other end of the spectrum involves greatest intentionality: here there are various interventions such
as the collaborative approach, participatory and action research, and organisational approaches where
the intention is explicitly to produce improved health-care performance as a direct consequence of
research engagement.
The second dimension in the proposed matrix is the scope of the impact made by research engagement.
Here there are two categories, broader and speciﬁc, and the studies of these focus on different issues.
Studies included in the ‘broader impact’ category take various forms, including:
l studies assessing whether or not those clinicians and health-care organisations who engage in research
are more likely than those who do not engage in research to apply the ﬁndings of research studies
conducted elsewhere
l studies assessing the more general health-care performance of clinicians, teams, and organisations
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16The ‘speciﬁc impact’ category covers two circumstances:
l studies assessing whether or not improved health-care performance arises as a result of the
subsequent rapid application of the ﬁndings from the speciﬁc research by those who engaged in the
research that produced the ﬁndings
l studies assessing whether or not improvement in health-care performance arises concurrently with the
speciﬁc research activity (or subsequently) as a result of those conducting the research applying the
evidence-based processes/protocols (but not the intervention regimens) associated with the research
activity to a broader range of patients than just those participating in that particular research project.
The difﬁculties of applying the matrix include the fact that some of the papers in our focused review have
features that ﬁt into more than one category on a certain dimension. Nevertheless, it is important to
attempt to make such categorisations because of the potentially very different mechanisms that may be at
work in these different circumstances on the two dimensions.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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The review involved the three stages set out in Figure 1. This is described as an hourglass review toreﬂect the scope of the conceptual analysis and the number of papers considered in detail (rather than
the sheer volume of titles reviewed) at each stage. The three parts of the review were a broad mapping
stage, followed by a focused or formal review on the core issue of whether or not research engagement
improves health care, and a ﬁnal stage which involved an exploration of a wider literature to help identify
and describe plausible mechanisms.
We consulted an international expert advisory group and patient representatives at key points in the
review process. Given the international nature of the advisory group the consultation was mostly by e-mail.
However, we met face-to-face with the patient representatives.
Ethical approval was obtained from Brunel University's Research Ethics Committee.Stage 1: planning and mappingWe made the initial scoping and planning phase as wide as possible in an attempt to ensure we captured
any coherent bodies of empirical evidence relating to the question and any plausible mechanisms. We
examined a large number of bodies of knowledge as listed in Box 2.
For this exercise we drew on our existing knowledge, team meetings and brainstorming sessions, and
consultation with the advisory group. We also started with an open mind about the types of research on
research that might have addressed our question, following the Institute of Medicine's deﬁnition of health
services research as a: ‘multidisciplinary ﬁeld of inquiry, both basic and applied, that examines the use,
costs, quality, accessibility, delivery, organization, ﬁnancing, and outcomes of health care services to
increase knowledge and understanding of the structure, processes, and effects of health services for
individuals and populations’ (p. 3).96
Our initial explorations presented us with a dilemma. Discussions with the project's information scientist
conﬁrmed that it would be impractical to conduct a focused search of all the bodies of knowledge that
might have something relevant to say on the topic. Yet, as far as we could tell, none of them appeared to
contain a sufﬁciently large number of relevant papers to make it sensible to focus explicitly on that area in
order to explore the various mechanisms involved.
We therefore decided to extend the initial stage to enable us to map the ﬁeld as widely as possible so as
to inform the later more detailed database search. This mapping phase continued the approaches
described above, plus hand-searching of journals, searching of relevant web sites, and searching the
Effective Practice and Organisation of Care Cochrane database. The journals on which we conducted a
preliminary hand search at this stage specialise in aspects of the relationship between research
engagement and improved health-care performance. They included: Journal of Health Services Research &
Policy; The Milbank Quarterly; Evidence & Policy; Implementation Science; and Health Research Policy &
Systems. Preliminary internet searches were conducted on the following websites: English Department of
Health; NIHR; National Institute for Health and Care Excellence; World Health Organization; numerous
Canadian health research organisations (including CHSRF); and the University of Birmingham Centre for
Health Services Management library.
Papers considered to be particularly relevant for the study were given a designated ‘KEY’ status, and we
used snowballing to explore further potentially relevant references cited in these papers.© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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Stage 1. Planning and mapping
A wide-ranging initial mapping of various
potentially relevant bodies of knowledge to
inform analysis of research engagement leading
to health-care improvement, including possible
theoretical perspectives and mechanisms.
Stage 2. Focused review
The focused review concentrated on one central
strand, seeking evidence of whether engagement
in research improves health-care processes or
outcomes. Of 10,398 papers identified, 473 full
papers were read and 33 papers were included in
the focused review.
Stage 3. Wider review
The analysis expanded into the wider review,
which drew on the mapping and focused review
to explore the mechanisms by which research
engagement might improve health care.
IGURE 1 The hourglass three-stage review.
METHODS
18FBOX 2 Bodies of knowledge explored in the initial mapping stage
Twelve bodies of knowledge were explored in the initial mapping stage:
l the organisation of health research systems and of collaborative approaches to the conduct of health
research including linkage and exchange
l the role of in-house industrial research, including concepts such as absorptive capacity
l diffusion of innovations/absorptive capacity in health-care systems
l performance at clinician, team, service and organisational level in health-care organisations, approaches
to the measurement of such performance, and overlaps with the concept of medical engagement
l the role of medical academics in translational research
l assessing the impacts of research and how the utilisation of research improves health-care performance
l quality improvement
l knowledge mobilisation and management, and knowledge transfer
l organisational processes and learning organisations
l medical education, continuing professional development, and critical appraisal
l evidence-based medicine
l the role of patient engagement in researchThe ﬁndings from this informal but extensive searching were used to develop initial maps of each of the
bodies of knowledge from the diverse range listed above, and to inform the search terms used in the next
stage – the focused review.Stage 2: the focused review
The search strategy
The focused, or formal, review concentrated on the speciﬁc question of whether or not engagement in
research improves health-care performance. We wanted a comprehensive search of as many databases as
possible. The search terms we used for the MEDLINE searches are given in Appendix 2. The search terms wereNIHR Journals Library www.journalslibrary.nihr.ac.uk
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empirical research studies where the concept of ‘involvement in research’ was an input and some measure of
‘performance’ was an output. We included the VHA as a search term because our initial mapping, and expert
advice, highlighted the importance of the VHA as a rare example of an organisation that had explicitly
attempted to integrate research fully into its operations in order to improve health-care performance. The
initial broad interpretation of our terms was tightened as we progressed through the review.
The search strategy covered the period January 1990 to March 2012 as the mapping phase suggested that
this was the most fruitful period for addressing the review topic. We used English-language terms,
although identiﬁed papers not published in English were considered for inclusion, and consideration was
given to terms used in other English-speaking countries (e.g. the use of the term ‘community’ in North
America can be noticeably different from its use in the UK). We sought papers containing empirical data
from a whole range of research approaches, both quantitative and qualitative, in line with our broad
interpretation of health services research. Our search was not, therefore, limited to clinical trials. We
searched MEDLINE, EMBASE, PsycINFO, Cumulative Index to Nursing and Allied Health Literature (CINAHL),
Web of Science, Applied Social Sciences Index and Abstracts (ASSIA), British Nursing Index, Health
Management Information Consortium (HMIC) and System for Information on Grey Literature in Europe
(SIGLE) databases. The search strategy was developed by members of the research team and a senior
information scientist from King's College London. These database searches were supplemented with more
focused hand-searches of the ﬁve journals initially searched in Stage 1 (as listed above), papers suggested
by our expert advisors and patient representatives, further searching of several national and international
websites (as listed above) and snowballing of papers considered to be key for the discussion. Searches
were conducted by an information scientist working closely with the review team.Steps in the focused review
First step – title review
This step involved examination of the title of each paper, and occasionally the abstract when the title
provided too little detail, to quickly exclude documents clearly not relevant to the review. The predominant
aim here was to be inclusive, only excluding papers clearly not relevant. Reasons for exclusion at this step
were: not health related, not a human study, no mention of research (or related terms), no clinical
outcomes or processes. At ﬁrst papers were reviewed by two reviewers independently, but this was
reduced to one reviewer after a short time as the numbers of abstracts to be studied was large and a test
indicated that the agreement between the reviewers was considered to be satisfactory.Second step – abstract review
In the second step of the review, we studied the titles and full abstracts in greater depth to assess the
eligibility of each paper that had not been excluded at the title review. A ﬁrst reviewer conducted this
exercise and then passed the paper (and, where appropriate, comments) to a second reviewer. The aim of
the ﬁrst reviewer was to be inclusive: the aim of the second reviewer was to be more selective. Where the
two reviewers disagreed they met to discuss the title and abstract. If agreement was still not possible then
the paper was taken through to the third step of the review for a study of the full paper, along with the
papers where there was agreement on inclusion.
Reasons for exclusion were: not health related, not a human study, no mention of engagement in research
(or related terms), no clinical outcomes or processes. Reasons for inclusion were: mention of engagement
in research or of research in combination with collaboration, multicentre, organisational, or other related
terms, mention of clinical outcomes or processes in the form of empirical data.Third step – full-paper review
The third step was a further relevance and initial quality check of all the included papers from the second
step to determine which papers were suitable to proceed through to the data extraction stage.© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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20Determining the inclusion criteria for this step was complicated because the special relationship between
research engagement and improved health care had to be demonstrated in some way in the included
papers. So, for example, in relation to clinical research, just because researchers who had been involved in a
particular trial were now using the ﬁndings of that trial was not, by itself, sufﬁcient. Instead, and as far as
possible, we attempted to include only studies that examined in some way whether or not those clinicians/
institutions who had been engaged in the research were adopting the ﬁndings more rapidly and/or
extensively than other clinicians/institutions, i.e. we were looking for some measure of control within the
study. For collaborative and action research, slightly different considerations had to come in to play because,
by the very nature of the research, it was intended to be most relevant for those engaged in the research.
During the earlier parts of the review we identiﬁed some potentially important papers describing activities
such as participation in research networks or action research that we considered to be a form of engagement
in research and that in some instances seemed to lead to improved health care. Therefore, while we had, as
noted, deﬁned research engagement quite tightly to refer to engagement in research, we also wanted to
make sure we captured the full range of activities that might come under that term and not restrict ourselves
to looking just at clinical trials as Clarke and Loudon31 had explicitly done. Therefore, to add precision to our
inclusion criteria, we explicitly set out some of the activities that we believed could be considered to be
included under the heading ‘engagement in research’. Our ﬁnal inclusion criteria are set out in Box 3.BOX 3 The final inclusion criteria for the focused review
Our ﬁnal inclusion criteria were:
(a) Includes empirical data
(b) Explicitly includes engagement in research in any way including:
l agenda setting
l conducting research
l action research
l research networks where the research involvement is noted
OR, implicitly includes engagement in research through membership of a research network and, even though
participation in a speciﬁc study is not noted, there is a comparison of health care between such settings and
other settings (could be the comparison shows a difference or no difference)
BUT NOT
l solely engagement with research, for example continuing medical education, evidence-based medicine,
implementation efforts, critical appraisal, etc.
l patient engagement in research
(c) Includes assessment of health-care processes/outcomes including, for example, use of clinical guidelines
BUT NOT
l just research utilisation; or
l just adoption of research in policy-making, with no follow through into improved health care in
organisations or services; or
l just improvements such as staff satisfaction or morale
NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8We applied broadly similar inclusion principles across all categories of papers, and, where possible,
reﬂected the spread of approaches we saw in the literature by including studies in organisational settings,
and collaborative and participatory studies. This meant, for example, seeking to include studies that made
some attempt to show that the use of the ﬁndings from engagement in collaborative or action research
resulted in improvements in health-care performance, and that the clinician/institution behaviour was
sustained beyond the period of the intervention. In other words, we attempted to distinguish a sustained
impact from a more temporary study effect. Ideally such studies would also show some evidence of
differential uptake of ﬁndings by the clinicians/institutions involved in the research, as measured against
control groups not involved. But we found that this was rarely studied: collaborative or action research is
often undertaken in response to the speciﬁc needs of the clinicians/institutions engaged in that research,
and frequently does not include any control.
All three reviewers agreed on the papers taken through to the ﬁnal data extraction stage of the review,
and a data extraction sheet was completed by one reviewer for each of these papers. A quality check was
informed by checklists available as part of the Critical Appraisal Skills Programme or similar, but the
diversity of methods used in the papers meant that no one quality appraisal tool could be rigidly applied.
The number of papers involved at each step of the focused review is set out in Figure 2.
Analysis in the focused review
The papers in our focused review are even more diverse than the 13 papers in the Clarke and Loudon
review,31 which did not involve a meta-analysis because the papers were too heterogeneous. Therefore,
we too decided not to conduct a meta-analysis, but instead to provide an account of each paper in tabular
form. Each paper that reached the ﬁnal data extraction stage was also analysed in relation to:
l Its importance to this review based on quality (especially the level of control in the study), size of the
study and relevance to our review question.
l Whether the ﬁndings were positive (showing research engagement did improve health care) or
negative (showing no positive impact) or mixed. Under this interpretation, a ‘negative’ ﬁnding did not
necessarily mean that health care worsened, it might have remained unchanged over the course of the
study. Some papers provided mixed data about improvement that were inconclusive and difﬁcult to
interpret. Findings that were partially positive and partially inconclusive we labelled ‘mixed/positive’;
ﬁndings that were partially negative and partially inconclusive we labelled ‘mixed/negative’.
l The degree of intentionality of the link between research engagement and health-care performance
(by-product, research network, or intervention).
l The scope of the impact made by research engagement (broader impact/speciﬁc impact).
l The level of engagement discussed (clinician or organisational). We initially intended to analyse papers
according to the four levels of engagement mentioned in the ITT – clinician, team, service or
organisational – but eventually used the two levels of clinician and organisation because, at levels
above that of individual clinicians, there is little consensus about the reporting terms used and we
could not readily apply the separate categories of team, service and organisation.
Finally, each of the papers was examined to identify any factors that the authors were proposing as
possible causes of the improvement in health-care performance.
This analysis was supplemented by the wider review described below.Stage 3: wider review and reportThe ﬁnal stage was an informal wider review. This was primarily intended to contribute to a fuller
understanding of the relationship between research engagement and improved health-care performance,
and, in particular, to help us identify and explore the mechanisms through which research engagement© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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FIGURE 2 Flow diagram of the literature search for the focused (or formal) review.
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22can improve health care. It was intended to build on relevant theories and supplement the focused review.
The papers considered for this wider review included all the papers from the full-paper review stage of the
focused review, plus papers considered potentially relevant from the initial mapping, and ongoing
snowball exercises but which had not been included in the focused review. The papers that were
additional to the 33 ﬁnally included in the focused review were interrogated and sorted into groups
according to the theoretical approaches outlined in Chapter 2 and the emerging categories of
mechanisms. At this stage many papers were excluded from further consideration as they were not
relevant to the issues being reviewed.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8The remaining papers in each category were reviewed in an attempt to identify any that met one or more
of the following criteria:
l despite not meeting the full inclusion criteria for the focused review, nevertheless illustrated positive or
negative ﬁndings about the impact of research engagement on performance, especially on aspects
about which there was a dearth of evidence from the focused review
l had at least reasonably strong empirical data describing progress some way along the pathway from
research engagement to improved health-care performance
l provided a strong descriptive account of initiatives involving mechanisms through which some form of
research engagement might improve health-care performance
l were relevant theoretical and/or review papers that helped illuminate the issues.
We then used papers identiﬁed through this process to help provide a fuller understanding and a context
for our ﬁndings from the focused review about whether or not research engagement improves health-care
performance, and to assist exploration of the suggested mechanisms through which this might happen
(see Chapters 5 and 6).
To produce the full report, team members took the lead in drafting different sections of the three chapters
of this report (see Chapters 4–6) which contain the results of the evidence synthesis. Each chapter was
then reviewed by all team members.© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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Thirty-three papers were ﬁnally included in the data extraction of the focused review.97–129 They included12 of the 13 papers in Clarke and Loudon's review,97–102,104,105,108–111 and an additional 21
papers,103,106,107,112–129 including 10 published since the beginning of 2009114–119,121,123,126,128 when Clarke
and Loudon conducted their search. We had a broader remit and conducted our search in a different way,
but we were able to beneﬁt from knowing which papers they had included and ensuring that our search
terms captured as many of these papers as possible.
Clarke and Loudon reported: ‘We were unable to do a meaningful meta-analysis within any of the
categories because of heterogeneity across the individual studies’ (p. 3).31 This was an even greater
problem for us as our additional papers added even more heterogeneity. The matrix described in
Chapter 2 is an initial attempt to provide us with a way to explore this heterogeneity.
A summary of the papers is presented in Table 2, which describes a range of information for each study,
including the clinical area, research question, methods, outcomes, and further notes for each study. It also
includes information about the ﬁrst four of the ﬁve dimensions on which we analysed the papers, as set
out in Chapter 3. These were: importance; whether the study was positive (or mixed/positive) or negative
(or mixed/negative); the degree of intentionality; and whether the impact was broader or speciﬁc.
Table 2 supplements the account given below, which is divided into three sections based on the three
categories of the degree of intentionality taken from one of the two main dimensions in the matrix
outlined in Table 1 in Chapter 2: by-product, research network and intervention. In what follows, we
collate and explore the collective data about the ﬁve dimensions against which we analysed the papers.
These are the four dimensions examined in Table 2, plus the level of research engagement (i.e. individual
clinician or organisational). The ﬁnal section of this chapter provides a brief overview of our ﬁndings from
all the focused review papers.By-product papersWe included a total of 21 papers in the by-product group.97–117 In this set of papers, the main purpose of
the research engagement of clinicians or organisations was to conduct, or participate in, one or more
studies of the efﬁcacy or effectiveness of some new procedure or therapy. The papers we examined were
separate studies, usually conducted later, that explored the impact on health care that had arisen as
‘by-products’ of the research engagement in the original study.
The 21 papers in this group97–117 included 12 from Clarke and Loudon,97–102,104,105,108–111 and a further nine
papers consisting of four published since the Clarke and Loudon search,114–117 and others that were the
result of our wider inclusion criteria. Some of the additional papers fell into both categories. For instance,
we included papers describing the ﬁndings from two surveys of health-care staff that used regression
analysis to establish a correlation between research participation and improved practice by those staff, one
of which was published prior to Clarke and Loudon's search113 and one after.117
The papers are from a small number of developed countries: USA, 4;99,106,108,110 Canada, 4;100,103,105,117
North America (Canada/USA), 1;109 Germany, 3;102,104,116 UK, 3;97,101,115 Denmark, 2;98,111 Spain, 2;113,114
Finland, 1;107 Australia, 1.112© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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46Of the 21 papers97–117 in the by-product category described above, 1797,99,101–105,107,108,110–117 produced
positive ﬁndings about the link between research engagement and improved performance. We classiﬁed
seven of the positive studies as important to our review.102,110,111,113,114–116 Four papers98,100,106,109 produced
negative, or mixed/negative, ﬁndings and we classiﬁed two of these as important.98,109
Most of the 17 papers97,99,101–105,107,108,110–117 reporting positive ﬁndings described measurable improvements
in the processes of care thought to lead to better outcomes, rather than better health outcomes per se.
Just six studies reported better health outcomes, three of which had been included in Clarke and Loudon's
review (du Bois et al.,102 Jha et al.105 and Majumdar et al.110) and three further studies (Karjalainen and
Palva,107 Pons et al.114 and Rochon and du Bois116).The specific/broader categories
Some of the studies listed in Table 2 show aspects of both broader and speciﬁc impact, but it was usually
clear which was most important in any particular study. We classiﬁed the impact in 1099,102,103,108,110,113–117
of the 17 positive by-product studies as being either entirely, or mainly, in our broader category. We also
classiﬁed six of these studies as being important studies.102,110,113–116 The ﬁrst two102,110 of these are the
examples that were cited in the NHS Confederation brieﬁng3 (described in Chapter 1) that claimed
research engagement does improve health-care performance, and both examples show improved
health-care outcomes not just improved processes. These two102,110 papers show that patients with a
particular disease – ovarian cancer in Germany, and unstable angina in the USA, respectively – have better
health-care outcomes (in terms of survival) if treated in a hospital with a research active team or service.
We classiﬁed the impact of the remaining seven97,101,104,105,107,111,112 of the 17 positive by-product studies as
being speciﬁc, but we classiﬁed only one of these as important.111Comment
It is worth considering what the four negative studies98,100,106,109 in this group tell us. These were studies in
which the hypothesis that research engagement improves health-care performance was not conﬁrmed.
In some studies a negative ﬁnding might reﬂect a limited scope for research engagement to make any
impact. For example, in the study reported by Andersen et al.98 adoption rates of a speciﬁc drug were
already > 66% before the trial, and therefore they suggested that their negative ﬁndings should be
interpreted with caution because the research engagement did not have the scope to operate as it might
in other circumstances.
As noted, if we identiﬁed a study as negative, this meant it did not support the hypothesis that research
engagement improves health-care performance. It did not necessarily mean the health care worsened.
However, several studies, while not themselves demonstrating that health care worsened, highlighted
potential reservations about, and even dangers of, research engagement. Clark et al.100 showed that
sometimes clinicians, including some of those conducting research, can ‘jump the gun’ and start applying
a theoretically attractive therapy before a trial has been completed. In this case, two of the three trials
showed the new therapy had a positive effect, and in the third trial it made no difference; therefore, here
there was no worsening of health care. Jones et al.106 claimed that the ﬁndings of the trial conducted in
their own hospital were not making an impact on practice in the hospital, and we therefore classiﬁed it as
a negative study. However, such examples raise the issue that, in some cases, involvement in trials might
lead to researchers adopting the ﬁndings of their own small trial even when the ﬁndings were not
necessarily the same as those from other studies. Similar pitfalls have been much discussed in the
literature; for example by Grimshaw et al.130 We discuss these important concerns further in the analysis of
the limitations of our review in Chapter 7.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8Network papersWe identiﬁed eight papers in the network group.118–125 All eight come from the USA with three relating to
various breast cancer networks,119,122,125 three relating to the Clinical Trials Network (CTN) of the National
Institute on Drug Abuse,118,120,121 and two describing aspects of PBRNs.123,124
Seven118,119,121–125 of these eight papers were positive about research engagement leading to health-care
improvement, at least in terms of the processes of care. We classiﬁed four118,119,121,122 of these studies as
important, as we did one study120 that reported more mixed ﬁndings, but with some positive claims about
research engagement leading to improvements in health-care performance.
The ﬁve studies that we regarded as important118–122 all focused on the service/organisational level. The
three we regarded as less important123–125 focused on the individual clinician level, including both studies
from the PBRNs.
Three of the studies described broader improved health-care performance resulting from engagement in a
research network;118,119,122 we classiﬁed all three as important, the ﬁrst was in substance abuse and the
other two in the breast cancer ﬁeld. Five other studies120,121,123–125 described a speciﬁc impact in that those
in the network who had been involved in a trial applied the ﬁndings of that study to a greater extent than
other clinicians and centres that had not been involved in the trial. Of these ﬁve studies, we classiﬁed two
as important120,121 and three as less important.123–125The specific/broader categories
The paper by Ducharme et al.120 also highlights the relevance of attempting to apply the speciﬁc/broader
categorisation, so as to analyse the issues arising. The study considered two different therapies for
substance abuse, a pharmacological innovation (buprenorphine) and a behavioural innovation, and three
different aspects of research engagement: prior involvement in trials in general; membership of the
research network (called CTN); and prior involvement in the network's trial of one of the two
interventions. In this study, any impact from prior involvement in trials in general and network membership
would count as broad impact, and participation in the single trial to a more speciﬁc impact. Overall, the
study found no evidence to support the claim that mere membership of the research network alone led to
improvements in health-care performance, but those centres in the network that had been involved in a
trial of buprenorphine were ﬁve times more likely than other centres to have adopted the medication
6 months after a baseline interview, and this is what accounted for the difference in adoption rate
between CTN centres and non-CTN centres. Therefore, this study is inconclusive about there being a
broader impact, but does provide a strong example of a speciﬁc-trial impact in the case of buprenorphine,
but not in the case of the behavioural intervention.
The study by Knudsen et al.121 was a partial follow-up of the Ducharme et al. study,120 conducted
24 months later. It focused on the pharmacological intervention and the comparison was restricted to
centres in the CTN, but it did conﬁrm the positive ﬁnding of the earlier study about the speciﬁc impact of
trial involvement.Comments
Nature of the positive papers
The overwhelmingly positive nature of this set of papers was related to recorded improvements in the
processes of care; none of the studies identiﬁed improvements in health outcomes.Provenance of the papers
All the papers in this group were from the USA. This apparent bias is, we believe, due to the more
substantial history of research networks in the USA. This picture is likely to change as research networks
are now becoming a more important feature in countries such as the UK, and one of several non-US© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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48papers in the wider review is an abstract describing a recently conducted UK study that was presented in
November 2012 while this report was under review.Intervention papersFour papers make up the intervention group,126–129 which contains papers that describe the impact of
initiatives that consist of interventions aimed at improving health care by involving health-care staff in
speciﬁc research studies. Three126–128 come from the USA and one129 from South Africa. Two describe the
VA's QI initiatives that involved research engagement interventions aimed at improving health-care
performance.126,128 The remaining two studies describe interventions that were not part of a major
initiative: Goldberg et al.127 relates to research associated with a continuous quality improvement (CQI)
effort in a large family medical centre, and Puoane et al.129 describe a PAR initiative in two rural South
African hospitals.
One128 of these four studies is positive and two126,129 mixed/positive as, although they have some positive
elements, they are limited in scope. Finally, we classiﬁed one study127 as mixed/negative because the
improvements in health-care performance were examined over a longer period than the intervention
project, but were soon reversed. Most of the improvement described in the studies was in health-care
processes, but some small improvements in health outcomes were reported in a couple of the studies;
however, one of these127 was the study where the improved outcomes were soon reversed when the trial
intervention was withdrawn, and so it was counted as a mixed/negative study and was not included in the
list of positive studies that had resulted in improved outcomes.The specific/broader categories
In all four cases the improvements that did occur related to the use (or increased use) of whatever
approach or therapy was developed in the speciﬁc intervention. Some examples of how the broader
impact category might also be important at the intervention level are discussed in the next chapters.Comment
Even among this small number of studies there was considerable diversity in terms of scope and outcomes.
As discussed further in the next chapter, it was particularly difﬁcult to deﬁne clear inclusion criteria to
enable us to distinguish these papers from the many others describing collaborative research approaches,
QI research initiatives, participatory and action research, and research initiatives at an organisational level.
As we did throughout the focused review, we attempted to identify studies that did have some measure
of research engagement and made some attempt to measure the improved health-care processes and/or
outcomes beyond the lifetime of the speciﬁc research. Many other similar studies that were identiﬁed
during the searches were excluded because they did not fully meet our inclusion criteria but were available
for us to draw on in the wider review.Overall commentsBringing the previous sections together, we have 33 papers,97–129 of which 2897,99,101–105,107,108,110–126,128,129
were positive (with six105,112,115,120,126,129 of those being only mixed/positive) in relation to the key question:
does research engagement improve health-care performance? Of these, 12102,110,111,113–116,118–122 were of
higher importance and 1697,99,101,103–105.107,108,112,117,123–126,128,129 of less importance. Five studies98,100,106,109,127
were negative (of which two100,127 were mixed/negative). Of these, two98,109 were of higher importance
and three100,106,127 of less importance. Four102,110,114,116 of the important studies and three105,107,129 of the less
important ones reported some improvement in terms of health outcomes, whereas the rest reported
aspects of improved processes of care.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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111–113,117,123–125 at the clinician level. Of the 28 positive and mixed/positive papers, 1997,99,102–105,107,110,
114–116,118–122,126,128,129 were institutional and nine101,108,111–113,117,123–125 clinician level. Of the ﬁve98,100,106,109,127
negative and mixed/negative papers, three98,109,127 were institutional and two100,106 clinician level.
Of the 2897,99,101–105,107,108,110–126,128,129 positive or mixed/positive studies, 1399,102,103,108,110,113–119,122 describe
broader impact and 1597,101,104,105,107,111,112,120,121,123–126,128,129 describe speciﬁc impact. Within this overall
balance, there was a contrast between 1099,102,103,108,110,113–117 out of 1797,99,101–105,107,108,110–117 of the
by-product studies showing broader impact (as would ﬁt with the absorptive capacity model), and all the
intervention studies showing speciﬁc impact (as would ﬁt a key element of the collaborative and action
research theories). (We discuss these issues further in the next chapter where we also draw on the papers
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research engagement and performance: exploring
possible mechanisms and drawing on the
wider review
During the literature search we took 473 papers to full-paper review. Only 33 met our full inclusioncriteria for the focused review, but many more contained some material that, we thought, might
contribute to the request in the ITT for a ‘theoretically and empirically grounded assessment of the
relationships, if any, between research engagement and performance’.
Our analysis of this wider body of evidence serves two overlapping purposes. First, it provides
supplementary information and understanding in relation to the ﬁrst question of whether or not research
engagement improves health-care performance. Thus, although we decided that our main focus should be
on studies that measured progress across the whole pathway from the research engagement to the
improved health care, we also recognised that important contributions might be made by initiatives and
studies that involved only some of the steps along the pathway. Second, this wider analysis allows us to
consider a broader range of material related to the plausible mechanisms through which research
engagement might lead to improved health-care performance.
In this chapter we use the matrix presented in Chapter 2 to build on the evidence presented in Chapter 4.
We present our analysis according to the three categories of intentionality used there (by-products,
research networks and interventions) and in each section use the second dimension in the matrix
(a broader or more speciﬁc impact on health care) to explore what the papers studied say about how
that impact was produced. In each section we ﬁrst discuss insights from the focused review papers.
We then expand the discussion to take account of evidence from the wider review and, where relevant,
to the theoretical approaches described in Chapter 2.Mechanisms and further evidence linked to insights from the
by-product papers
Mechanisms from the by-product papers in the focused review
The 21 ‘by-product’ papers97–117 in Table 2 are the largest group in the focused review. In these papers the
main purpose of the original research engagement (by clinicians or institutions) was to conduct, or
participate in research studies to evaluate new therapies, procedures, etc. The by-product papers we
examined were separate studies, usually conducted later, that explored the impact on health care that had
arisen as ‘by-products’ of the research engagement in the original study. Nevertheless, the authors of
these studies examining the impact of the research engagement have sometimes analysed, or speculated
about, what might have caused this impact. In Chapter 2 we suggest that different mechanisms may be at
play when research engagement has a broad impact (the use of research ﬁndings from wherever they
come) as opposed to a more speciﬁc impact (use of research ﬁndings from a speciﬁc study in which the
research engagement occurs). The positive ‘by-product’ papers divide almost equally between those
reporting a broad impact (10 papers99,102,103,108,110,113–117) and those reporting a more speciﬁc impact
(seven papers97,101,104,105,107,111,112).Studies reporting a broad impact
At an individual level, an important mechanism is the change that research engagement can promote in
attitudes and behaviour. Several of our studies surveyed clinicians. For example, Pancorbo-Hidalgo et al.113
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52was closer to the recommendations of clinical guidelines than those who had not and state: ‘We think that
this is because these professionals have more motivation and a more favourable attitude towards the
implementation of research results’ (p. 336). In addition, Salbach et al.117 show that therapists who
reported that they had participated in research were 4.3 times more likely than those who did not to use
the research literature regularly, and claim: ‘It is reasonable that research participation, positive attitudes,
and self-efﬁcacy to implement EBP are inter-related and important factors that facilitate the incorporation
of research ﬁndings into clinical decision making’ (p. 8).
Kizer et al.108 also focus on clinicians, but concentrate more on the processes of trials as being important.
Kizer et al.108 hypothesise that ‘physicians who participate in RCTs both by their prescribing behavior and
their incorporation of drug recommendations in RCT design, apply ﬁndings in the literature more promptly
and thoroughly than physicians in routine clinical practice’ (p. 81).
At an institutional level, an additional mechanism is the infrastructure that may be created to support
trials. This might be used more widely, or for a longer period to improve patient care. Thus Rochon and
du Bois116 claim that ‘patients in study hospitals have a better outcome than patients in non-study
hospitals because hospitals participating in trials accumulate knowledge and develop special infrastructures
associated with study participation’ (p. vii18). Majumdar et al.110 explore whether or not hospital
characteristics essential to hospital-based clinical trials also led to better clinical processes in the form of
adherence to guidelines and better patient outcomes, and suggest that the key characteristics are
physician leadership, shared goals and infrastructure support. These authors do not explicitly revisit these
factors in their later analysis but they do claim to have ‘demonstrated an independent association between
hospital trial participation and outcomes’ (p. 662). Looking at the other side of the coin, Chen et al.99
suggest that the reasons for lower uptake of new treatments at community hospitals and centres
compared with teaching/research facilities ‘may be lower awareness of treatment advances, lack of
multidisciplinary expertise or availability of speciﬁc treatments at the facility, or referral bias’ (p. 837).Studies reporting a specific impact
Where the focus is on speciﬁc impact linked to the research engagement of individual clinicians,
mechanisms such as a greater awareness and understanding of the speciﬁc research ﬁndings might come
into play, with clinicians being more likely to implement the ﬁndings of a speciﬁc study on which they
were working. Meineche-Schmidt et al.111 claim that ‘experienced GPs [general practitioners] import
treatment modalities from the trial into the daily clinic’ (p. 1124), the inference being that their research
experience allows them to understand those modalities better than their colleagues who are not working
on that study.
At the institutional level, the processes and protocols applied in a speciﬁc study (not counting any impact
from the regimens in the intervention arm) can lead to improved health-care performance. Two studies
that are quite difﬁcult to classify demonstrate this. Karjalainen and Palva107 highlight the role of
study protocols:NIHRThe patients in the trial area benefited from the clinical trials, which suggests that the use of a
treatment protocol improves the end results of treatment. In other words, the results favour a
systematic treatment schedule in preference to a schedule determined by the free choice of
a clinician.
p. 1069107Janni et al.104 show how being part of a study meant that 80% of centres who responded to their survey
claimed to have noted an improvement in their professional knowledge because of the regular ﬂow of
information via newsletters, study meetings, etc. According to Janni et al.,104 ‘these results support the
hypothesis that carrying out the study has a positive effect on the current medical care of participating
patients, irrespective of the knowledge gained later from the actual ﬁndings of the study’ (p. 3665).Journals Library www.journalslibrary.nihr.ac.uk
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papers linked to the by-product concepts
The above section described a range of suggestions, or speculation, about the mechanisms through which
research engagement might result in improved health-care performance. However, none of the
suggestions were made by more than one or two authors, or supported by a range of evidence.
Here, therefore, we draw on both the focused review and the wider body of evidence, and, in particular,
two analyses published in 2011. These are by Krzyzanowska et al.95 from the Selby set of papers, and by
Kahn et al.131 from a set of three papers131–133 describing a RAND Corporation (RAND) study funded by the
National Institutes of Health (NIH) in the USA that explored a range of issues related to translational
research. Neither of these two analyses speciﬁcally associate themselves with the by-product concept, but
some of their thinking helps to inform the analysis here. The ﬁrst provides useful insights into the range of
mechanisms that might be at work. The second demonstrates how an increasing recognition of the
‘by-product’ type beneﬁts from research engagement has encouraged further thinking about how best to
build on and regularise these opportunities.
Krzyzanowska et al.95 describe various potential mechanisms through which outcomes may be improved in
research-active settings. These include the possibility that research-active staff may be systematically
different from their peers in non-research-active settings. They offer several possible explanations,
including the personal characteristics of the staff, multidisciplinary collaboration, additional training and
education, or through specialisation. They suggest that ‘acquisition of new skills or technology as required
for some clinical trials may lead to their systematic application and outcome improvements throughout an
institution or health system’ (p. vii11).95 They also claim that the conduct of clinical trials often requires
new physical infrastructure such as specialised equipment that might remain once the research
is complete.
Kahn et al.131 suggest engagement in research can beneﬁt community clinicians by helping them to remain
current with new innovations and to learn and implement what is best for their patients. They also suggest
some factors that might be particularly relevant for the USA context but can have wider application. They
claim that many patients seek out clinicians who are at the cutting-edge of research and thus provide
access to the best diagnostic and treatment options: in a competitive system this could mean that a higher
proportion of patients are receiving care from such clinicians. More generally, they suggest that ‘Clinician
participation in research builds infrastructure that can facilitate engagement with managed care’ (p. 2).131Absorptive capacity and broader impacts including attitudes and capacities
The idea that those conducting research have an attitude, capacity and interest in examining and possibly
adopting the research conducted by others ﬁts most neatly with the original absorptive capacity concept
developed by Cohen and Levinthal37,38 in relation to the beneﬁts for industrial companies of funding some
of their staff to conduct research. We saw this in the focused review in, for example, the surveys of
nurses113 and therapists.117 The concepts here are consistent with our broader level of impact because the
research that is absorbed is part of the global stock of knowledge rather than research produced
by themselves.44
Further support for these ideas comes from other papers from our wider review papers, often from studies
exploring research utilisation – a key step in the pathway between research engagement and improved
performance. Belkhodja et al.132 conducted a rigorous study of the extent and organisational determinants
of research utilisation in Canadian health service organisations that did not quite meet our inclusion criteria
for the focused review because it did not demonstrate improved health-care performance. This paper drew
on the absorptive capacity concepts (though primarily the revised version from Zahra and George41).
Following a large-scale survey, the regression analysis Belkhodja et al.132 conducted on a range of factors
linked to research utilisation by managers and professionals revealed that previous research experience was
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54Various studies examined research engagement and research utilisation by nurses, including a trial by
Tranmer et al.133 This was the one study included in the Clarke and Loudon review31 that we felt did not
quite meet our inclusion criteria because it mainly focused on attitudes towards research and research
utilisation per se, rather than on changes in health-care processes or outcomes (research utilisation scores
were higher for nurses who had been involved in research participation units than for nurses in units that
did not participate). Niederhauser and Kohr134 reported that conducting clinically relevant studies was seen
by clinicians as a facilitator of research utilisation. Tsai135 also demonstrated a link between research
participation and research utilisation. Other smaller studies (e.g. that of McCoy and Byers136) amount to
‘insider accounts’ which provide a comparison only over time rather than with other comparable
institutions, but which, nevertheless, add further examples of how increasing the research engagement of
nursing staff can help facilitate EBP. Some studies applying the Payback Framework explicitly used the
concept of absorptive capacity to help explain how engagement in health research can lead to beneﬁts
beyond the direct ones from the research ﬁndings.44
There is therefore some evidence of an association between engagement in research and being open to
and implementing new ideas. Overall, it seems reasonable to suggest there is growing evidence to support
the idea that research engagement by itself seems to engender research utilisation, which is a step
towards improved health care.
It will always be difﬁcult to establish the direction of causality between conducting research and having an
attitude of being open to, and seeking out, new ideas on how to improve patient care. However, there is
some evidence of the two going together, at least in the accounts of some medical academics.137 Some
evidence to support this comes from a study in the USA in which a team of researchers interviewed 24
clinically excellent internal medicine physicians at eight academic institutions.138 The collation of these
interviews provides self-reported evidence from these physicians about how their practices were inﬂuenced
by the emphasis on research, including one who claimed:NIHRI think in an academic model you have to still maintain an academic interest which I would define as
not just wanting a status quo, but wanting to always get better and also having the interest of
developing better practices.
p. 482138One among many reasons claimed for the successful improvements in health-care quality achieved by the
VA in the USA (see Chapter 6 for a detailed discussion) is that the funding provided to medical academics
to allow them to spend some time conducting research made the VA an attractive destination for some of
the highest quality physicians.139Absorptive capacity and specific impacts
Perhaps the most basic aspect of the idea that participation in a study leads as a by-product to improved
health care occurs at what we have classiﬁed as our speciﬁc level of impact, and comes about because
those who conducted the study implement its speciﬁc ﬁndings more rapidly than others. However, the
mechanisms at play here do not relate to the classic version of absorptive capacity discussed above. Instead
they are more akin to those identiﬁed as belonging to the ‘stages of innovation’ model and probably
relate to the superior knowledge and understanding of the ﬁndings, and perhaps trust in their validity, that
is gained through participation in the speciﬁc study. This was shown in the Meineche-Schmidt et al.111
study from the focused review. Meineche-Schmidt et al.'s111 conclusions reﬂect an earlier report of a survey
of 54 British radiology units140 that noted that almost half the respondents participated in clinical trials and
claimed that centres:. . . able to participate in clinical trials were more likely to change practice than those who were not.
Most of the 63% of respondents using a one or two fraction regimen had participated in clinical
trials, and “trial results” was the most frequently cited reason for change in practice.
p. 72140Journals Library www.journalslibrary.nihr.ac.uk
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research systems and attempts are being made deliberately to foster them in some of the initiatives
described later. Daniel et al.141 claim that participation in ‘national demonstration projects by hospitals
provides opportunities for learning, collaboration, and early improvements’ (p. 301). There are of course
important differences between research engagement, and activities merely aimed at promoting
implementation. We could use Rogers' distinction,52 drawn from Myers,142 between ‘(1) experimental
demonstrations, which are conducted to evaluate the effectiveness of an innovation under ﬁeld conditions,
and (2) exemplary demonstrations, which are conducted to facilitate diffusion of the innovation to other
units’. And even with Rogers' ‘experimental demonstrations’,52 as with similar approaches, the scope of
the mechanisms that link research engagement to speciﬁc impacts will be limited because clinicians will
not improve health care solely by implementing studies in which they have been involved.143
Nevertheless, it is possible that we can expand the concept of a speciﬁc impact because we can also ﬁnd
evidence from the wider review of a local effect in which health-care staff in one region of the English
NHS had a particularly favourable attitude towards a local programme of research.144 In such instances, it is
the fact that health-care staff know (and trust) the local researchers that might create the impact: they do
not actually have to have conducted the research themselves. The diffusion of innovation literature has
long put emphasis on the role of informal social networks as a means by which ideas are spread, with the
research in the medical ﬁeld by Coleman et al.145 making an important contribution. It is possible to see
how a wide distribution of research-engaged medical academics within a health-care system could help
the uptake in their localities of the speciﬁc treatments with which they had been involved in trials.
What we have said about attitudes and behaviour change emphasises the positive impact of engagement
in research, as did the majority of papers in the focused review. It is also important to note, however, that
the wider review provides evidence that many clinicians do not view research engagement as a way of
improving the health care they provide. Following an extensive series of interviews, Kahn et al.131 list many
barriers that clinicians in the community identiﬁed regarding participation in research, including the view
that the study questions were not pertinent to topics of interest to themselves, their practice or their
patients. Furthermore, they report ‘Clinicians need reassurance that research engagement does not
threaten the doctor–patient relationship’ (p. 6).Processes of care and building team and institutional infrastructure
The analysis of building capacity through research activities can be taken further, and here there can be a
building from speciﬁc impacts to broader impacts. It is claimed that the process of designing and
conducting research involves the accumulation of knowledge and skill (and sometimes teams) that will be
necessary for the research, but can also be a mechanism for improved health care. Several studies in the
focused review described how the protocols and processes developed for research studies could then be
applied more widely to the clinicians' patients outside as well as inside the trial, thus providing improved
health care.104,107
Further evidence to support these concepts comes from Haynes et al.146 Haynes et al.146 conducted an
international study exploring whether or not the implementation of a 19-item surgical safety checklist
(based on research and designed to improve team communication and consistency of care) would reduce
complications and death. The study found the implementation of the checklist was associated with
reductions in the rate of death and complications. Although the implementation of the checklist in this
study was the primary purpose and not a by-product, it provides evidence to support the concept of
by-product beneﬁts from the protocols developed and used in primary research studies. Furthermore, the
improved processes from one study can then be carried over through being incorporated into aspects of
the protocols used in subsequent studies.
Some studies from the focused review take the argument even further and explain attributes of the setting
in which care is delivered, such as accommodation, equipment and personnel, which are brought in to
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56Rochon and du Bois116 suggest that their model ‘rather implied the hypothetical assumption that patients
in study hospitals have a better outcome than patients in non-study hospitals because hospitals
participating in trials accumulate knowledge and develop special infrastructures associated with study
participation’ (p. vii18). They further suggested that their hypothesis was supported by the data that the
observed beneﬁts from study participation were not limited to the patients in the trial, but were obtained
by other patients in the trial hospitals. The medical academics interviewed in the US study reported above
also thought that although research took up time that could be used directly in health-care provision, it
also brought in more resources that could be used to provide better clinical care.138Building and spreading the capacity to benefit from the by-products of
engaging in health research
We have seen that Zahra and George41 deliberately reconceptualised the absorptive capacity concept. We
believe one facet of the original deﬁnition that is often overlooked is the key to our analysis of how the
absorptive capacity concept contributes to understanding the mechanisms. This is the notion that it is the
actual processes of research engagement that help prepare health-care staff and organisations to be able
to absorb and use research and thus improve health care. Although this older notion still seems
appropriate, we also agree with much of the newer literature on absorptive capacity that promotes the
deliberate fostering of the capacity of institutions to be able to absorb research so as to produce beneﬁts.
Along somewhat similar lines and as the type of issues discussed so far in this chapter are perceived to be
important, then increasingly there are deliberate attempts to promote ‘by-product’ beneﬁts. This might, in
particular, be viewed as a desirable consequence of initiatives designed to boost clinical research such as
the US NIH's 2003 Roadmap for Medical Research. This is the initiative discussed in the RAND series of
articles referred to earlier in this section.131,147,148 Inevitably, such initiatives overlap with the network and
collaborative approaches discussed later in this chapter. We did not identify any articles that show whether
or not the research engagement encouraged by this NIH initiative has led to improved health-care
performance. However, an article from 2012149 describing the progress made set out the wide scope and
aims of the NIH in promoting this. The authors claimed that by increasing community-based provider
participation in research (CBPPR) in various ways:NIHR. . . through Clinical and Translation Science Awards, federally funded provider-based research
networks, and other mechanisms, the NIH has sought to advance the science of discovery by
conducting research in clinical settings where most people get their care, and accelerate the
translation of research results into everyday clinical practice.
(p. 3)149Mechanisms and further evidence linked to insights from the
network concepts
Mechanisms from the research network papers in the focused review
The set of eight papers in the networks section of Table 2118–125 describe the situation broadly in the
middle of our spectrum of intentionality. We again apply the broader/speciﬁc categorisation, but on this
occasion start with the speciﬁc category because it seems that some mechanisms at work here, especially
in the adoption of research ﬁndings from the speciﬁc research in which the practitioners participated, are
similar to those described above from the by-product category.Studies reporting a specific impact
At an individual level, two studies describing the impact of different trials in the PBRNs in the USA,
Rhyne et al.123 and Siegel et al.,124 both show how clinicians involved in a trial in the network adopted the
ﬁndings from their speciﬁc trial to a greater extent than did other clinicians. In both cases the authors
thought the network had inﬂuenced this rapid adoption. Relevant factors included the increased relevance
of the research, and the increased knowledge and understanding of the ﬁndings gained throughJournals Library www.journalslibrary.nihr.ac.uk
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the reported changes; (1) focus of the PBRN study on an area of concern for clinicians; (2) interactive
clinician education . . . (3) rapidly diagnosed condition; (4) “teachable moment”; (5) increased clinician
self-efﬁcacy’. The authors also note several of these components of PBRN ‘while not exclusive to PBRNs,
are accomplished more effectively and efﬁciently through the longitudinal structure of a PBRN’ (p. 501).
Along similar lines, Siegel et al.124 claim that their results ‘suggest that implementing a study in a PBRN
had a positive and lasting effect on the study practitioners. This effect also shows that PBRNs can be
successful in translating research into practice’ (p. 523). The evaluation by Warnecke et al.125 of a
research network created by the US National Cancer Institute (NCI) [the Community Clinical Oncology
Program (CCOP)] reinforces this message and adds further detail. They suggest the CCOP model in
which community physicians' participation directly in clinical research probably works best is when the
science is changing rapidly and when keeping current with these changes is critical: ‘The theory by
which the treatment is justiﬁed is intelligible, thereby reducing uncertainty about the new treatment,
because participating physicians attend scientiﬁc meetings where the rationale is discussed as protocols
are developed’ (p. 338).
At an institutional level, Knudsen et al.121 show that the centres involved in a trial, and who had therefore
applied the protocol, were over six times more likely to have adopted the drug trialled 24 months after a
baseline interview than centres in the network that had not been involved in the trial. They claim that this
speciﬁc impact, at the institutional level, ﬁts with the theory from Rogers69 about the ‘trialability’ of
innovations being important in allowing organisations to gain experience of them on a limited basis:
‘Clinical trials offer such experience, where an organization does not have to commit to longer-term
adoption but can try an innovation for a limited period with a speciﬁed number of clients’ (p. 311).
Perhaps the main distinguishing feature between this situation and some of the by-product mechanisms
described above is that centres in networks are likely to be more frequently involved in clinical trials than
others, and, therefore, might have this opportunity more frequently.
The study by Knudsen et al.121 was a follow-up to an earlier study120 conducted 6 months after the
baseline interviews and this also found those centres involved in the trial had adopted the drug trialled to
a much greater extent than either other centres not involved in the trial, or other similar centres not in the
network. This provided strong evidence about the speciﬁc impact of research engagement through the
network, but also showed, in this instance, that there were no broader beneﬁts from research
engagement through involvement in the network where that did not involve trial participation. A further
issue in this case was that those centres that had been involved in a trial of a different treatment did not
adopt it any more rapidly than other centres. In contrasting the adoption pattern of these two treatments
that had been the subject of trials, the authors noted that the second treatment had been around for
longer and had been more widely adopted prior to the trial conducted in the network. Therefore, they
suggest the second treatment was ‘comparatively farther along the “S-shaped curve” that characterises
the diffusion of innovations (Rogers, 1995). It may be that different models are needed to understand the
adoption of innovations in the earlier stages versus the later stages of diffusion’ (p. 328).120 This is an
important point for our analysis; it suggests that the experience of conducting a trial on an innovation
might not encourage adoption of innovation (through the knowledge gained about it) when that
innovation is already quite widely adopted. This is consistent with the ﬁndings of Andersen et al.98 in the
focused review (see Chapter 4).Studies reporting a broader impact
At an institutional level, three network studies show that institutions in a research network adopted
various forms of EBP to a greater extent than comparable institutions not in the network.118,119,122 Each of
these studies, however, highlights different facets of networks as a mechanism. Abraham et al.118 suggest
that centres within networks may build up a record of implementing research ﬁndings: ‘These ﬁndings
support the idea that exposure to the process of implementing innovation treatment technologies over
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58factors such as network membership possibly increasing the likelihood of physicians recommending
guideline concordant treatment and suggest that they ‘may be useful in improving the quality of
care’ (p. 471).
The study by Carpenter et al.119 raises issues that are of wider interest. For example, whereas institutional
membership of a network was shown in the multivariate analysis to be associated with greater uptake of a
new treatment, other organisational factors previously associated with cancer care quality – teaching
afﬁliation and surgical volume – did not contribute independently to the early adoption of innovative
breast cancer treatments. The precise nature of the mechanisms at work are difﬁcult to disentangle
because the study examined the effect of membership of two research networks with some overlapping
membership, with the highest adoption rates being for those afﬁliated to both networks. However, a
higher adoption rate was associated with membership of the American College of Surgeons Oncology
Group (ACOSOG) alone than with membership of the other research network alone. The range of reasons
suggested by Carpenter et al.119 include the integrated, programmatic approach to improving the quality
of cancer care in organisations afﬁliated to the ACOSOG, plus the professional education, training and
national meetings provided by the college ‘which would reinforce the external communication associated
with this afﬁliation’ (p. 177). The authors examine adoption patterns over several years, and show that the
impact of network membership was greatest in the period nearest in time to when the intervention was
approved by Medicare. They, too, draw on Rogers52 and claim ‘These ﬁndings reinforce diffusion theory,
which speciﬁes S-shaped diffusion curves that differ between early adopters and later adopters’ (p. 176).119Expanding the analysis with additional evidence from the wider review
linked to the network concepts
The mechanisms associated with research networks represent a partial establishment and use on a regular
basis of some of the points discussed in the by-product section. A range of studies from the wider review
provide further evidence to support the examples from the focused review of how the PBRNs themselves
might be seen as effective mechanisms. These include two papers explaining how there were some
improvements resulting from the Dental Practice-Based Research Network.150,151 The papers indicate
various ways in which mechanisms associated with the operation of this dental network might lead to
improvements in health care, including through attendance at network meetings.
In 2005, Mold and Peterson152 analysed the role of PBRNs and suggested that PBRNs operate at the
interface between research and QI. Mold and Peterson152 claimed that ‘PBRNs appear to be evolving from
clinical laboratories into learning communities, providing grounds for generalisable solutions to clinical
problems, and the engines for improvement of primary care delivery systems’ (p. S12). Their discussion of
this evolution, and of the mechanisms through which the improved health-care performance is achieved,
ties in with the distinctions we make in our matrix. First, they make the ‘by-product speciﬁc impact’ point
that when clinicians participate in a project they are more likely to use the results. Second, they show that
there are a range of mechanisms (including practice facilitators, project development meetings and
network convocations) that allow two-way knowledge exchange through the research network, enabling
clinicians to engage with question generation and the conduct of the resulting research, and ensuring
therefore that the research is more relevant to practitioners.
Mold also co-authored a systematic review of the role of practice facilitators that showed that health-care
professionals who assist primary care clinicians in research and QI projects play an increasingly important
role in PBRNs.153 A 2004 report analysed publications from several PBRNs and suggested that these
networks ‘overcome the second translational block . . . [and] have the potential to help translate our rich
basic and clinical knowledge into patient care’ (p. III-47–III-48).154 A further illustration of the expanding
and evolving role of PBRNs, and, potentially, their part in enabling research engagement to improve
health-care performance, comes from the suggestion in a 2011 commentary by Williams and Rhyne155 that
they should be renamed as ‘Health Improvement Networks’.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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NCI CCOP, is also a PBRN. Its work is discussed in detail in a descriptive study in which Minasian et al.56
identify various mechanisms through which this programme operates, including:
l the provision of relevant training and educational opportunities thought necessary to maintain
high-quality research
l two-way communication between academic researchers and community physicians involved in the
research network including at conferences where topics include planned or ongoing trials, trial
management, etc., and at which community physicians may gain greater understanding about why
certain research protocol features are important.
Minasian et al.56 conclude that ‘The CCOP network is an example of how PBRNs can be mechanisms to
effectively address the challenges facing clinical research and practice; continue medical progress that
beneﬁts patients, providers, and society; and more effectively translate research into practice’ (p. 4446).56
Further evidence from the wider review about the impact of cancer research networks comes from
Aiello et al.,156 who show how integrated health-care delivery systems in the US Cancer Research Network
rapidly adopted the positive results of randomised controlled trials (RCTs) on adjuvant aromatase inhibitor
treatment even before the full process of guideline development had been completed. Its ﬁndings are
consistent with other studies from cancer research networks which were better controlled.
The wider review, therefore, does provide more evidence about how research networks act as a
mechanism (operating through a variety of detailed approaches) through which research engagement can
improve health-care performance.Limitations and the potential importance of context
The wider review also allows a more rounded assessment because some studies reveal limitations to what
can be achieved by research networks. Bodenheimer et al.157 analysed data from 17 PBRNs who received
grants to study and encourage the adoption of interventions to improve patients' health-related
behaviours. Here the focus was primarily on the role of practice-based research per se as a facilitator of
practice improvement, rather than on the role played by the networks themselves. Lessons emerged about
sustainability of the approach and a potential conﬂict between improvement goals for all practices and the
requirement that some practices be in a control arm.
Teal et al.149 analysed the implementation of the US NIH's Roadmap for Medical Research (mentioned
above) and report that the community practice organisations varied in how far they were able to achieve
the objectives of the CBPPR initiative. They highlight the importance of context and claim that, by doing
research in their own practice settings, providers may feel a greater sense of ownership and trust in clinical
research results, which in turn may increase their commitment to acting on research ﬁndings, ‘CBPPR does
not occur spontaneously or effortlessly. To participate in research, community-based providers often must
implement systematic changes’ (p. 18). The authors continue by explaining that providers ‘must develop an
organizational culture (shared values) that supports CBPPR and evidence-based practice . . . CBPPR is
difﬁcult to create and sustain in the absence of management support from local, afﬁliated hospitals and
health systems’ (italics added). Almost echoing Williams and Rhyne,155 Teal et al.149 suggest that it might
be useful to frame CBPPR as ‘quality enhancement’ rather than ‘research’. They also note several ways in
which the research network of the NCI had in fact actively engaged with the chief executives of
participating hospitals and health-care systems to provide support.
Similarly, the study by RAND that examined the circumstances necessary for the NIH's Roadmap for
Medical Research to be successful identiﬁed various weaknesses in current research networks, especially
the PBRNs, that limited their scope for achieving successful health-care improvements.148 They suggest that
‘PBRNs are not in a position to provide sufﬁcient infrastructural support to consistently engage clinicians
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60Studies from outside the USA
The wider review also identiﬁed some evidence of a growing international interest in the beneﬁts that
might come from research networks. In the UK, a comparative case study of four primary care research
networks158 drew on guidance for managing clinical networks published by the NHS SDO programme159
and concluded that generic primary care networks can help to integrate academic and service initiatives.
The authors suggest that primary care organisations ‘may be ambivalent about engaging in research if they
see it as a distraction from service priorities’ (p. 239),158 and may fear that research participation will
become a barrier to practice improvement, citing Bodenheimer et al.157 to support this claim. This study
focused on research process and did not report any health-care outcomes; it was also conducted prior to
the introduction of the system of research networks that is now a central feature of the NIHR.
A paper by Darbyshire et al.57 in the 2011 supplement of the Annals of Oncology provides a detailed
descriptive account of the development and role of clinical research networks within the NHS, and
concludes that there is compelling evidence that ‘Patients and health-care professionals from all parts of
the country are able to participate in and to beneﬁt from clinical research and that health research and
patient care are being integrated’ (p. vii42). In addition, an abstract presented in November 2012 describes
the preliminary analyses from a study that aimed to determine whether or not the increase in National
Cancer Research Network colorectal cancer research activity was associated with improved outcomes for
colorectal patients in the NHS. Preliminary analyses indicate there was a signiﬁcant reduction in 30–day
mortality and improvements in survival for patients treated in high research activity hospitals compared
with those with no activity.160 Whicher et al.161 describe how a research network in Ontario, Canada
supported comparative effectiveness research that linked decision-making with evidence generation in a
transparent and efﬁcient way. A study from Germany162 describes how evidence from the USA about the
beneﬁts of networks is being adopted in Germany with the creation of a morbidity registry in the ﬁeld of
general practice. It seems likely that the international evidence about the impacts from research networks
will continue to grow.Mechanisms and further evidence linked to insights from the
‘intervention’ papers: collaborations and action research
Mechanisms from the intervention papers in the focused review
There are four ‘intervention’ studies in the focused review.126–129 These are studies in which the degree of
intentionality (about achieving health gain from research engagement) is high. The interventions described
include collaborative approaches, QI research initiatives, participatory and action research, and
organisational approaches where the intention is explicitly to produce improvements in health-care
performance as a direct consequence of the research engagement of the organisation.
These papers largely describe the adoption of the speciﬁc research that featured in the intervention.
However, they also raise issues about how broader impact can be achieved throughout an organisation
which, not surprisingly, resonate with those explored above about how research networks operate: issues
such as the importance of effective collaboration and the need for a supportive context.
Thus, in a report of QI research conducted in the Department of Veterans Affairs, as part of its QUERI,
Hall et al.128 conclude: ‘Providers believed that the collaborative produced a “culture change” from patient-
centered to family-centered care and viewed program leadership and health services researchers' involvement as
crucial for success’ (p. S18). This illustrates the importance of collaboration as a mechanism through which
research engagement can improve health-care performance. In addition, a report of an action research project129
also illustrates the value of involving stakeholders in research aimed at improving local clinical services.
A study by Chaney et al.126 of another VA initiative had an extremely complex protocol; it describes
collaboration at more than one level – a collaborative approach to redesign was taken to encourage the
use of an evidence-based collaborative care model.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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whether or not delivery systems could be designed to conduct CQI as part of clinical care provision. It
involved researchers working with practitioners and experienced initial success. However, the successes
were reversed when resource constraints meant the support structures associated with the trial were
discontinued. According to the authors, health-care systems can, by conducting such trials, ‘become
learning organizations. CQI programs of all kinds will likely never ﬂourish, however, until QI and
reimbursement mechanisms have become better aligned’ (p. 156). They claim, therefore, that system
change is superior to educational interventions.Expanding the analysis with additional evidence from the wider review
linked to the concepts of collaboration and action research
Many reports on collaborative or action research studies did not get into our focused review for a number
of reasons, but nevertheless can make a contribution that adds to the insights. There are overlaps within
this category, as when collaborations may adopt a participatory action approach, and between this
category and others, but we discuss each group separately.Collaboration
There is a large literature on collaborative approaches. Over 40 papers met the criteria for our full-paper
review, but most did not get into our focused review for various reasons (e.g. they did not cover the whole
pathway from research engagement to improved health care, and/or they were descriptive insider accounts).
Here we draw in particular on studies that were included in major reviews, although in some cases the
reviews were themselves conducted to inform evaluations. We start by considering an example of the
latter from the ﬁeld of health services management, an area in which it is often thought difﬁcult to
achieve evidence-based management163 let alone to demonstrate that research engagement by managers
leads to improved health-care performance. In 2012, Bullock et al.164 published an article, ‘Collaboration
between health service managers and researchers: making a difference?’ describing key ﬁndings from their
formative evaluation of the SDO's Management Fellowship Programme that was set up to ‘encourage
greater engagement, linkage and exchange between research and practice communities in health-care
management’ (p. 12).165 Here the main mechanism is a relatively intensive approach in which an NHS
manager is placed with a selected SDO-funded academic research project as a Management Fellow,
usually for 12 months full-time equivalent over the life of the research project.
The evaluation concludes that all those involved thought that the Management Fellows had improved the
quality and relevance of the research and, in a small number of cases, were beginning to develop capacity
as conduits of research ﬁndings in the workplace. The range of capabilities developed by the Fellows
included being able to assess, appraise and use research. However, there is also some evidence of
‘improved management skills and improved personal conﬁdence’ (p. 14). Nevertheless, a number of
limitations were identiﬁed, including that ‘engagement structures were often not in place’ (p. 15). Overall,
this evaluation suggests that some broader impacts are beginning to emerge from the research
engagement, but no evidence is given of improved health-care performance.
Bullock et al.165 also conducted a targeted review of previous research partnership programmes which found
that there ‘were a number of existing or past programmes which focused on improving implementation,
using a collaborative approach, but few ﬁtted the model of the SDO Management Fellowships and fewer
still were evaluated’ (pp. 29–30).165 This indicates that this particular mechanism has not been used very
much. As a more general context to the article describing the evaluation, Bullock et al.164 highlight some of
the most relevant previous studies, and claim ‘The few evaluations of collaborative research programmes,
largely from outside the UK, indicate positive outcomes’ (p. 3). Three articles are cited to support this
statement,166–168 but none of these three studies met the inclusion criteria for our focused review.
In the ﬁrst, Denis et al.166 evaluated a Quebec Social Research Council (CQRS) grant programme to
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62transform scientiﬁc knowledge production and professional practices. Both researchers and practitioners
agreed their involvement within collaborative research teams contributed to the development of new skills
and practices, and fostered the implementation of new modes of knowledge production and intervention.
Both groups, however, encountered some difﬁculties in putting the dimensions of the collaboration that
they valued into practice.
The second involved research programmes funded by the CHSRF in which health system managers and
public policy-makers participated in research programmes. It was, on balance, a beneﬁcial experience
according to the participants.167 A key ﬁnding for our review is that several interviewees referred to the
participating decision-makers becoming ‘more reﬂective about their activities’ (p. S2:30). Again, this is a
long way from showing improved health care, but it is a step on the pathway.
The Canadian examples, combined with the theoretical position of linkage and exchange,64 developed by
Lomas at the CHSRF, illustrate a considerable interest in developing collaborative programmes as a way of
improving health-care performance through research engagement. A considerable degree of collaborative
activity has been further stimulated by the Canadian Institutes of Health Research (CIHR).
Other signiﬁcant examples from Canada include an evaluation of the Need to Know Project in Manitoba,
Canada, that was funded by the CIHR,169 and successful attempts to engage health-care managers in
research in Canada through the Executive Training for Research Application (EXTRA) Program funded by
the CHSRF.170 In the latter, the 26 participants in the second cohort were surveyed at entry and at
graduation nearly 2 years later. The proportion who thought their knowledge of research-based evidence
was excellent or very good increased from 17% to 90%, and the proportion who thought their ability to
promote the use of research in evidence in their own organisation was excellent or good increased from
16% to 86%.
Another of the extensive attempts to evaluate partnership initiatives in Canada involved a further
evaluation of the CQRS and showed how the collaborative nature of the research undertaken increased its
applicability to health and social service institutions.171
However, the ﬁndings are not always positive. Work in Canada on the collaborative approach has also
identiﬁed situations in which the engagement does not always lead to increased use of the ﬁndings
compared with those not engaged in the study. Kothari et al.172 examine the responses to a report on
performance in breast cancer prevention by three units that were involved in the development of the
report, and three units for whom it was relevant but were not involved in its development. The authors
report that the interacting units had a greater understanding of the report's analysis and attached greater
value to it, but:NIHR. . . interaction was not associated with greater levels of utilisation in terms of application. Both
interacting and comparison units used the research findings to confirm that their ongoing program
activities were consistent with the research findings, and to compare their performance relative to
other units.
p. 117172There are also partnership initiatives in the USA that have some similarities with those described above
from Canada. Two studies of these were included in the focused review.126,128 There are a range of others
that did not get into our focused review. For example, Gold and Taylor173 indicate that 30 out of a set of
50 collaborative projects had some operational effect, but the details were not sufﬁciently well described
for inclusion in the focused review. In the USA, there are also more comprehensive and long-term
organisational approaches such as the VA. (These are considered in the next chapter.)
The impact that can be made by the collaborative approach in general has been demonstrated in several
systematic reviews, including those by Lavis et al.85 and Innvær et al.86 (described in Chapter 2). Many ofJournals Library www.journalslibrary.nihr.ac.uk
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policy-makers' use of research rather than on health-care performance and, second, because the nature of
the collaborations meant it was not always clear how far it focused on engagement in research, as
opposed to collaborative efforts after the research had been conducted. Nevertheless, Lavis et al.85 provide
quite a strong endorsement for the principle of collaboration with their conclusions that ‘interaction
between researchers and health-care policy-makers increased the prospects for research use by
policy-makers . . . relationships with or involvement of health care staff in the research process increase
the prospects for research use by managers’ (p. S1:39).
Although there was less evidence for the second of these conclusions than the ﬁrst, the second is more
relevant to our review. Just three papers were found to support this, and although none of them went
quite far enough to meet the inclusion criteria for our focused review, they all make important points
about collaboration as a mechanism through which research engagement might lead to improved
health-care performance. Harries et al.174 and Elliot and Popay175 describe the same study and attempt to
identify factors facilitating or impeding evidence-based policy-making at a local level in the NHS. They
show the importance of continued dialogue between researchers and those in the NHS who commission
the research and who could become involved in the research process. The third study was an early one by
Glaser and Taylor176 who examined a range of applied projects funded by the National Institute of Mental
Health in the USA. This paper provides support for the claim that engagement in research by members of
an organisation increases the relevance of the research and the likelihood that its ﬁndings will be used.
Speciﬁcally, Glaser and Taylor176 claimed of the practitioners in the host agency, if they ‘were actively
involved in the development of the project, if they had good rapport with the research team and did not
feel exploited, if their responses to the developing ﬁndings were sought and heeded, then there was
greater likelihood that they would use the ﬁndings in their practice.’ The authors also suggested that such
an endorsement also ‘would be instrumental in promoting use of the ﬁndings in comparable agencies
elsewhere’ (pp. 144–5).
Further examples of how the collaborative approach contributes to progress along the pathway from
research engagement to improved health-care performance were included in a review33 of studies
assessing the impact of health research. Two of these studies show how the Health Technology
Assessment (HTA) programme in Quebec involved some levels of collaboration between researchers and
users of the HTAs, and the reports produced made some impact in the health-care system.177,178 In the
third paper, the Alberta Heritage Foundation for Medical Research assessed the impact of a series of
projects that it had funded and found that there was some evidence to conclude that research teams that
included decision-makers or users were more successful than those that did not.179
Furthermore, there are a few case studies within larger sets of case studies of research impact
assessments46,180 that might have met our inclusion criteria but it did not seem suitable to include such
individual case studies in the focused review. Nevertheless, they provide further demonstrations of the
health-care beneﬁts that can come from the collaborative approach.
Evidence about the value of collaborations also comes in the form of the increasing number of initiatives
from funders who are looking to encourage collaboration, including over research engagement. A good
example of how this can work very effectively is provided by the research centre funded by the Medical
Research Council (MRC) and the medical research charity Asthma UK at King's College London and
Imperial College London. Following a site visit by the House of Lords Science and Technology Committee,
the committee highlighted the importance of the collaborative approach in its 2007 report on allergy:© Que
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Park, SWe visited a striking example of effective collaboration at the MRC-Asthma UK Centre in Allergic
Mechanisms of Asthma . . . The Centre combined their research strengths into one cohesive strategy,
with its research priorities informed by national consultations on asthma research.
paragraph 7.17181en's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
ed that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
sed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
outhampton SO16 7NS, UK.
63
ANALYSING THE RELATIONSHIPS BETWEEN RESEARCH ENGAGEMENT AND PERFORMANCE
64Finally, an international dimension comes from a paper by Sankaranarayanan et al.182 which describes
various research and training initiatives organised by the International Agency for Research on Cancer
(IARC) in collaboration with national institutions and local health-care services in many low- and
middle-income countries. Right from the planning stages, one major emphasis in IARC research studies,
it is claimed, was to organise them ‘with quality assurance of different inputs and in such a way that the
infrastructure, trained human resources and quality assurance practices, in-built as part of the research
programme, contributes to improving the capacity of local health systems’ (p. vii26).Participatory and action research
Over 40 action research or PAR studies met the criteria for the full-paper review, but examination of the
full paper often revealed that the study did not fully meet our inclusion criteria for research engagement
(sometimes with issues about the boundaries with educational or QI intervention) and/or did not go as far
as demonstrating some measurable improvement in health-care performance in terms of care provided or
health outcomes. This pattern reﬂects the comments made in Chapter 2 from the systematic reviews by
Soh et al.87 and by Munn-Giddings et al.89
However, the paper by Puoane et al.129 was included in the focused review because it described a health
gain in the 12 months after implementation of the action research. Some of the papers not included also
demonstrate progress being made along the pathway towards improved health care. Many of the action
research papers describe studies involving nurses or allied health professionals. These include the study by
Ullrich et al.,183 who claim that by employing a participatory worldview and action research they were able
to introduce protected mealtimes for older people in a residential care setting in South Australia. Other
studies describe a broader group of health-care professionals such as a study based in a centre for
women's health in Boston, USA, that again did not give quite enough detail on improved health-care
performance to be included in the focused review. In this study, the authors claim: ‘By engaging the
workforce, collaborative interactive action research can help achieve lasting change in the health care
workplace and increase physicians' and staff members' work satisfaction’ (p. 211).184
The theme of increased staff satisfaction emerges in a number of action research studies, and can also link
to helping develop positive attitudes towards the use of evidence and towards career development.
Alligood185 reports on an action research study in the USA that was explicitly designed to improve care
quality and nursing staff satisfaction. Alligood185 claims that ‘Attention to nursing practice stimulated
career development among the nurses to pursue bachelors, masters, and doctoral degrees’ (p. 981).Overall results from Chapter 5Several major points emerge from the ﬁndings in this chapter:
1. The wider review demonstrates the existence of a diverse range of studies that in many cases
support the idea that research engagement improves health-care performance, albeit with less
well-controlled evidence and often going just some steps along the pathway from research
engagement to improved health-care performance.
2. Much of the evidence from the wider review is broadly in line with that of the focused review,
strengthening the suggestions and speculation about various mechanisms.
3. There is a growing literature on research networks, and an increasing understanding of the mechanisms
through which they promote health gain and of the limitations encountered: context matters.
4. There is also a growing and increasingly inﬂuential literature on interventions, particularly on
collaborative approaches.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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supporting research engagement
In this chapter we return to the analysis in Chapter 1 about how organisational support for researchengagement can improve performance and the mechanisms through which that change occurs. We
mentioned the ﬁnding by Crilly et al.74 that learning processes and their relationship with organisational
design were important themes in the health-care literature, but that the question of organisational form
had received little attention. We also identiﬁed one or two examples of health-care organisations that had
paid particular attention to engagement in research in their overall approach to improved performance.
We expand these comments below, drawing mainly on papers from the wider review. First we explore
what the literature tells us about performance measurement and performance management and their
relevance for research engagement. Then we consider the complexity of health-care organisations and the
need to explore how various mechanisms operate at various levels, but not necessarily in harmony. Finally,
we discuss the use of mechanisms through which research engagement operates at organisational level to
improve performance, and the importance of local contexts.Performance measurement and performance managementIn a recent review of the relevant literature, Fryer et al.186 distinguish between performance measurement
and performance management, noting that performance measurement provides information about the
past whereas performance management ‘extrapolates the data to provide information about the future’
(p. 480).186 These authors list the key features of a successful performance measurement and management
system that are identiﬁed in the literature. These features include:
l alignment of the performance management system and the existing systems and strategies of
the organisation
l leadership commitment
l a culture in which performance management is seen as a way of improving and identifying good
performance and not a burden that is used to chastise poor performers
l stakeholder involvement
l continuous monitoring, feedback, dissemination and learning from results
l being ﬂexible and capable of developing as the management style and culture evolves.
Another, earlier review was undertaken by Bourne et al.187 as part of a study looking at the use of
performance measures and how performance measurement impacts on performance. This review
showed that:
l there was little ﬁeld research on the process of using performance measures to manage performance
and the consequential impact on performance, and in practice the organisational context and the
performance measurement content and process will all impact on the outcome
l the signiﬁcant number of the contextual, process and content variables identiﬁed mean that studying
the impact of performance measurement on performance is difﬁcult; and that a better question might
be ‘Under what circumstances does performance measurement positively impact on organisational
performance?’ (p. 374).
The case studies on which Bourne et al.187 report were based in an organisation that had multiple business
units operating in a similar manner in the same marketplace. The case studies fell into two groups. In
average-performing business units, performance was managed using a simple control approach. Data were
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66The results were then communicated and acted on. The same approach was evident in high-performing
business units, but this was not the main source of control. In high-performing business units, the simple
control approach was used to verify performance at the end of the period, but the main drive for
performance came from continual interaction with the performance data. Branch managers had their own
data collection systems and indicators of performance. They created their own approaches to analysis and
used these to project forward future performance. They then intervened using their knowledge of the
situation throughout the period, rather than waiting for period-end feedback. Branch managers in
high-performing business units were more sophisticated and explicit in their understanding of the drivers
of performance, more intense in their communication and more varied in their courses of action.
In summary, Bourne et al.187 concluded that the ‘interactive’ nature of how they managed performance
was the most prevalent difference observed between high- and average-performing business units. This
characteristic reﬂects the features of continuous monitoring, feedback, dissemination and learning from
results identiﬁed by Fryer et al.186
These insights from the management literature resonate with what we know about the drivers of
large-scale change in health care. In a recent review, Best et al.188 analyse the literature on large-scale
transformations in health-care systems and provide a synthesis of what is known about underlying
mechanisms. This is a realist review that identiﬁes health-care systems as complex adaptive systems and
was guided by the working assumption that a particular intervention triggers particular mechanisms in
speciﬁc contexts. From the literature, Best et al.188 identify a list of ﬁve ‘simple rules’ (broad principles that
apply across all large-scale transformation programmes). These are (1) blend designated leadership with
distributed leadership; (2) establish feedback loops; (3) attend to history; (4) engage physicians; and
(5) include patients and families. Notably, the broad principles identiﬁed by Best et al.188 include some,
though not all, of the key features of successful performance management systems identiﬁed by
Fryer et al.,186 although the language used is very different.
In 1995, the VHA initiated a radical redesign that aimed to ensure predictable and consistent provision of
high-quality care everywhere in the system and optimal health-care value.77 Among other key factors such
as the development of an integrated electronic patient record, the creation of a national administration
system with regional and local autonomy, and the development of integrated service networks, a central
aspect of the VHA's transformation was a new performance management and measurement system.
As reported in numerous papers, the VHA's national performance on a range of measures improved
dramatically in succeeding years, generally meeting or exceeding performance in other national health
systems.76,189–194
So what were the characteristics of this performance management and measurement system that led to
this success, and is it legitimate to see it as an example of an organisational mechanism through which
research engagement leads to improved performance?
In an account of the history of the VHA's performance management and measurement system,
Perlin et al.195 describe it as rigorous and data intensive, identifying key features such as:
l a relatively small set of performance measures (including, but not limited to, clinical performance
measures) that were chosen to be both ambitious and transformative – ‘stretch goals’
l clinical performance measures that were based on evidence-based guidelines and generated through
collaborations between in-house professionals and afﬁliated academic health systems in a collective
effort ‘to systematically translate the best evidence into recommendations for best practice’ (p. 830) – a
process that Perlin et al.195 describe as ‘an evidence-based approach that extends the principles of
evidence-based medicine to the administrative arena, a concept that might be termed “evidence-based
quality management”’ (p. 830)
l administrative staff and clinical managers who worked collaboratively to implement the performance
measures locallyNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8l an annual performance contract that was created collaboratively by central management and ﬁeld
leaders and cascaded to clinicians and managers throughout the system in an attempt to reduce
‘you–us’ tensions
l public reporting and regular feedback widely shared throughout the system.195
Further crucial features of this system emerge from this and other accounts. Perlin et al.195 note that this
performance management and measurement system was supported by other features of the VHA, such as
a system-wide information system that incorporated an electronic patient record and patient-centred care
co-ordination that extended across the whole continuum of care. Kizer and Kirsh196 describe how this
system was used prospectively to achieve data-driven process improvement and forward-looking change,
and how regional and local directors were given ‘signiﬁcant autonomy to innovate and design strategies
tailored to their particular needs, resources and environments of care’ (p. 396).196
As Perlin et al.'s195 comment about evidence-based quality management suggests, and the description
above conﬁrms, the VHA performance management and measurement system launched in 1996 was
evidence-based and incorporated all the key features of a successful system described by Fryer et al.186
The answer to the question posed above is therefore ‘yes’ on both counts, but with one important
qualiﬁcation. The literature conﬁrms that the development of the VHA performance system does provide
an example of a deliberate change to what Crilly et al.74 called ‘organisational form’, and overwhelmingly
the papers we looked at indicate that this change was associated with a deliberate policy to engage
systematically in research not only to support the development of individual performance measures but
also to support the design of the performance system as a whole. (An exception in the literature was
Craig et al.,189 who do not mention research engagement as a factor in the transformation of the VA.)
The key qualiﬁcation however is that, crucially, this change did not occur in isolation. It was part of a
wider multipronged change initiative that sought to transform the whole VHA, linking performance
measurement, information technology, organisational restructuring and aligned research efforts to improve
performance.139 It is to this broader concept of organisational change that we now turn.The complexity of health-care organisationsThe VHA is not the only health system in which the research function has been fully integrated into the
organisational structure. Commenting on its success, Lomas192 also describes another US health system,
Kaiser Permanente, in which health services research is used throughout to guide the decisions of its
managers and clinicians. Many other organisational structures have been designed to support ongoing
partnerships between researchers and users of research in health-care organisations in the USA and
elsewhere. In the USA, in addition to the VHA (and its QUERI) and Kaiser Permanente, these include the
University of Pennsylvania Health System,197 the United Healthcare Corporation's Center for Health Care
Policy and Evaluation,198 and the Agency for Healthcare Research and Quality's (AHRQ) Integrated Delivery
Systems Research Network (IDSRN).173 In the UK, there are now Biomedical Research Centres and Units,
Academic Health Science Centres, and the CLAHRCs. The CLAHRCs were established in 2008 to engage
local health-care organisations and services in health research, and thereby improve their performance.
They are therefore relatively new and are still being evaluated, but there are some emerging lessons about
how these collaborations are operating and the mechanisms through which they hope improvements will
be achieved. For example, Kislov et al.199 suggest that CLAHRCs ‘have been charged with an ambitious
goal of creating a new, distributed model for the conduct and application of applied health research that
links producers and users’ (p. 8) and hypothesise that this requires the cultivation of new multiprofessional
and multiorganisational communities of practice.
The common features of these organisational structures can be summed up, perhaps over-simplistically,
in three words: complex, comprehensive and collaborative. For example, Garrido and Barbeau200 describe
how Kaiser Permanente is supported by collaborations with external research institutions and is involved
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68in-house research and clinical champion and on the widespread participation of clinicians, and can call on
data with high integrity and granularity and on statistical and analytic capacity. There is senior operational
support.200 Further details from papers describing initiatives for Kaiser Permanente and the other US
organisations listed above are provided in Table 3.
The key message from the literature examined in this chapter is that it is these characteristics, taken as a
whole, that promote improvement in performance. In other words, this comprehensive approach facilitates
more progress than a focus on single mechanisms through which research engagement works in isolation
at various levels within a health system or health-care organisation to improve performance. If this is
correct then in seeking an answer to our review question we need to explore how multiple mechanisms
work simultaneously, if not always harmoniously, at different levels to promote change in environments
subject to many other pressures. To paraphrase Bourne et al.,187 we need to reassess our review question
and ask ‘under what circumstances does engagement in research positively impact on
organisational performance?’.
This is not a simple question. Best and Holmes201 have described how our understanding of knowledge
management and research implementation has moved from a linear approach in which knowledge is a
product of research that passes from researchers to users by diffusion and can be generalised across
contexts, to a relationship model in which knowledge from multiple sources is exchanged between
researchers and end-users through interpersonal relations and focused networks that involve a
collaborative production–synthesis–integration cycle. In this second model, knowledge is context
dependent and must be adapted to local circumstances, and its degree of use is a function of effective
relationships and processes. The third and ﬁnal model is a systems model in which knowledge can be both
explicit and tacit, and is generated, assessed and used within speciﬁc contexts and cultures dominated by
different priorities. This knowledge cycle is mediated throughout by relationships and must be understood
from a systems perspective, in the context of the organisation and its strategic purposes. The degree of
use is a function of effective integration with the organisation and its systems.
When exploring organisational engagement in research, it is this complexity that needs to be explored. But
this is difﬁcult, which explains why we found only three empirical studies on the organisational
mechanisms through which research engagement improves performance in our focused review. It is not
easy to disaggregate the impact of this particular set of mechanisms from that of other change
mechanisms within health-care organisations. To do so requires sophisticated evaluation methodologies.
To take one example: the transformation of the VHA and the development of its QUERI programme have
generated a huge literature, and these papers, taken together, provide a compelling narrative about the
role that research engagement, among other factors, played in that transformation. However, among all
the papers we reviewed we found only one controlled study (by Chaney et al.126) of an organisational
intervention that had used research engagement as a mechanism to promote change. This was a cluster
RCT of an evidence-based quality improvement project in which clinical managers worked with researchers
to make use of prior evidence on effective care models, taking account of local contexts. Chaney et al.126
report some improvement in some of the processes of care, and this paper therefore adds to the
accumulating evidence that research engagement is one of a number of factors that improve health-care
performance. However, their description of the difﬁculties involved in this evaluation is salutary, and
indicates that attempts to enlarge this evidence base and distinguish the precise contribution of research
engagement will need to overcome complex methodological hurdles. Francis and Perlin139 make a similar
comment about the VHA, as do Nutley et al.202 in a discussion of systems based research use, and
Krzyzanowska et al.,95 who note that: ‘Broadly, at the heart of understanding the relationship between
research and its impact, whether through infrastructure, processes of care or other areas such as
knowledge generation, lies complex adaptive systems theory’ (p. vii11).NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8The use of organisational mechanismsFinally, we turn to the use of the mechanisms through which research engagement at organisational level
operates (research networks, QI projects, performance management and measurement systems, etc.) and
to the need to consider local contexts.
The implementation of the VHA performance contract was deliberately designed to allow regional and
local directors signiﬁcant autonomy, and considerable latitude was given on how to reach performance
targets at the local level.139 This emphasis on devolved decision-making runs right through accounts of the
VHA. Francis and Perlin139 talk about the development of clinical guidelines and performance measures
being as much a bottom-up as top-down activity within the VHA, ‘belying the common misconception
that, as a federal health system with many connections to the military, change occurs through “command
and control”’ (p. 65). Kizer and Kirsh196 suggest that it was a combination of ‘VA's compelling mission, the
clarity of performance expectations, healthy intra-organisational competition, substantial local autonomy
and a sense of professional fulﬁlment’ (p. 396) that drove rapid improvement. They also point out that in
recent years things have changed: a more centralist approach is being taken in the VHA and this has
undermined the ﬂexibility to tailor local improvement strategies.196
In a similar vein, another US study, by Bernard et al.,197 emphasises the importance of a comprehensive
and inclusive approach in which all of the health-care team are involved at all stages in decision-making in
a way that gives them ownership of health and disease management programmes in an academic health
system. In the UK, the way in which the CLAHRCs have been developed as local collaboratives that involve
local communities of practice also reﬂects this thinking. The CLAHRCs are committed to developing strong
interorganisational and interpersonal relations and promoting effective two-way collaboration, not just
token involvement. NHS managers and clinicians as well as patients and the wider public are encouraged
to play an active role in all stages of the research cycle from question generation and formulation through
to evaluation and implementation of research ﬁndings.
This widespread engagement has built-in implications for the type of research pursued. What is sought is
research that answers to speciﬁc concerns, and this (deliberately) results in a programme of research driven
by the needs of the health-care system and its users – needs-based action research. However, this
requirement can lead to tension between managers and clinicians in health-care organisations seeking
speedy answers to local problems (relevance) and academics seeking to produce generalisable research
(rigour). These difﬁculties are not insurmountable: ‘The VHA experience demonstrates that both are
possible and that beneﬁts can be translated in a timely manner when there is active dialogue among
clinicians, researchers and policy-makers’ (p. 69).139 However, alleviating them requires an ability to balance
competing concerns, sufﬁcient culture change on both sides to promote better understanding, and
supportive external structures. In the USA, the VHA and the other health systems cited above largely got
this right, and were helped by a university system that is generally more supportive of extracurricular
activities outside formal academic research than the UK system, although here the new impact category in
the Research Excellence Framework may help.
In summary, the literature tells us that at an organisational level the mechanisms through which research
engagement promotes performance improvement are, and need to be seen as, one facet in a wider,
multipronged change strategy. These mechanisms operate in complex systems, and exploring and
evaluating how they operate is not straightforward. Although there is little deﬁnitive empirical evidence
from single studies, the wider literature does provide examples of health-care systems in which the
research function has been fully integrated into the organisational structure. These accounts indicate that
this integration worked well, promoting a virtuous cycle in which research of greater relevance to the
needs of those served by the system is identiﬁed, pursued and implemented, and has led to
improved performance.© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8Chapter 7 Discussion and conclusionsDeveloping appropriate methods for data collection
and analysisThis review took an innovative form because of the research topic (largely unexplored, but potentially
important) and the disparate nature of the evidence that was identiﬁed. A review by Clarke and Loudon,31
published after our proposal had been submitted, was also inﬂuential because it suggested that the
evidence base to support the widely held assumption that research engagement improves health-care
performance was less strong than some had thought. We therefore felt it important to see if (as our initial
scoping exercise indicated) we could identify, and analyse, a larger body of evidence through conducting a
focused review that would involve a more recent search than Clarke and Loudon's in 2009,31 and would
have a somewhat wider scope.
By itself, however, such a focused review seemed unlikely to enable us fully to address the request in the
ITT for an evidence synthesis ‘which maps and explores the likely or plausible mechanisms through which
research engagement might bear on wider performance at clinician, team, service or organisational
levels’.1 For example, both our original scoping exercise and advice from an expert suggested we should
consider the way in which some health-care organisations support research engagement as part of an
overall strategy to improve the quality of the health care they provide, and it was clear that important
evidence on such issues came from descriptive articles that would not meet the inclusion criteria for the
focused review.
We responded to these challenges by developing what we have called an hourglass review. This consisted
of three stages:
1. A broad scoping or mapping stage in which we explored a large number of bodies of literature that we
thought might be relevant to the review topic.
2. A focused (or formal) review on the narrower (though still large) core question of whether or not
research engagement improves health care. For this review we searched extensively, but applied quite
tight inclusion criteria.
3. Finally, a wider (but less systematic) review of relevant papers that we had identiﬁed during the two
earlier stages (plus continuing snowballing). We therefore included papers that did not meet our
inclusion criteria for the focused review, but nevertheless had something important to say, in particular
about the mechanisms through which research engagement might improve performance and about the
role of organisations.
The hourglass shape refers to the scope of the analysis at each stage, and to the number of papers
considered in detail; in terms of the sheer volume of titles and abstracts processed, the throughput of the
review was greatest in the second (or middle) stage.The matrixIt became clear at the mapping stage that no neat patterns were emerging from the literature. Therefore,
we developed a matrix to help us characterise the circumstances in which research engagement might
improve health-care performance and the mechanisms that might be at work.© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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76We identiﬁed two main dimensions along which to categorise our research on research studies: the degree
of intentionality of the link between research engagement and performance and the scope of the impact
on health care. (These are explained in detail in Chapter 2 and illustrated in Table 1.)
The three overlapping categories of intentionality we used in our analysis were:
l least intentionality – where the improved health-care performance resulting from engagement in
research arises as a by-product of a trial or other research which has been conducted to test a speciﬁc
therapy or approach
l a middle category – where structures such as research networks promote the conduct of research on
speciﬁc therapies in a particular ﬁeld but can also have the wider remit of informing network members
about research more generally and addressing their identiﬁed research needs
l greatest intentionality – where various interventions such as collaborative approaches, participatory and
action research, and organisational approaches explicitly seek to produce improvements in health-care
performance as a direct consequence of research engagement.
The two categories related to the scope of the impact were:
l broader impact – those who have engaged in research becoming more willing and/or able (because of
individual or unit capacities) to provide evidence-based care that is not related to the speciﬁc ﬁndings
of the research on which they were engaged
l speciﬁc impact – those who have engaged in research becoming more willing and/or able (because of
increased knowledge/understanding of the ﬁndings and/or infrastructure related to the procedures,
etc.) to provide evidence-based care that is related to the speciﬁc ﬁndings or processes of the research
on which they were engaged.Emerging themes about the role of research engagementl Systematic analysis of the data related to research engagement seems to be in its infancy, despite the
widely help assumptions about the beneﬁts of research engagement.
¢ There is still a relatively small number of papers on this topic. The previous review by Clarke and
Loudon,31 plus the 2011 analyses by Selby93 in Annals of Oncology, both called for further studies
to be conducted.
l In our focused review, we were able to identify more evidence than had previously been collated
on the question of whether or not research engagement improves health-care performance
(see Chapter 4).
¢ We identiﬁed a somewhat more substantial body of evidence than Clarke and Loudon31 because
the scope of our review was wider (e.g. not limited to trials) and we conducted it at a later date.
We ﬁnished with 33 papers97–129 in our focused review, including 1297–102,104,105,108–111 of the 13 that
Clarke and Loudon had identiﬁed.
¢ Twenty-eight papers97,99,101–105,107,108,110–126,128,129 were positive (of which six105,112,115,120,126,129 were
positive/mixed) in relation to the key question of whether or not research engagement improves
health-care performance. Just ﬁve papers98,100,106,109,127 were negative (of which two100,127 were
mixed/negative).
¢ The pattern of our ﬁndings is similar to that of Clarke and Loudon.31 Only a minority of the positive
cases (seven102,105,107,110,114,116,129 out of 28) reported some improvement in health outcomes. For the
rest, the improved care took the form of improved (usually more evidence-based) processes of care.
¢ We identiﬁed 21 papers97–117 in our ‘by-product’ category, including all 1297–102,104,105,108–111 of
the papers from Clarke and Loudon31 that we included in our review. Of these we classiﬁedNIHR Journals Library www.journalslibrary.nihr.ac.uk
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in the research network and the intervention categories, we increased the total number of papers
by a further 12.118–129 The eight included network papers118–125 were classiﬁed as being positive, or
positive/mixed; as were three126,128,129 of the four126–129 intervention studies. These papers are of
considerable importance in enabling us to go further than previous evidence in suggesting research
evidence does improve health-care performance.
¢ Of the 2897,99,101–105,107,108,110–126,128,129 positive or mixed/positive studies, 1399,102,103,108,110,113–119,122
describe broader impact and 1597,101,104,105,107,111,112,120,121,123–126,128,129 describe speciﬁc impact. Within
this overall balance 1099,102,103,108,110,113–117 out of 1797,99,101–105,107,108,110–117 of the by-product studies
showed broader impact (as would ﬁt with the absorptive capacity model), and all the intervention
studies showed speciﬁc impact (as would ﬁt a key element of the collaborative and action
research theories).
¢ We also considered the levels of research engagement. Clarke and Loudon31 had examined two
levels: practitioners and institutions. In practice we found it very difﬁcult to be more discerning
than this because there is little consensus about the reporting terms used and we could not
readily apply the separate categories of team, service and organisation. Therefore, we followed
Clarke and Loudon31 in using a twofold distinction between clinicians and institutions.
Twenty-two studies97–99,102–105,107,109,110,114–116,118–122,126–129 were at the institutional level, and
11100,101,106,108,111–113,117,123–125 at the clinician level. Of the 2897,99,101–105,107,108,110–126,128,129 positive
and mixed/positive papers, 1997,99,102–105,107,110,114–116,118–122,126,128,129 were institutional and
nine101,108,111–113,117,123–125 clinician level. Of the ﬁve98,100,106,109,127 negative and mixed/negative
papers, three98,109,127 were institutional and two100,106 clinician level.
l Analysing the mechanisms (see Chapter 5).
¢ For this analysis we drew on the focused review and the wider review, and applied the matrix.
¢ The positive papers in the focused review describe a diverse variety of mechanisms through which
research engagement might improve health care. We have more evidence than previously collated
(and the wider review added even more), but we have also shown that there are many
circumstances and mechanisms at work, that more than one mechanism is often operative, and
that the evidence available for each one is limited.
¢ The wider review allowed a fuller data collection, and the matrix facilitated a more nuanced
analysis of the various roles of research engagement.
¢ Using the by-product and network categories from the matrix we can reasonably suggest that
when clinicians and health-care organisations engage in research there is the likelihood of a
positive impact on the health-care performance, even when that has not been the primary aim of
the research. This ﬁnding is further supported by evidence from the wider review, which provides
examples of studies that illustrate some progress along the pathway from research engagement to
improved health care. However, the wider review also indicated situations in which the impacts
seemed less likely to arise, and the operation of networks proved not always easy to sustain.
¢ There were only four papers in the intervention category in the focused review, but a much higher
number in the wider review. The latter demonstrate how collaborative or action research can
encourage some progress along the pathway from research engagement towards improved
health-care performance. However, various studies also demonstrated that there can be
considerable obstacles to overcome, particularly with one-off initiatives.
l Organisations that have incorporated research engagement as part of a comprehensive approach
to health-care improvement demonstrate how research engagement can be most effective
(see Chapter 6).
¢ Health-care organisations and systems provide the context within which research engagement
operates at other levels. And organisations in which the research function is fully integrated into
the organisational structure can out-perform other organisations that pay less formal heed to© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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78research and its outputs.76,189–193 However, at the organisational level, as at other levels,
engagement in research operates through a variety of mechanisms and is only one of many
inﬂuences on performance. Disaggregating how these mechanisms operate in complex systems is
not straightforward.
¢ Widespread engagement in research by all the key groups of relevant stakeholders often inﬂuences
the type of research pursued. What is sought in these circumstances is research that answers
speciﬁc concerns, and this (deliberately) results in a programme of research driven by the needs of
the health-care system and its users.
l There are various initiatives aimed at deliberately increasing research engagement with the explicit aim
of improving health-care performance.
¢ In the USA, these initiatives include the 2003 Roadmap for Medical Research from the NIH149 in
which resources have been devoted to boost CBPPR through the Clinical and Translation Science
Awards. The NIH has funded a large-scale project aimed at identifying how this initiative might best
operate.131,147,148
¢ In the UK, the NHS Commissioning Board has a duty to promote research and innovation: ‘The
NHS Commissioning Board's objective is to ensure that the new commissioning system promotes
and supports participation by NHS organisations and NHS patients in research funded by both
commercial and non-commercial organisations, most importantly to improve patient outcomes, but
also to contribute to economic growth’.204 In addition, the goal of the Academic Health Science
Networks is to improve patient and population health outcomes by translating research into
practice and developing and implementing integrated health-care systems.205
¢ Various studies have indicated that new structures such as research networks and schemes aimed
at involving individual health-care professionals more fully in research can face difﬁculties in making
progress, particularly if there are not changes at the organisational level to support the
initiatives.127,169
¢ The moves towards trials and other well-found research taking place within networks, and as part
of wider interventions, means that increasingly research engagement leading to improved
health-care performance shifts from being a by-product to an intended outcome.Pulling together the evidence related to mechanisms
through which health care might be improved in
research-active settingsThe majority of the papers in the focused review were by-product papers, and the majority of these were
positive about the relation between research engagement and improved performance. Various potential
mechanisms were suggested, including:
l a speciﬁc impact, at individual level, through the increased awareness and understanding of speciﬁc
ﬁndings arising from research participation
l a speciﬁc impact, at institutional level, through an increased use of the protocol and processes
associated with a speciﬁc research study
l a broader impact, at individual level, through changes in attitudes to research and resulting behaviour
l a broader impact, at institutional level, through infrastructure development associated with
research participation.
We also saw that the mechanisms associated with research networks (the second largest group of papers
in the focused review) represent a partial formalisation and use on a regular basis (through the provision of
more effective collaboration and more supportive contexts) of some of these potential mechanisms. Finally,
we saw how this partial formalisation had been taken still further in interventions deliberately designed to
integrate the research function into organisational structures (as described in the intervention papers in the
focused review and more extensively covered in the wider review).NIHR Journals Library www.journalslibrary.nihr.ac.uk
BOX 4 Mechanisms in research-active settings through which health care improved
1. Absorptive capacity: this is most relevant for wider adoption of research in institutions:
Changes in the structure of institutions – improvements in infrastructure
l Attributes of the setting in which care is delivered, such as accommodation, equipment and personnel,
which are brought in to perform research-related activities and may remain in place after the research is
completed, for example in the UK the capital spend on the Biomedical Research Centres which resulted
in new co-located research and clinical facilities
Changes in human capital
l Training/updating staff through research engagement leading to the acquisition and use of new skills,
other gains in knowledge and changes in attitudes towards research and research ﬁndings
l Enhancement of group and individual behaviour including:
¢ more rapid uptake of new treatments and greater likelihood of following clinical guidelines
¢ improved collaboration, establishment of expert teams, etc.
2. Improvements in the processes of care related to conducting a speciﬁc trial
l A more rigorous process of deﬁning the standard of care for patients irrespective of their inclusion in
the trial
l More close monitoring and support
l Early access to novel technologies
3. Organisational mechanisms within health-care systems
l For example, in the VA, where the whole organisation uses research to improve health care in various
and integrated ways, including conducting research to address known issues in the health-care system,
allowing physicians time to conduct research and thus being an attractive organisation to work for,
conducting research to identify best performance targets to set, using research in QI, etc.
4. Collaborative approaches between organisations, teams and individuals as a mechanism
l Linkage and exchange that improves the relevance of research and policy-makers'/managers'/clinicians'
willingness to use it
l Academic Health Science Centres, teaching/research hospitals
l Research networks as an increasingly important mechanism
5. Action research and participatory research as mechanisms that improve relevance, understanding of
research and willingness to use research
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80Building on these ﬁndings, on the theoretical approaches discussed in Chapter 2, and on previous work on
potential mechanisms by Krzyzanowska et al.,95 we can start to develop a taxonomy of the various mechanisms
and submechanisms through which outcomes may be improved in research-active settings (Box 4).
Limitations and robustness of the conclusions
This evidence synthesis could be described as research on research on research: it is an evidence synthesis of
studies that assess the impact of research engagement. Conducting reviews of this nature is a complex task
and it is not surprising that there are various potential limitations to this study. The ﬁrst relates to locating
the relevant literature. At the outset we anticipated that there would be many bodies of literature
addressing the review question. We used the initial mapping stage to explore the potential locations of
relevant literature and our ﬁndings informed the search strategy for the focused review. The search terms
remained quite broad in order to cast the net as wide as possible and catch papers published in different
ﬁelds, journals and countries. As a consequence, a signiﬁcant amount of time within the review process was
spent on mapping, reﬁning the question and developing search terms. Owing to the nature of the research
question, the search terms included a number of generic and widely used terms including ‘research’ and
‘engagement’. We sought expert advice and worked with an information scientist to develop the search
strategy and conduct a search that was sufﬁciently sensitive to identify relevant papers. Despite the difﬁculty
of the task, we were reassured that we identiﬁed nine of the 13 papers in the previous review by Clarke
and Loudon31 using the search terms (and the others were added by snowballing).
In order to make the search feasible, the review focused on engagement in research, rather than using
the wider deﬁnition of research engagement that would have included engagement with research.
The focused review shares the limitations of many systematic reviews. In pursuing a narrow question, we
inevitably excluded large volumes of potentially interesting, relevant research that did not meet the
inclusion criteria. As with other reviews, we have also had to exclude a number of papers owing to the lack
of information provided by the authors about key elements of the study (such as design and outcomes). We
have tried to address these limitations by conducting a wider additional synthesis (the wider review) to help
explain the ﬁndings of the focused review and give the ﬁnal review more explanatory power.
In Chapter 4, we discussed concerns that arose in our analysis of two studies in the focused review about
the extent to which engagement in small individual studies could improve performance,100,106 compared
with relying on reviews of all the studies in a ﬁeld. We suggest this depends on the context, in this case
the existing knowledge base, which provides the basis for judgements about whether or not a study is
well-found and whether its ﬁndings are supported or challenged by other studies in the same ﬁeld. One of
the limitations of our review is that it was not always possible to make these judgements.
Finally, another common limitation reﬂects the reliance of reviewers on what is already published in the
literature. This meant that the review was only able to capture very recent developments (such as the
outcomes of UK research networks) through an abstract. The section of the focused review on networks
draws exclusively on US studies of research networks. This reﬂects the more established nature of research
networks in the USA, and also an approach to evaluation that is consistent with the rigorous inclusion
criteria used for the focused review. Linked to this is another challenge common to other systematic
reviews: the impact of publication bias. As with other ﬁelds, there is likely to be a bias towards the
publication of studies with positive results to share with the academic community. We have sought to
address this by searching the grey literature, conducting a web search and writing to some key authors in
the ﬁeld to identify unpublished literature. We have also kept this potential limitation in mind in
conducting the analysis. Furthermore, in at least some of the studies it is complicated to interpret the
ﬁndings in terms of the issues we were considering.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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from the advisory group. We were advised that our review question was likely to contain too many diverse
aspects to conduct a meaningful realist synthesis. We drew on narrative synthesis methods at various
stages, including the mapping stage, but felt the need to develop our own approach to adequately
address the review question.
Despite the limitations described above, we found the hourglass review approach had various advantages.
It allowed us the opportunity to start broadly, which was useful when it was difﬁcult to locate the
examples of the phenomenon we were seeking. The hourglass approach was also useful because the
detailed mapping allowed us to explore issues from many angles. It also meant that we could then
conduct a more focused, or formal, review on the central question of whether or not research
engagement improves health care. This was particularly desirable in the context of the review published
after the submission of our proposal31 which concluded that the evidence for suggesting research
engagement improves health-care performance was not as strong as seemed to be widely assumed.
Finally, the wider review allowed us to collate a wider range of evidence and more fully address a range of
issues related to the mechanisms through which research engagement might improve health-care
performance. In relation to networks, it allowed us to bring in examples from beyond the USA, and also
brought in some examples of problems with networks to counteract the examples in the focused review,
which were all positive. In relation to issues of collaborative research and the organisational dimension, the
wider review allowed us to consider a wide range of papers that did not meet the inclusion criteria
adopted for the focused review.
One of the main reasons for developing the hourglass review methodology was to allow for a ﬁnal, wider
review stage and, as is demonstrated above, it was this less formal approach that enabled us to draw on a
more diverse range of literature.
So, the approach we developed allowed considerable progress to be made, but was very resource intensive.Discussing future research needs and the scope for developing
performance indicatorsClarke and Loudon31 recommend that RCTs should be conducted in this area in an attempt to generate
stronger evidence, but acknowledged the considerable difﬁculties involved. Pater et al.94 analyse in
considerable detail how clinical trials and other well-found research studies in this ﬁeld could be designed,
but the focus of their proposed question was narrower than the one we addressed in our review. They
were asking whether or not patients who receive care in a research environment derive beneﬁts that are
attributable to that general research activity, but not simply because these patients were exposed to a
successful intervention as patients in a research project. They state: ‘this question has been deliberately
phrased to indicate our concern with beneﬁts that occur contemporaneously with the research
activity’ (p. vii58).
In conducting our review, we identiﬁed several areas where there appeared to be less evidence available
than we might have expected to ﬁnd. These included empirical studies related to the role of medical
academics. In relation to research networks there seemed to be fewer studies from the UK than from the
USA on how the beneﬁts of research engagement might arise. There might be some problems in
replicating exactly the type of studies identiﬁed in the focused review because there has now been such a
growth of research networks in the UK; nevertheless, that only serves to highlight the importance of
this area.81
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82As explained in Chapter 1, our review focused primarily on the issues of performance in relation to the
quality agenda. We did, however, identify one study that undertook a data envelopment analysis
comparing the performance of academic medical centres with other hospitals in Germany, and identiﬁed
an ‘emphasis on research’ as a factor that increased efﬁciency.206 This study compared the level of research
undertaken with other factors, but failed to meet the inclusion criteria for our focused review because the
data on health-care performance related to the volume of work and not the quality of care. Nevertheless,
this is an approach on which it might be worth conducting a scoping exercise in the UK.
The issue of research engagement as a factor in performance improvement has, largely, not previously
been systematically researched as a topic in its own right. The studies we identiﬁed have mainly been one-
off studies and/or considerations of the issue as part of a wider study. Therefore, we believe there would
be scope for deliberately considering aspects such as the potentially negative impacts of research
engagement alongside beneﬁts. Organisation-wide interventions designed to promote research
engagement also require further research. However, there are signiﬁcant methodological challenges in
conducting evaluations of these complex interventions and there is a need for methodological
development to improve evaluations of how different mechanisms operate in complex systems (as we
suggest in Chapters 5 and 6). There is also a role for social theory in developing and understanding the
role of research engagement in promoting health-care improvement. Therefore, overall we believe there
would be scope for a programme of work in this ﬁeld that identiﬁed the various roles that could be played
by a range of different methods that would be appropriate for the various topics identiﬁed. Such methods
could include observational studies of research engagement within organisations, applications of social
theory, and the use of large data sets.
Through the Quality Accounts, NHS trusts have reported on the number of patients recruited annually to
participate in research approved by local research ethics committees. This is a useful development, but
given the importance that is now being attached to research there could be value in monitoring key issues
such as the relevance of the research conducted, and establishing whether or not this research activity is
producing beneﬁcial change. Experience suggests, however, that it is difﬁcult to capture such items,
especially through the small number of indicators that it is likely to be practical to introduce. This is an
issue that requires careful analysis. Furthermore, one of the key elements of the VA's use of research
engagement was to identify the most appropriate performance indicators (PIs) to apply within the
organisation to show improvements in the processes of care.
Overall, a key role for PIs could be to encourage research participation and a culture of maximising the
beneﬁts from such engagement. Therefore, some illustrative examples of the approach towards indicators
that might be used by NHS trusts and Clinical Commissioning Groups are provided below.
1. An indicator for research activity approved by local research ethics committees could continue along the
lines already collected through the Quality Accounts.
2. An indicator could be developed to explore the beneﬁts that arise as by-products from research
engagement, while recognising the difﬁculties that arise in doing this. In the guidance for such an
indicator the following items could be listed as ones that might be explored:
i. changes in care settings (e.g. additional accommodation, equipment or personnel brought in as part
of a research project or programme and remaining in place afterwards)
ii. changes in human capital (e.g. training or updating staff through research engagement), or changes
in team or individual behaviour (including more rapid uptake of evidence-based treatments)
iii. changes in processes of care (e.g. improvements in following clinical guidelines, improvements in
monitoring and support, early access to new technologies).
3. An indicator of the percentage of eligible staff who have participated in research studies involving NHS/
NIHR-wide research networks might be useful.
4. There might also be scope for an indicator to demonstrate the extent to which the Trust or
Commissioning Group has arrangements in place to work with staff and patients to identify speciﬁcNIHR Journals Library www.journalslibrary.nihr.ac.uk
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thinking strategically as well as in the short term.ConclusionsThe focused review identiﬁed more evidence (33 papers97–129) than has previously been collated on the
question of whether or not research engagement improves health-care performance. This evidence was
broadly positive, with 28 papers97,99,101–105,107,108,110–126,128,129 drawing positive conclusions about the impact
of research engagement (with six105,112,115,120,126,129 of these being positive/mixed). Just ﬁve
papers98,100,106,109,127 were negative (of which two100,127 were negative/mixed). Drawing on the focused
review (especially the by-product and network categories from the matrix) we can reasonably suggest,
therefore, that when clinicians and health-care organisations engage in research there is the likelihood of a
positive impact on health-care performance, but this is more likely to be on improved health-care
processes than improved patient outcomes.
The wider review added additional evidence. In particular, although there were only four papers from the
focused review in the intervention category of the matrix (covering interventions such as collaborative and
action research), a much higher number from the wider review contribute to our analysis of the
mechanisms and, for example, demonstrate how research engagement can encourage some progress
along the pathway towards improved health-care performance.
Overall, we have also seen that there are many circumstances and mechanisms at work, that more than
one mechanism is often operative, and that the evidence available for each one is limited. This limits the
immediate implications for practice. The large-scale initiatives now being developed to encourage research
engagement as a means of improving performance may also highlight the need for more research on
research engagement and for adequate PIs of research engagement and of research quality in NHS trusts,
building on what has previously been sought through the Quality Accounts and on the suggestions set out
above. However, our ﬁndings do tell us that the mechanisms through which research engagement might
improve performance overlap and rarely act in isolation, and that their effectiveness often depends on the
context in which they operate. Generally, at lower levels of intentionality (where improved health-care
performance is a by-product of a research study) we identiﬁed a series of one-off studies in which a
diversity of detailed mechanisms were applied. At higher levels of intentionality (e.g. networks and
collaborations) there had been more formalisation of potential mechanisms and research processes
themselves had become an increasingly important means through which research engagement can
improve health-care performance.
The number of research networks is growing, and these new structures continue to develop and evolve.
The contribution of collaborative approaches to research is also developing. At an organisational level, the
mechanisms through which research engagement promotes performance improvement are often only one
facet within a wider, multipronged change strategy. Organisations that have deliberately integrated the
research function into organisational structures demonstrate how research engagement can, among other
factors, contribute to improved health-care performance.Recommendations for research1. Further explorations of how particular mechanisms promote research engagement. Evaluations of
research networks and of existing schemes to promote the engagement of clinicians and managers in
research would be particularly valuable.
2. Detailed observational research focusing on research engagement within organisations, to build
understanding of mechanisms, and to explore potentially negative impacts of research engagement
alongside beneﬁts.© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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843. Analysis of organisation-wide interventions designed to promote research engagement also requires
further research. There are signiﬁcant methodological challenges in conducting evaluations of these
complex interventions and a need for methodological development to improve evaluations of how
different mechanisms operate in complex systems.
4. Scoping exercises to identify possibilities of using large databases of research production and
hospital performance.
5. The application of social theory in developing and understanding the role of research engagement in
promoting health care improvement.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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clinician, team, service and organisational level in
healthcare organisations
1. Aims/Objectives
This evidence synthesis aims to identify, analyse and synthesize the evidence related to the question:
l Does engagement in research improve performance at a clinician, team, service and organisational
level in healthcare organisations?
The overall question has several aspects. These include questions and debates about:
l What deﬁnitions or aspects of engagement in research might be relevant for addressing the
overall question?
l What dimensions of performance in healthcare organisations will be relevant for addressing the overall
question, and how is improvement best measured?
l Does research engagement increase the ability and/or willingness of healthcare staff and systems to
absorb and use relevant research ﬁndings from wherever they originate?
l Does research engagement by a range of stakeholders in healthcare organisations lead to the
production of knowledge that addresses the needs of healthcare staff and patients more effectively
and that will be more likely to be used in the local setting, and possibly other similar ones?
l In what ways does the adoption/utilisation of research improve performance (however measured) at
clinician, team, service, and organisational level?
l Does research engagement encourage a more questioning and open culture that facilitates
performance of healthcare staff and/or systems?
We do not believe there is an existing coherent body of evidence that has explicitly focused on the overall
question. Hence, an initial objective will be to identify and explore ﬁrst, the theories that support the
assumptions underpinning these questions and second, whatever bodies of literature might have
something relevant to say on the question or a range of related issues. This initial exercise will be
undertaken as a way of helping to focus the project and the literature search.
Once the scope of the literature search has been determined and the search undertaken the objective will
be to map the resulting evidence so as to guide the analysis. The literature is likely to be highly diverse and
of variable relevance to the question being addressed. A key objective will be to ﬁnd a way of including
as broad a range of literature as possible while using it to address the research question appropriately
and effectively.
A ﬁnal objective will be to make the ﬁndings as relevant as possible to the NHS by attempting to illustrate
how far different types of research and modes of engagement in research improve performance at the
various NHS levels, and identify the mechanisms that might be involved.2. Background
Taking the wording of the Invitation to Tender (ITT), and the questions set out above, two key phrases
emerge: ‘research engagement’ and ‘improved performance’. Very loosely bounded bodies of knowledge
are speciﬁcally connected to each of these, and are thus relevant to our review. Related to the phrase
‘research engagement’ there is the literature about the different types of engagement in research, the
beneﬁts that come from health research and how they might be assessed, and the different ways in which
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102knowledge related to the issue of the meaning and measurement of improved performance in health care
systems - how far research engagement features in this will need to be examined. In this section we
outline these two bodies of work. Where studies can be identiﬁed that have attempted to link research
engagement (however interpreted) and improved healthcare performance they will, of course be very
important, and there are a few examples of studies that do link aspects of research engagement (for
example, involvement in clinical trials) to aspects of performance (for example, levels of mortality and
guideline adherence) (Majumdar et al., 2008).
We also believe, however, that there is also a much wider literature that covers a range of potentially
relevant and sometimes overlapping topics which might provide lessons and will be included in the review.
We will need to interrogate and arrange the various bodies of knowledge carefully before a clear picture,
or evidence synthesis, can emerge, and those wider bodies of knowledge are brieﬂy introduced later in
section 5 on the contribution of existing research.Research engagement, the organisation of the health research system and the
assessment of impacts from research
Discussions about reforms to health research systems help deﬁne the scope of the phrases ‘research
engagement’, and ‘engagement in research’, that are used in the ITT. The 2006 health research strategy
document from the Department of Health (DH) also illustrates the desire to involve the healthcare system
in research (DH, 2006). In line with such documents we view the term ‘research engagement’ broadly and
take it to include healthcare staff either being involved in undertaking research studies in some way, and/
or undertaking research training for a research degree. We also recognise that it can include playing a role
in research design and commissioning, and in research networks, partnerships or collaborations. For
example, the DH 2006 strategy document speciﬁcally referred to providing support for the NHS Chief
Executive's Forum of the Service Delivery and Organisation (SDO) Programme (DH, 2006). It can also mean
joining journal clubs and taking critical appraisal courses in order to understand and interpret research
ﬁndings better.
Engagement in research includes engagement in the full range of health research from biomedical work
through clinical studies to health services research and psychosocial care research. Indeed, clinical staff
undertaking basic research can generate ﬁndings that, it is sometimes claimed, have a better chance than
other such research of leading to more applied research and contributing to major advances in healthcare
(Hanney et al., 2006; Wooding et al., 2011). There have been various analyses of the ways in which
different groups of healthcare staff might engage in research, including, for example, the role of nurses
and the allied health professions – considered by a taskforce set up to advise the Higher Education
Funding Council for England (HEFCE) and the DH (HEFCE, 2001).
More generally, much of the discussion about how to organise health research systems has traditionally
focused on the best ways to produce research. But alongside this there have been growing attempts to
broaden this analysis and consider the needs of various stakeholders, including patients, in relation to
health research (Hanney et al., 2010). Several overlapping aspects of this discussion are potentially relevant
to the evidence synthesis proposed here. First, there is the notion that staff within a healthcare system
who engage in research are more likely to absorb and utilise research ﬁndings from research undertaken
anywhere. Second, there is the idea that engaging healthcare staff and patients in health research leads to
research being undertaken that is more likely to be relevant to the needs of the healthcare system and
thus more likely to be used by healthcare and management staff. These two concepts overlap and some
of the literature about both, and its relevance to the overall research question raised in this ITT, are
explored below.1. Research engagement as a way of increasing ability and willingness
to use research
When clinicians and managers in a healthcare system are seen as stakeholders in the research system then
their engagement in research can be a way of boosting their ability and willingness to use research fromNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8wherever it might originate. Drawing on parallels with the literature from analyses of industrial research
(Cohen and Levinthal, 1989; Rosenburg, 1990), Buxton and Hanney at the Health Economics Research
Group (HERG) included this increased capacity to use research as one of the beneﬁts identiﬁed in their
multidimensional categorisation of beneﬁts from health research (Buxton and Hanney, 1994, 1996 and
1998; Hanney et al., 2004).
The concept of ‘absorptive capacity’ described by Cohen and Levinthal in the context of industrial research
was further developed by various others, including Zahra and George (2002) in their article, Absorptive
Capacity: A Review, Reconceptualisation, and Extension. As indicated in its title, this article and much of
the later writing on absorptive capacity has broadened understanding of this concept in which originally
the extent of an organisation's engagement in research was a key factor. The result is that the earlier
interpretation has perhaps sometimes been overlooked or downplayed. One paper, for example, identiﬁes
the three key measures of absorptive capacity as environmental scanning, collection of satisfaction data,
and the level of workforce professionalism (Knudsen and Roman, 2004). We note, however, that some
work to apply the concept (including aspects of the original conception) to health organisations has also
been conducted in Canada as part of a stream of research on knowledge utilisation led by Rejean Landry –
an important article in this stream of work is discussed below (Belkhodja et al., 2007).
Despite the apparently rather limited application of the term absorptive capacity within healthcare
research, the speciﬁc concept used in Buxton and Hanney's Payback Framework - the notion that
engagement in health research helps to increase the capacity to use health research – has been replicated
in other health research impact assessment frameworks that build on the Payback Framework, for example
in Canada (Frank and Nason, 2009; Canadian Academy of Health Sciences, 2009). However, empirical
examples of the application of this concept in the studies of the payback from health research are often
somewhat hidden because they appear in case studies applying the full payback framework, nevertheless,
some can be identiﬁed including Buxton et al. (1994) and von Walden Laing (1997).
The concept of absorptive capacity is relevant to all parts of the healthcare system within a country. At a
national level, for example, one of the beneﬁts of undertaking research in the UK on the best way to audit
the performance of intensive care units was so that key ﬁndings from the considerably larger body of
research on this topic in the USA could fruitfully be absorbed into the UK (Elliott and Hanney, 1994). More
generally, however, some of these issues are of critical importance when the development of health
research systems in developing countries is being considered by the World Health Organisation
(Pang et al., 2003) and other international bodies.
Without necessarily being explicit about the concept of absorptive capacity, there have been repeated
attempts in England over the last 20 years to build a health R&D system more closely into the NHS. The
major reports on this include the House of Lords report (House of Lords, 1988) that led to the creation of
the NHS R&D Programme (DH, 1991; Peckham, 1991; Harrison and New, 2002; Shergold and Grant,
2008). This was seen as the ﬁrst attempt in any country to build a health research system so
comprehensively into the national healthcare system (Black, 1997). After some retrenchment with the
abolition of the regional level within the NHS (Hanney et al., 2010), the recent reforms have sought to
further develop this approach (DH, 2006). In particular, recent developments such as Biomedical Research
Centres and Units, and the Collaborations for Leadership in Applied Health Research and Care (CLAHRCs)
are important attempts to develop collaboration, build research capacities and more fully incorporate
research into the NHS (NIHR, 2009; Marjanovic et al., 2009). Analysis of these developments highlights
that even within NIHR two rather different notions of building the research system into the health care
system are at work: the Biomedical Research Centres (and subsequently the Academic Health Science
Centres) are ways to bring a concentration of cutting edge research into the healthcare system, whereas
the CLAHRCs are attempting to integrate research into the healthcare system more widely (Hanney et al.,
2010). Many of the accounts of the wider developments over the last 20 years have focused less on the
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104improve the relevance and usefulness of the research that is undertaken. Some of the key literature on this
second topic is outlined next.2. Research engagement as a way of ensuring the research produced has
more likelihood of being used to improve the healthcare system
Denis and Lomas (2003) traced the development of a collaborative approach to research in which
researchers and potential users work together to identify research agendas, commission research, and so
on. They identiﬁed the study by Kogan and Henkel of the English health department's R&D system (Kogan
and Henkel, 1983) as a key early contribution (see also Kogan et al., 2006). Considerable work to analyse
and operationalise this collaborative approach has been undertaken in the Canadian Health Services
Research Foundation led by Jonathan Lomas (Lomas, 1990, 2000). His concept of ‘linkage and exchange’
between users and researchers has been particularly inﬂuential.Collaborative approaches to research
somewhat mirror the concept of ‘Mode 2’ research, i.e. research that is context-driven, problem-focused
and interdisciplinary (Gibbons et al., 1994; Nowotny et al., 2001). It is now widely argued that a
collaborative approach will lead to research that is more likely to meet needs of a healthcare system, and
hence be used and improve performance. Clear evidence to support this hypothesis comes from the
evaluation of the impact of the NHS Health Technology Assessment Programme (Hanney et al., 2007). This
stream of work has considerable overlaps, as noted, with the work on absorptive capacity described above.
In current initiatives and writings there is often overlapping emphasis on: ﬁrst, collaborative working with
users of research so as to produce applied research that is more likely to be of use and be applied by
potential users; and second, on engaging users in the wider research enterprise in a variety of ways and
through various networks, to encourage the uptake of research ﬁndings more generally. The following
deﬁnition by Walshe and Davies (2010) of role of CLAHRCs highlights these overlapping issues:
‘The collaborations have three key interlinked functions: conducting high quality applied health research;
implementing the ﬁndings from this and other research in clinical practice; and increasing the capacity of
local NHS organisations to engage with and apply research.’Defining what is meant by performance at a clinician, team, service and
organisational level in healthcare organisations
Turning to performance, the other key issue in the ITT, the case for the universal measurement of clinical
and organisational performance is now well established (Goddard et al., 2002). But the speciﬁc nature of
performance measurement is a contested topic about which there is a considerable literature. There is
much dispute about how to deﬁne performance and no neat prescriptions for the design of performance
measurement systems in the NHS and the public sector more generally. There is also vigorous debate
about the relative merits of top-down hierarchical systems and approaches based on horizontal networks
(Goddard and Mannion, 2004).
A variety of systems to assess NHS performance have been used in recent years – the star rating system for
NHS trusts, clinical governance reviews, National Service Framework reviews, national and local audits,
performance monitoring by strategic health authorities, and quality accounts. (Mannion et al. 2010,
Mannion et al., 2005; House of Commons at www.parliament.uk/brieﬁngpapers/commons/lib/research/
brieﬁngs/snsg-05237.pdf) The star rating system was originally developed by the Commission for
Healthcare Improvement and has been described as the fulcrum around which the NHS performance
management system operates. But its coverage has also been challenged; many NHS staff think that
important areas of clinical practice are under-valued or missed completely (Mannion 2005). A quick trawl
through these systems reveals some indicators related to research activity or wider research engagement
within trusts. The relatively new ‘Quality Account’ will, where relevant, include data about the number of
trust patients recruited to clinical research and help NHS organisations to develop indicators that have the
potential to consider the quality of research. Our review will explore these and related issues, including
how far the concept of performance as a professional involves engagement with research.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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research projects in terms of the production of knowledge and impact of the projects in terms of
contributing to wider impacts such as improved health policies and health outcomes (Wooding et al.,
2011). On a related but slightly different point, however, a Spanish study found a low to moderate
correlation between a hospital's risk-adjusted mortality ratio and the weighted citations ratio of the
research conducted by the hospital (Pons et al., 2010). We will also explore the relations between research
engagement, organisational culture and the performance of healthcare organisations. In addition we will
attempt to gather evidence about whether the nature and quality of researchers’ engagement with
patients in research studies is associated with improved healthcare performance. We will necessarily look
back to the systems in operation over the last few years. However, in seeking to make this review relevant
to the NHS now, we will also take heed of the present Government's most recent decisions.
Of the questions listed above, the one about whether the utilisation of research improves performance
probably forms a key link between the two main issues of research engagement and improved
performance. Furthermore, it is probably one of the questions where the existing evidence base is
strongest because there is now a considerable body of literature that demonstrates that the ﬁndings from
health research can lead to outcomes such as improved health and sometimes greater cost-effectiveness
within the healthcare system. An important element of this evidence is based on the Payback Framework
(Buxton and Hanney, 1996), and further details of this evidence are described below in the section on the
need for the research. Not all approaches to research impact assessment attempt to go as far as the
Payback Framework in including a wide range of beneﬁts that could be considered as improvements to
healthcare performance, but it might be useful to explore how far it is useful to draw on the more
comprehensive approaches to try to establish pathways between research utilisation and improved
healthcare performance.
This debate also links into the issue of the various levels within healthcare organisations at which it might
be hoped that research engagement might improve performance. There are clearly complex overlaps
between improved performance at the various levels of healthcare organisations: if individual clinicians
improve their performance (for example, as assessed by clinical outcomes) as a result of utilising research
ﬁndings then the performance measured on similar outcomes at team and service levels will presumably
also improve. However, in at least some cases a key to improved uptake of research ﬁndings by clinicians is
an improvement in the way in which the organisation itself is structured and managed.
The discussion about performance at different levels of healthcare organisations is complicated, but also
illuminated, by discussions about distributed leadership which suggest that the complex nature of health
care organisations as professional bureaucracies means that leadership is needed at different levels and not
simply at the top and that there is a requirement for a large number of leaders from various professional
backgrounds. Of particular importance are the clinical microsystems with which healthcare professionals,
including doctors, often identify. Research suggests that team leadership of microsystems is a key factor in
achieving high levels of performance. There is also evidence that constellations of leaders are needed at
different levels when major change programmes are undertaken: ‘Improvement is likely to be conﬁned to
microsystems and teams unless there is alignment between top level leadership, and those working in
other parts of the organisation.’ (Ham and Dickinson, 2008). In terms of improved performance resulting
from the implementation of research ﬁndings, the relevance of these types of arguments is likely to
depend partly on the types of research ﬁndings being implemented, as discussed above.3. Need
As noted in the ITT, ‘the increasing investment in NHS R&D over recent years has focused attention on
how NIHR measures or understands the impact of its investment in health research.’ The research
proposed here will contribute to the NHS in several ways that have been identiﬁed in previous studies of
the beneﬁts of health research conducted for the NHS (Buxton et al., 2000). First, such studies are an
important part of the processes of providing accountability for public expenditure by demonstrating the
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106been argued that the assessment of the beneﬁts accruing for health research can also contribute to the
development of ways to improve the conduct, management and organisation of health research so as to
enhance those beneﬁts.
Since 1993 a portfolio of work assessing the payback from health research that has been conducted at the
Health Economics Research Group (HERG) by members of the research team, and by others. The payback
framework developed by HERG consists of a multi-dimensional categorisation of beneﬁts form health
research and a model of how best to assess them. The multi-dimensional categorisation of beneﬁts includes
not only traditional outputs from research (such as the knowledge contained in papers and the building of
research capacity) but also additional beneﬁts such as improved health policies, better health care and
economic beneﬁts. The model incorporates the thinking of Kogan and Henkel described above and
highlights the importance of the permeability at the interfaces where researchers and potential users of the
research might interact as set out in the collaborative approach. A number of studies conducted by HERG
have demonstrated the wide range of beneﬁts that have, and in some cases continue, to accrue from several
NHS R&D programmes: the North Thames NHS Region R&D Programme (Buxton et al., 2000; Hanney et al.,
1999, 2000); the NHS Implementation Methods Programme (Soper and Hanney, 2007); the NHS Health
Technology Assessment Programme (Hanney et al., 2007). Other studies have shown the impacts from
some other NHS programmes of research, including other regional programmes (Ferguson et al., 2000;
Elliott and Popay, 2000), other NHS central R&D Programmes (Wisely, 2001a and 2001b) and from the
SDO Programme (Peckham et al., 2008). In addition, HERG led an evaluation for the MRC/Wellcome
Trust/Academy of Medical Sciences of the economic value of all UK medical research, including that
funded by the NHS, in the ﬁelds of cardiovascular disease and mental health (Buxton et al., 2008).
However, and as noted in the brief overview of the literature above, there is comparatively little evidence
about the beneﬁts from research engagement per se and almost no attention has been paid to assessing
this activity through the performance measurement systems currently used in the NHS. This is a large gap.
The improvements in healthcare performance that could be linked to research engagement are not
alternatives to the paybacks already identiﬁed as coming from research; they are both overlapping and
additional ways in which impacts might be enhanced. We believe, therefore, that there could be
considerable beneﬁts from a proper analysis of whether research engagement per se leads to
improvements in healthcare performance.
The second main contribution that will come from this project is that it will analyse how research
engagement might improve performance, through what mechanisms, and in what contexts. In the current
climate of deﬁcit reduction in the public sector it is important that the health research system does not
only seek to identify and demonstrate the beneﬁts that accrue from the resources spent on health
research, but is also able to illustrate how it is attempting to identify more effective mechanisms for
achieving and enhancing those beneﬁts. Exploring the nature of research engagement and its impact on
performance across the service is one way of doing this. Such an analysis should make an important
contribution to current efforts to organise the interface between the health research system and the
healthcare system so as to maximise the beneﬁts that might emerge from engagement in research
(DH, 2006; NIHR, 2009).
This work should, therefore, complement, and add value, to a considerable range of initiatives that are
currently underway in the English health R&D system, such as the development of the CLAHRCs (NIHR,
2009). As explored in detail by Steve Hanney and Bryony Soper, and colleagues, recent reforms in the
health R&D system are a further major advance in a series of attempts to ensure the R&D system more
closely meets the needs of a range of stakeholders, including practitioners, managers, and policymakers
within healthcare organisations, and patients and the public (Hanney et al., 2010). As far back as the
House of Lords report of 1988, and indeed earlier, there have been attempts to ensure the health research
is embedded into the NHS. The Best Research for Best Health reforms took this process further (DH, 2006)
and the Cooksey Report (Cooksey, 2006) ensured that the whole publicly funded R&D system in the UK
was considered at a coherent system-wide level.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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approach being adopted (Hanney et al., 2010). In this review of research engagement we will take a broad
perspective. But it was also shown that progress was being made in the R&D system because attention
was being given to developing mechanisms at various interfaces between the health research system and
various stakeholders. Even here, however, several areas were identiﬁed where the mechanisms had not yet
been fully developed, and it was therefore unlikely that the system was achieving its full potential. In the
case of the beneﬁts that might come from research engagement the issues have so far been so under-
explored in any systematic way that it is very unlikely the most effective set of mechanisms (that might
work in speciﬁc contexts) have been identiﬁed. This project will aim to make progress in this area.4. Methods
Background
This evidence synthesis draws on recent and on-going methodological developments in the ﬁeld of
conducting systematic reviews. Whilst our task is somewhat different from that of Greenhalgh and
colleagues (2005), we propose to draw, in particular, on the approach developed by that team as it
provides a rigorous and comprehensive approach to reviewing literature. This approach has six distinct
phases: the planning phases, the search phase, the mapping phase, the appraisal phase, the synthesis
phase and the recommendations phase. Each of these will be dealt with in turn in this section. We have
also accepted an invitation to participate in the network created by the SDO-funded RAMESES project, set
up to further methodological development in the ﬁeld of realist reviews and meta narrative synthesis.1. Planning the review
The team has been drawn together to reﬂect some of the key disciplinary ﬁelds relevant to the review
process: the social science literature on improve the uptake of research (SH, AB), translational research
(AB), organizational change (BS), health services research (SH, AB and BS), and science and policy (CD).
Further relevant expertise will be accessed via the advisory group. This phase will start before the formal
ﬁrst month of the project (see timetable below) and could involve review planning, discussions with
advisory group members including the two public and patient representatives, and team ‘brainstorming
meetings’ to begin to scope the review. At this stage, the review does not have a single, focused question,
but, rather, a menu of questions reﬂecting the tender speciﬁcation and issues elaborated on earlier. These
questions include:
l What deﬁnitions or aspects of engagement in research might be relevant for addressing the
overall question?
l What dimensions of performance in healthcare organisations will be relevant for addressing the overall
question, and how is improvement best measured?
l Does research engagement increase the ability and/or willingness of healthcare staff as individuals to
absorb and use relevant research ﬁndings from wherever they originate?
l Does research engagement increase the ability and/or willingness of healthcare teams to absorb and
use relevant research ﬁndings from wherever they originate?
l Does research engagement increase the ability and/or willingness of healthcare services and
organisations to absorb and use relevant research ﬁndings from wherever they originate?
l Does research engagement by a range of stakeholders in healthcare organisations lead to the
production of knowledge that will be more likely to be used in that setting, and possibly other
similar ones?
l Does the engagement of patients in research agenda setting and advisory groups, etc. lead to the
production of knowledge that will be more likely to be utilised, including by patients themselves
drawing it to the attention of healthcare staff and organisations?
l In what ways does the adoption/utilisation of research improve performance (however measured) at
clinician, team, service, and organisational level?
l Does research engagement encourage a more questioning and open culture that facilitates
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108l Are some types of research engagement, and types of research, more likely to produce improved
performance than others?
l Can we identify the levels of healthcare organisations that are most likely to improve performance as a
result of the various types of research engagement?2. Search strategy
Greenhalgh et al. (2005) recommend an initial search based on intuition, informal networking and
browsing to begin to develop an understanding of the ﬁeld under review. This approach will be used (in
addition to collaboration with information scientists) to identify key words and conﬁrm the likely range of
databases and the years to be searched.
The more focused, systematic search will include three elements: database searches, web searches and
expert contacts. The bibliographic searches are likely to be conducted of the following databases (ASSIA,
British Nursing Index, CINAHL, EMBASE, HMIC, IBSS, Medline, PsychInfo and Sociological Abstracts) and is
likely to include as a minimum papers from 1980–2010. In addition an internet search will be conducted.
Key internet sources would include the Department of Health website, NIHR website, World Health
Organization and the websites of a number of Canadian health research organizations that have
conducted research in this area. References from article reference lists and recommendations will also be
used to identify papers. We will also communicate directly with authors to follow up on references to on-
going research. We will consult with the expert advisory group in order to access any unpublished work
and any new or ongoing research. This process has been found to be particularly useful in previous
reviews (Boaz et al., 2009).
We believe the grey literature may be particularly relevant as part of the search and data collection in this
review, and therefore set out here in more detail how we shall conduct it, although some of this overlaps
with the general description above. The search will include: a search of SIGLE (the grey literature
database), web searches including key organizations in the ﬁeld such as NICE, Department of Health,
NIHR, Canadian Health Services Research Foundation, a search of relevant library catalogues including the
University of Birmingham Centre for Health Services Management library and an e-mail consultation with
key experts in the ﬁeld (to access new and unpublished research). We will also consult with the research
advisory group. Initial sifting will be based on titles and abstracts, with full papers obtained where there is
any uncertainty regarding inclusion. The initial inclusion criteria will be relevance to the review questions. A
data sheet will be completed for all papers included in the review, reporting the bibliographic details, the
research question, methods, theoretical approach, ﬁndings etc.3. Mapping
It is often considered to be good practice to include a mapping or scoping stage in the review process or
indeed to consider scoping exercises as rigorous outputs in their own right (Arksey et al., 2005). From our
previous experience of conducting reviews in the ﬁeld of assessing the impact of research (Boaz et al.,
2009, Hanney et al., 2007), and our initial analysis of the literature related to research engagement, we
are aware that the literature we are seeking is diverse in terms of methodological approaches and types of
output (for example, we will need to include reports as well as academic papers). It is located in many
different ﬁelds and will involve database searches in various ﬁelds including health and social sciences.
These ﬁelds are described in the next section on the contribution of existing research, but will include
medical education, organizational change, evidence based medicine, social studies of science. The
mapping stage will seek to capture this wider literature on, for example, types of involvement, levels of
engagement, types of people, teams and organizations, types of research undertaken, and when and how
professionals are involved.
This map will be used to stimulate discussion within the team and with the advisory group and funders in
order to develop a focused review question for a more rigorous and systematic review. Additional searches
will be carried out to address any gaps identiﬁed. As articulated the research question currently contains a
number of unknowns which the mapping phase should help to clarify.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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We will use the more generic appraisal questions developed by Dixon Woods et al. (2004) when sifting for
relevance, using methodologically speciﬁc checklists to check for validity. It is likely that this review will
draw together a wide range of types of research. This will involve using a wide range of quality appraisal
tools. These have recently been drawn together in a number of texts (for example, Pettigrew and Roberts,
2007) We will therefore use appropriate appraisal techniques to evaluate the studies identiﬁed. Quality
appraisal tools are considered to be useful in making quality judgements explicit (Dixon Woods et al.,
2007). AB has considerable experience of both teaching critical appraisal and contributing to
methodological development in the ﬁeld. For example, she developed a generic critical appraisal tool (Long
et al., 2004) which can be used where no quality criteria exist (for example, policy documents and service
user evidence). Quality scores will be reported in the data tables and on the data extraction forms.
Drawing on the work of Dixon Woods and colleagues (2007) we will exclude studies that are considered
to be fatally ﬂawed following quality appraisal.5. Synthesis
A variety of approaches to synthesis have emerged in the past ten years (Boaz et al. 2006), although many
of them are still in the process of being tested and developed. Methodological developments in research
synthesis have generated a wide variety of approaches to analysis, ranging from conventional tabulation
and thematic analysis to ideas webbing, concept mapping and theory building. Our approach is informed
by the work of Popay et al. (2006), Greenhalgh and colleagues (2005) and Pawson (2006). Greenhalgh
et al. (2005) and Pawson (2006) are particularly relevant to complex review questions and diverse
literatures (in terms of both types of research and research drawn from different ﬁelds). In their review of
the diffusion of innovation literature, Greenhalgh et al. (2005) developed an approach to synthesis that
can bring together diverse bodies of literature as meta-narratives. Realist Synthesis (Pawson 2006) can also
be used with very diverse literatures (for example, a review of mentoring studies included qualitative
research, surveys, evaluations, a path analysis, a theoretical piece and a meta analysis). Rather than seeking
to synthesise all research identiﬁed, a purposive sample of studies is used to revise an existing explanatory
model (derived from an earlier mapping stage) exploring how a mechanism might work, for whom and in
what circumstances.
A ﬁrst stage of the synthesis process will involve extraction of key information and collation. Popay et al.
(2006) describe this essential stage of description, tabulation and grouping and clustering as the
preliminary synthesis. All papers will be read by at least two members of the team. Descriptive information
about the papers (country of origin, year of publication, disciplinary background etc.) will be recorded and
reported in a tabular form.
The second stage of the synthesis process seeks to move beyond simple descriptions. The methods will be
driven by both the question we seek to address and the type of research data identiﬁed. For example, our
understanding from previous research in the ﬁeld is that the literature on the impact of research
engagement on performance is not as established or formalised as the diffusion of innovation literature,
and hence establishing meta narratives as a product of the synthesis may not be possible. If key theories
(or competing theories) emerge from the early stages of the review it might be possible to use a Realist
approach. Using key themes identiﬁed at earlier stages of the process of synthesis (see stage 2–3), Realist
Synthesis begins by identifying key theories underpinning an intervention or practice. The process of
synthesis gradually reﬁnes these theories using the research data. Where there are competing theories, the
research data are used to settle disputes about which will best support policy change in which
circumstances. For example, for this review, the theory of absorptive capacity or learning organizations
might be interrogated. If this is not possible, we will use a more conventional thematic analysis, coding
themes that arise from the studies that are relevant to the review questions. We would be happy to
discuss with the SDO the question of which approach would be best to adopt. The analysis will also
explore conﬂicting ﬁndings and ﬁndings that do not ﬁt within the emerging analysis. We would also use
concept mapping to represent visually the links between individual studies using diagrams and ﬂow charts
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110phase to the synthesis process which involves an assessment of the robustness of the synthesis. This
opportunity for critical reﬂection will be particularly valuable given the likely complexity of the synthesis
involved in the proposed review and the continuing debate within the RAMESES project and elsewhere
about approaches to research synthesis.6. Producing recommendations
Although we will encourage ongoing involvement of stakeholders in the review, the ﬁnal phase of the
review process is dedicated to reﬂection and consultation with the intended users of the review and the
advisory group in order to develop meaningful recommendations for policy and practice. This stage will
involve a distillation of key messages from the research (and a consideration of how these relate to other
relevant information and the production of recommendations for policy, practice and research). We will
also seek out opportunities to discuss these recommendations with potential users and the advisory group,
via a meeting/conference call to discuss and validate the emerging recommendations. The liaison with
potential users of the review could continue after the project has been formally completed.5. Contribution of existing research
Given that this study is a synthesis of the evidence it will focus to a considerable extent on analysing and
synthesising the contribution of existing research. In this section, therefore, we provide an outline of some
of the bodies of knowledge to be reviewed that are additional to those on research engagement and
improved performance that have already been described in the Background section. This additional
literature covers a range of potentially relevant and sometimes overlapping topics, some of which are likely
to more relevant at one level of performance in healthcare organisations than others. Much of this comes
from the health ﬁeld and includes studies on: organisational process, learning organisations, the role of
medical academics, medical education and continuing professional development, critical appraisal, quality
improvement (QI), evidence-based medicine (EBM), medical engagement, and the diffusions of
innovations. Furthermore, as with the notion of an ‘absorptive capacity’, some of the concepts and
theories used in this diverse body of work originated elsewhere, often from studies of the role that
research engagement plays in industry and in commercial ﬁrms. However in terms of addressing the
questions set out above, this literature currently resembles an unsolved jigsaw puzzle, and although some
of it does try to indicate how links can be made between research engagement and performance, in other
bodies of literature the links are more tangential. We will need to interrogate and arrange the various
bodies of knowledge carefully before a clear picture, or evidence synthesis, can emerge. We start with a
very brief account of some of the literature from studies about research in industry.
Learning from research on industry The speciﬁc term ‘absorptive capacity’ was referred to above because
it was directly incorporated into assessments of health research such as the payback framework. In this
sub-section we consider other literature that sometimes covers similar themes but relates to broader
movements. In 2004 the UK Government published the ten-year Science and Innovation Investment
Framework (SIIF), making a strong case for a strong public science base to support improvements in
welfare and seeing the outputs from the science base as new knowledge, skilled people, new
methodologies, and new networks. This Framework provided part of the context for the 2006 DH R&D
strategy: “Best research for best health”, mentioned above. The SIIF was based on a wide-ranging review
of the available evidence, and this included substantial evidence from industry. One of the key lessons for
this particular review from this body of work is the importance to ﬁrms of effective in-house R&D, and
here the evidence includes some historical analysis with the claim, for example, that “German industry in
the 1870s had already established the new pattern of in-house R&D leading to the introduction of new
products and new processes” (Freeman and Soete, 2000).
Organisational process Organisational process has been described as the missing link between research
and practice. For example, Rosenheck builds on a 1999 report by the US National Institute of Mental
Health entitled ‘Bridging Science and Services’ to describe how the operational characteristics of large,
complex organizations and strategies have been used to facilitate implementation of innovative
programmes (Rosenheck, 2001). His observations were largely descriptive and had not been subject toNIHR Journals Library www.journalslibrary.nihr.ac.uk
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report on the organisational determinants of research utilisation in Canadian Health Services Organisations
and conﬁrm the importance of the linkage mechanisms, research experience, unit size, and research
relevance for the users (Belkhodja, 2007). Part of the more general literature on innovation (within ﬁrms,
nationally and internationally) is also relevant to this discussion. For example, a recent paper links
self-directed learning, organisational learning, knowledge management capabilities to organisational
performance in 21 technology companies (Ho, 2008).
Learning organisations The literature on learning organisations is again somewhat overlapping with the
above concerns, and ranging much more widely than just healthcare. But it is seen as a important
concept within attempts to analyse and encourage the use of knowledge advances within healthcare
organisations (Davies et al., 2000). And the concepts can be speciﬁcally linked to the use of research
(Nutley et al., 2007).
Knowledge transfer and mobilisation and research utilisation There are increasing attempts within the
healthcare and health research systems to encourage the use of knowledge. This again could be seen as a
link between research and improving healthcare. Crilly et al. (2010) review a large body of relevant
literature from both the health and management ﬁelds.
The role of clinician scientists, or medical academics, in translational research There are a number of
papers focusing on the particular role that physician (or clinician scientists) might play as catalysts for
translational research (Archer, 2007; Bevan, 2007; Chung et al., 2007). Liang (2003) describes the
potential role as follows: ‘To the clinician scientist studying healthcare it is to translate the promise of
contemporary molecular medicine and the social and behavioural sciences and bring them inseparably to
the intelligence, sensitivity and morality of the master clinician; and to translate the promise of medicine
into actual healthcare for all and to the most vulnerable among us.’(Liang, 2003: 721). This literature tends
to focus on the considerable potential in encouraging physician scientists. Eckert et al. (2006) describe the
increasing numbers of physician scientists as a win-win situation, although it has been acknowledged that
it will take some time to see the results (Bevan, 2007). The critical factors required to encourage physician
scientists include early training opportunities and opportunities for physicians to do PhDs (Bevan, 2007). In
contrast, Chung (2007) focuses on the decline in the number of physician scientists and cites their long
training, lack of mentors, income issues and other responsibilities as barriers. Reports on such issues in the
UK from the Academy of Medical Sciences (2003) were a major factor behind the new R&D strategy
developed by the DH (DH, 2006).
This stream of thinking has some parallels with analyses of the beneﬁts in the ﬁeld of education from
partnerships and interactions between researchers and research users (Huberman, 1993; Cousins and
Simon, 1996), and the beneﬁts of practitioners as researchers (Fox, 2003; Stenhouse, 1979). A House of
Lords report into Allergy services in the UK highlighted the role of the MRC-Asthma UK Centre in Allergic
Mechanisms of Asthma in fostering translational research (House of Lords, 2007). In the healthcare ﬁeld
there are some particularly striking examples of care provided by clinicians who implement their own
cutting edge research that is of high quality and improves the care provided. In some instances this can be
in ﬁelds where there are a small number of cases of the particular illness, and the care provided by the
leading medical academic is at the national centre for the disease, or at one of a small number of specialist
centres. In these cases quite a high proportion of the patients with that speciﬁc illness may end up
receiving this high quality treatment.
Medical education, continuing professional development and critical appraisal The medical education
literature includes various analyses of the types of engagement in research that are possible for clinicians,
and also sets out why it is seen as beneﬁcial for clinicians. In some of the literature the emphasis is on
doing research, as in a recent review of programmes to engage medical students in research in two US
universities (Laskowitz et al., 2010). Other literature, including regular articles in the BMJ, focuses on
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112attempts in the HERG payback stream of work (Buxton et al., 2000) and elsewhere to see how far critical
appraisal courses contribute to improved healthcare. As part of making this review as relevant as possible
to the needs of the NHS we shall consider reports on issues relevant for different groups of healthcare
professionals who are being encouraged, for example, to undertake various types of higher degrees. There
are also overlaps between consideration of medical education and the literature on the role of medical
academics, highlighted in various reports in the 2000s (Academy of Medical Sciences, 2003).
Evidence-based medicine The literature on EBM is extensive and it overlaps with the some of the work
on assessing the impacts of health research as it represents a very explicit attempt to get research evidence
used to improve healthcare performance. There was a considerable growth of interest in this approach in
the 1990s following publication of a paper by the Evidence-Based Medicine Working Group in 1992, but
later there were debates about how far the initial approaches advocated for getting evidence into practice
were making an important impact (Coomarasamy and Khan, 2004; Gabbay and le May, 2004; Sheldon
et al., 2004; McCulloch, 2004).
Quality improvement There is a considerable literature on how best to improve quality in healthcare
organisations, and SH and BS also have recent practical experience as part of a team evaluating two large
Health Foundation schemes involving seventeen projects in total (Soper et al., 2008; Ling et al., 2010). Key
recommendations from this work highlight the importance of recognising the various levels and issues that
can be involved in improved performance within health care organisations: ‘QI should be part of the
education, training and appraisal of health professionals. This not only concerns ‘heroic’ leadership but
also dispersed leadership and the ability to maintain effective dialogue with managers, service users and
other clinicians.’ (Ling et al., 2010). We will interrogate this literature to see what has been said here
about engagement in research as a contribution to improving quality. An initial scan of the literature
suggests that much of it might not relate to research engagement at all, but that there will be some
studies that have relevant points to make, such as the evaluation of the US Quality Enhancement Research
Initiative (QUERI) programme (Graham et al., 2009).
Medical engagement A correlation between medical engagement and service improvement has been
demonstrated in two recent studies cited in the ITT (NHS Institute for Innovation and Improvement and
Academy of Medical Royal Colleges, 2008; Mannion et al., 2010). While the impact of research
engagement on service improvement was not speciﬁcally explored in either study, the report by Mannion
et al. does note the motivational force of maintaining or developing a reputation as a high status
organisation, describing it as a key inﬂuence on the formation of a highly developed performance
management culture within an organisation. And, importantly, reputation here is interpreted not just as
service excellence but as national and international academic and research excellence (Mannion et al.,
2010, p. 206) A similar picture emerged from the review of the impacts of the NIHR-funded Biomedical
Research Units undertaken by BS with RAND Europe (Marjanovic et al., 2009). We will seek to build on
and further explore these insights.
The diffusion of innovations The many bodies of research that contribute to explaining the diffusion of
innovations have been reviewed for the SDO by Trisha Greenhalgh and her colleagues (Greenhalgh et al.,
2004, 2005). For the current synthesis it will be highly relevant to explore how far notions of research
engagement were seen as important in the literature reviewed by Greenhalgh et al. An initial review might
suggest that research engagement plays a limited direct role, but some of the research traditions included
in Greenhalgh et al's review form part of the literature described above. Some articles on the spread of
innovations, or technologies, in healthcare that were included in that review, and later ones, will be
examined. For example, Ferlie et al. (2005) conducted two qualitative studies in the UK health care sector
to trace eight purposefully selected innovations. Complex, contested, and nonlinear innovation careers
emerged. Developing the nonlinear perspective on innovation spread further, they theorised that multi-
professionalisation shapes “nonspread”, i.e. social and cognitive boundaries between different professions
retard spread as individual professionals operate within uni-disciplinary communities of practice.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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have some relevance for the question of whether engagement in research improves performance of and
within healthcare organisations. But to be of value to the NHS it will be necessary to add to the body of
knowledge by identifying and synthesising those parts of it that can help address the question. The ITT
notes that the evidence synthesis should map and explore the likely or plausible mechanisms through
which research engagement might bear on wider performance at each level. Hanney et al. (2010)
identiﬁed a series of mechanisms that assist the English DH's research system meet the needs of the
various stakeholders. Such a list provides a starting point for identifying the mechanisms through which
research engagement might improve the performance of healthcare organisations. In line with the realist
approach to synthesis that will inform parts of our study, we believe that it is also vital to consider the
various contexts in which these mechanisms are used.6. Plan of Investigation
Pre-project preparatory work
Initially in this phase we will make the necessary ethics arrangements; recruited the research assistant; and
ﬁnalised the membership of the advisory group. This phase will also include an intense process of scanning
the very wide ﬁeld to consolidate our initial understanding of the issues, the conceptual difﬁculty of which
is compounded by the wide scope. We shall begin the process of consultation.Month 1: Planning phase
Starting with the ﬁrst formal team meeting we will undertake a ‘conceptual brainstorming exercise’ to
attempt to identify the pieces, or at least the edges, of the jigsaw puzzle of literature described above as
being potentially relevant to addressing the series of questions about whether research engagement (of
various types) improves performance of healthcare organisations (at various levels). The immediate purpose
of this will be develop a search strategy for the review. Some discussions will be had with selected experts,
both service user members of the advisory group and more widely. At the end of month 1 we will have
developed a draft search strategy to be shared with the advisory group.
Milestone: draft search strategy.Month 2: Searching phase (initial search)
We will collate comments from the advisory group members. We will divide the research areas to be
searched among the team, and will conduct the initial, more informal searches and informal networking.
Once responses have been collated and analysed the team will meet to make key decisions about the
search strategy. In collaboration with the information scientists we will have reﬁned the search strategy by
the end of month 2. This will inevitably be challenging because we shall want to include as much of the
literature as is potentially relevant despite the danger that the search terms identiﬁed from such a diverse
body of knowledge will be too numerous and broad.
Milestone: Reﬁned search strategy.Month 3: Data collection
In month three we will begin to undertake the data collection. The search strategy for the more systematic
review will include three elements: database searches, web searches and expert contacts.
l Databases, key words, inclusion and exclusion criteria will be established during the mapping stage of
the review. However, the bibliographic searches are likely to be conducted of the following databases
(ASSIA, British Nursing Index, CINAHL, EMBASE, HMIC, IBSS, Medline, PsychInfo, Sociological
Abstracts, SIGLE - the grey literature database) from 1980–2010.
l In addition an internet search will be conducted. Key internet sources would include the Department of
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114health research organizations that have conducted research in this area, and a search of relevant library
catalogues including the University of Birmingham Centre for Health Services Management library.
l References from article reference lists and recommendations will also be used to identify papers. In
particular, we will consult with the expert advisory group in order to access any unpublished work and
any new or ongoing research. Initial sifting will be based on titles and abstracts, with full papers and
publications obtained where there is any uncertainty re inclusion.
A data sheet will be completed for all papers and publications included in the review. The papers will be
coded using appropriate software (e.g. Nvivo). All papers will be read by at least two members of the
team. Descriptive information about the papers (country of origin, year of publication, disciplinary
background etc.) will be recorded and reported.
Milestone: Data searches.Month 4: Continue data collection and plan mapping phase
The data collection will continue, but also in month 4 the team will meet to plan the mapping exercise.
The mapping stage will seek to capture this wider literature on, for example, types of involvement, levels
of engagement, types of people, teams and organizations, types of research undertaken, when and how
professionals are involved.Month 5: Conduct mapping
Month 5 will be the main phase of the mapping exercise. Further meetings might be held with relevant
members of the steering group. Some speciﬁc consultancy work might be commissioned at this stage from
some advisory group members.Month 6: Continue mapping and plan more focused review
The mapping exercise will continue but towards the beginning of month 6 the team will meet to discuss
the shape of the map that is emerging and how it should be drafted. This map will be used initially to
stimulate discussion within the team and with the advisory group and funders in order to develop a
focused review question for a more rigorous and focused review. Following the brief, a question of interest
would address whether different types of research engagement are effective in inﬂuencing practice.
However, this topic currently contains a number of unknowns. The mapping stage will clarify the range of
ways in which healthcare organisations can be engaged in research and the types of change they might
have on practice. As part of this we shall also need to consider the mechanisms through which
improvements might be made. We shall also need to consider how the various types of research
engagement could potentially lead to improved performance at various levels of the healthcare system.
Following the question identiﬁcation we will run further database searches.
Milestone: Draft map sent for comment. Further database searches.Month 7: Appraisal stage and synthesis planning
All papers for inclusion in the ﬁnal review will be critically appraised. Team members will hold an initial
meeting to review comments on the map and plan the synthesis of the evidence gathered. The data
analysis will continue throughout month 7. A further meeting will be held to review progress on the
analysis and plan the synthesis (including selecting an approach to ﬁt both the research question and
emerging data) and how it will be reported.
Milestone: completed critical appraisals.Month 8: Synthesis
The ﬁrst stage of the synthesis will involve tabulation and description of the included studies. The second
stage will be conducted using either meta-narratives, Realist Synthesis or a thematic approach combinedNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr01080 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 8with conceptual maps. Towards the end of the month, the synthesis report will be drafted and sent to the
advisory group and the funder for review.
Milestone: Draft evidence synthesis sent for comment.Month 9: Review, preparing final report and dissemination
The comments on the draft report will be collated. We will hold a conference call/meeting (for those
members of the advisory group able to attend) to discuss the draft synthesis. If time and resources allow it
we would hope to involve users in this and make it an opportunity to discuss and validate the emerging
recommendations. The ﬁnal drafting of the map will be held back until this stage so that insights from the
synthesis can be fed back into it. The synthesis report will be revised in the light of the comments received
and will be disseminated as described below.
Milestone: Completed evidence synthesis report and map.Post project dissemination work
The team will be available to discuss the recommendations emerging from the review with potential users,
but we shall also develop a proactive dissemination plan depending on the precise nature of the ﬁndings.
As appropriate, the team will seek opportunities to present ﬁndings to policy and practice communities,
both in general and in a more targeted way. In order to share the ﬁndings widely, including with the
research community, these outputs will be: written up as one or more academic journal articles; presented
at conferences where opportunities arise; and made available through the HERG, KCL and SDO websites.
A further possibility that would very much depend on what emerges from the review, is that if especially
interesting studies are identiﬁed from the international literature it might be worth exploring whether their
authors could be invited to contribute to an event such as an SDO conference.
The team have existing networks which are ideally suited to mobilizing interest in the ﬁndings, and
potentially uptake of any recommendations. These include links with speciﬁc organisations and individuals.
In the last three years a number of new schemes have been established by NIHR which aim to increase
collaboration between healthcare researchers and NHS staff and users, and between universities and NHS
organisations, and to develop research capacities. These include the Biomedical Research Centres and
Units and the CLAHRCs. These new entities present real opportunities to use the outputs of this review in
a timely fashion. For example, the establishment of the CLAHRCs is a pioneering attempt to develop
mechanism to achieve improvements in healthcare performance through wider engagement of healthcare
organisations in research. SH and BS are members of the one of the teams that successfully applied to the
SDO to conduct the formative evaluation of the whole CLAHRCs initiative. The director of one of the
CLAHRCs is a member of the proposed advisory group for this current study. Therefore, the applicants on
this proposal are likely to have various opportunities to discuss the ﬁndings of this evidence synthesis with
leading members of the CLAHRCs initiative. AB works within two of the Biomedical Research Centres
based at King's College London and is ideally placed to feed the ﬁndings into the wider network of BRCs
and BRUs. Additionally, other members of the advisory group will be well placed to assist with
dissemination of the ﬁndings to key target audiences.
Furthermore, from previous discussions, and research activities, members of the research team know of
various key players with the UK health research system who have expressed an interest in the potential
beneﬁts from there being widespread engagement in research activities by staff of healthcare organisation.
We would aim to disseminate the ﬁndings to them both formally and informally. Finally, various members
of the advisory group would also be well placed to help with dissemination of the ﬁndings to international
audiences. Through Dr Tikki Pang, such audiences will include WHO. With the planned World Health
Report 2012 being on the importance and beneﬁts of health research (Pang and Terry, 2011), WHO is
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1167. Project Management
Steve Hanney and Annette Boaz will share project management activities, and they will liaise regularly.
Given the complexity of the literature to be reviewed they both intend to devote 20% FTE time to the
project. SH will have overall responsibility for project management and monitoring of progress. He will be
particularly responsible for the work being conducted by the members of the team from HERG, including
the Research Assistant who will undertake many of the basic tasks of gathering and collating data. AB will
be responsible, in particular, for monitoring the progress of the work being conducted at King's, including
the input of the information specialists who will run the database search, as described below.
A virtual project advisory group will be established to provide expert input at various points about a range
of issues, including the methods being used in the review, the literature being identiﬁed, and the ﬁndings
emerging from the synthesis. Most of the input from the virtual advisory group is expected to be by email,
but it is hoped to organise one meeting/conference call towards the end of the project. The membership
of the advisory group is listed separately in the Management Plan.8. Service users/public involvement
We have taken advice from the London Research Design Service (RDS) lead on Patient and Public
Involvement on how to engage patients and the public in this synthesis. We have invited two individuals
with wide experience of representing the patient/public perspective to join the project's virtual advisory
group, and consultation with them begins in the early stages of the project.
Whilst most of the involvement of members of the advisory group is intended to be via email commentary
on progress reports sent round by the project team, we also hope to talk individually to some members of
the group to gain their particular perspective. The two service user advisors will join the team for the ﬁrst
formal project meeting in September to meet the team, learn about the planned research and discuss their
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Citations and Ovid MEDLINE (R) <1946 to present>
Date run
6 March 2012.Limits
Search dates: 1990 to current.
Search ﬁelds: title and abstract.
Languages: all.
Publication type: case reports; classical article; clinical conference; clinical trial; controlled clinical trial;
corrected and republished article; evaluation studies; festschrift; government publications; guideline;
journal article; meta-analysis; multicenter study; review; practice guideline; published erratum; RCT; review
of reported cases; research support – all; technical report; validation studies.Search strategy1. (engag$ adj2 research$).ti,ab. OR (engag$ adj2 trial?).ti,ab. OR (engag$ adj2 case stud$).ti,ab. OR
(engag$ adj2 clinical stud$).ti,ab. OR (engag$ adj2 experimental therap$).ti,ab. OR (engag$ adj2 RCT?).
ti,ab. OR (engag$ adj2 randomi?ed controlled trial?).ti,ab. OR (engag$ adj4 clinical trial?).ti,ab. OR
(participat$ adj4 research$).ti,ab. OR (participat$ adj4 trial?).ti,ab. OR (participat$ adj4 case stud$).ti,ab.
OR (participat$ adj4 clinical stud$).ti,ab. OR (participat$ adj4 experimental therap$).ti,ab. OR (participat
$ adj4 RCT?).ti,ab. OR (participat$ adj2 randomi?ed controlled trial?).ti,ab. OR (participat$ adj4 clinical
trial?).ti,ab. OR (involv$ adj2 research$).ti,ab. OR (involv$ adj2 trial?).ti,ab. OR (involv$ adj2 case stud$).
ti,ab. OR (involv$ adj2 clinical stud$).ti,ab. OR (involv$ adj2 experimental therap$).ti,ab. OR (involv$
adj2 RCT?).ti,ab. OR (involv$ adj2 randomi?ed controlled trial?).ti,ab. OR (involv$ adj4 clinical trial?).ti,
ab. OR (interact$ adj2 research$).ti,ab. OR (interact$ adj2 trial?).ti,ab. OR (interact$ adj2 case stud$).ti,
ab. OR (interact$ adj2 clinical stud$).ti,ab. OR (interact$ adj2 experimental therap$).ti,ab. OR (interact$
adj2 RCT?).ti,ab. OR (interact$ adj2 randomi?ed controlled trial?).ti,ab. OR (interact$ adj4 clinical trial?).
ti,ab. OR (tak$ part adj3 research$).ti,ab. OR (tak$ part adj5 trial?).ti,ab. OR (tak$ part adj3 case stud$).
ti,ab. OR (tak$ part adj3 clinical stud$).ti,ab. OR (tak$ part adj3 experimental therap$).ti,ab. OR (tak$
part adj3 RCT?).ti,ab. OR (tak$ part adj2 randomi?ed controlled trial?).ti,ab. OR (tak$ part adj4 clinical
trial?).ti,ab. OR (initiat$ adj2 research$).ti,ab. OR (initiat$ adj2 trial?).ti,ab. OR (initiat$ adj2 case stud$).
ti,ab. OR (initiat$ adj2 clinical stud$).ti,ab. OR (initiat$ adj2 experimental therap$).ti,ab. OR (initiat$ adj2
RCT?).ti,ab. OR (initiat$ adj2 randomi?ed controlled trial?).ti,ab. OR (initiat$ adj4 clinical trial?).ti,ab. OR
(follow$ adj2 research$).ti,ab. OR (follow$ adj2 trial?).ti,ab. OR (follow$ adj2 case stud$).ti,ab. OR
(follow$ adj2 clinical stud$).ti,ab. OR (follow$ adj2 experimental therap$).ti,ab. OR (follow$ adj2 RCT?).
ti,ab. OR (follow$ adj2 randomi?ed controlled trial?).ti,ab. OR (follow$ adj4 clinical trial?).ti,ab. OR
(introduc$ adj2 research$).ti,ab. OR (introduc$ adj2 trial?).ti,ab. OR (introduc$ adj2 case stud$).ti,ab.
OR (introduc$ adj2 clinical stud$).ti,ab. OR (introduc$ adj2 experimental therap$).ti,ab. OR (introduc$
adj2 RCT?).ti,ab. OR (introduc$ adj2 randomi?ed controlled trial?).ti,ab. OR (introduc$ adj4 clinical
trial?).ti,ab. OR (conduct$ adj2 research$).ti,ab. OR (conduct$ adj2 trial?).ti,ab. OR (conduct$ adj2 case
stud$).ti,ab. OR (conduct$ adj2 clinical stud$).ti,ab. OR (conduct$ adj2 experimental therap$).ti,ab. OR
(conduct$ adj2 RCT?).ti,ab. OR (conduct$ adj2 randomi?ed controlled trial?).ti,ab. OR (conduct$ adj4
clinical trial?).ti,ab. OR (learning organi?ation?).ti,ab. OR (research intensive organi?ation?).ti,ab. OR
(academic medical centre?).ti,ab. OR (academic medical center?).ti,ab. OR (academic health science© Queen's Printer and Controller of HMSO 2013. This work was produced by Hanney et al. under the terms of a commissioning contract issued by the Secretary of State for
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124centre?).ti,ab. OR (academic health science center?).ti,ab. OR (research network?).ti,ab. OR (research
collaboration?).ti,ab. OR (study hospital?).ti,ab. OR (teaching research facilities).ti,ab. OR (trial hospital?).
ti,ab. OR (veterans health administration).ti,ab. (67,083)
2. ((improve$).ti,ab. OR (inﬂuence$).ti,ab. OR (determine$).ti,ab. OR (affect$).ti,ab. OR (effect$).ti,ab. OR
(increase$).ti,ab. OR (decrease$).ti,ab. OR (declines$).ti,ab. OR (diminish$).ti,ab. OR (weake$).ti,ab. OR
(worse$).ti,ab. OR (beneﬁ$).ti,ab. OR (impact$).ti,ab. OR (better).ti,ab. OR (worse).ti,ab. OR (greater).ti,
ab. OR (lesser).ti,ab. OR (lower).ti,ab. OR (higher).ti,ab. OR (evaluat$).ti,ab. OR (compar$).ti,ab.) adj5
((performance).ti,ab. OR (patient$ adj4 outcome?).ti,ab. OR (process quality).ti,ab. OR (process
assessment?).ti,ab. OR (health care adj4 outcome?).ti,ab.OR (healthcare adj4 outcome?).ti,ab. OR
(clinical adj4 outcome?).ti,ab. OR (quality adj4 care).ti,ab. OR (compar$ adj4 outcome?).ti,ab. OR
(patient$ adj4 mortality).ti,ab. OR (routine adj clinical practice).ti,ab. OR (mortality adj4 outcome$).ti,ab.
OR (organi?ational process$).ti,ab. OR (organi?ational determinant$).ti,ab. OR (organi?ational
characteristic?).ti,ab. OR (organi?ational innovation?).ti,ab. OR (organi?ational culture).ti,ab. OR (organi?
ational support).ti,ab. OR (clinical adj2 care).ti,ab. OR (treatment outcome).ti,ab. OR (adhere$ adj4
guideline?).ti,ab. OR ("use$" adj4 guideline?).ti,ab. OR (clinical practi?e).ti,ab. OR (patient$
satisfaction).ti,ab.) (7,650,724)
3. (practice adj4 change?).ti,ab. OR (service adj4 change?).ti,ab. OR (organi?ational change?).ti,ab. OR
(treatment change?).ti,ab. OR (prescri$ change?).ti,ab. (713,416)
4. 2 OR 3 (10,879)
5. 1 AND 4 (4,804)NIHR Journals Library www.journalslibrary.nihr.ac.uk
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